121268-17-5 | sodium trihydrate hydrogen (4-amino-1-hydroxy-1-phosphonobutyl)phosphonate

Packsize	Purity	Availability	Price	Discounted Price
1g	98%	in stock	$8.00	$5.00
10g	98%	in stock	$13.00	$9.00
25g	98%	in stock	$19.00	$13.00
100g	98%	in stock	$66.00	$46.00

Description

• Catalog Number: AI13773
• Chemical Name: sodium trihydrate hydrogen (4-amino-1-hydroxy-1-phosphonobutyl)phosphonate
• CAS Number: 121268-17-5
• Molecular Formula: C4H18NNaO10P2
• Molecular Weight: 325.1237120000001
• MDL Number: MFCD20488817
• SMILES: NCCCC(P(=O)(O)O)(P(=O)(O)[O-])O.[Na+].O.O.O

Computed Properties

• Complexity: 293
• Covalently-Bonded Unit Count: 5
• Heavy Atom Count: 18
• Hydrogen Bond Acceptor Count: 11
• Hydrogen Bond Donor Count: 8
• Rotatable Bond Count: 5
• Undefined Atom Stereocenter Count: 1

Literature

• Demographic and clinico-pathological characteristics of breast cancer patients with history of oral alendronate use.

  Medical oncology (Northwood, London, England) 20121201

• Cost-effective intervention thresholds against osteoporotic fractures based on FRAX® in Switzerland.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20121101

• Reduced colon cancer incidence and mortality in postmenopausal women treated with an oral bisphosphonate--Danish National Register Based Cohort Study.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20121101

• Farnesyl diphosphate synthase, the target for nitrogen-containing bisphosphonate drugs, is a peroxisomal enzyme in the model system Dictyostelium discoideum.

  The Biochemical journal 20121101

• The effect of alendronate doped calcium phosphates on bone cells activity.

  Bone 20121101

• Upper gastrointestinal tract transit times of tablet and drinkable solution formulations of alendronate: a bioequivalence and a quantitative, randomized study using video deglutition.

  Calcified tissue international 20121101

• Transient osteoporosis of the hip, complete resolution after treatment with alendronate as observed by MRI description of eight cases and review of the literature.

  Clinical rheumatology 20121101

• In brief: effervescent alendronate.

  The Medical letter on drugs and therapeutics 20121015

• Local drug delivery of alendronate gel for the treatment of patients with chronic periodontitis with diabetes mellitus: a double-masked controlled clinical trial.

  Journal of periodontology 20121001

• Oncologic doses of zoledronic acid induce osteonecrosis of the jaw-like lesions in rice rats (Oryzomys palustris) with periodontitis.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20121001

• Alendronate coated poly-lactic-co-glycolic acid (PLGA) nanoparticles for active targeting of metastatic breast cancer.

  Biomaterials 20121001

• The comparative gastrointestinal tolerability of proprietary versus generic alendronate in patients treated for primary osteoporosis.

  Bone 20121001

• Quantification by energy dispersive x-ray spectroscopy of alendronate in the diseased jaw bone of patients with bisphosphonate-related jaw osteonecrosis.

  Oral surgery, oral medicine, oral pathology and oral radiology 20121001

• Treatment of spontaneous osteonecrosis of the knee (SPONK) by a bisphosphonate.

  Acta orthopaedica 20121001

• Cytostatic activity of a 5-fluoro-2'-deoxyuridine-alendronate conjugate against gastric adenocarcinoma and non-malignant intestinal and fibroblast cell lines.

  Anticancer research 20121001

• Atypical femoral fracture after long-term alendronate treatment: report of a case evidenced with magnetic resonance imaging.

  The Kaohsiung journal of medical sciences 20121001

• Alendronate-conjugated amphiphilic hyperbranched polymer based on Boltorn H40 and poly(ethylene glycol) for bone-targeted drug delivery.

  Bioconjugate chemistry 20120919

• Systematic study of the physicochemical properties of a homologous series of aminobisphosphonates.

  Molecules (Basel, Switzerland) 20120912

• Prevention of disuse osteoporosis in rats by Cordyceps sinensis extract.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20120901

• Three years of alendronate treatment does not continue to decrease microstructural stresses and strains associated with trabecular microdamage initiation beyond those at 1 year.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20120901

• Effect of alendronate on HIV-associated osteoporosis: a randomized, double-blind, placebo-controlled, 96-week trial (ANRS 120).

  AIDS research and human retroviruses 20120901

• Development of a novel self-dissolving microneedle array of alendronate, a nitrogen-containing bisphosphonate: evaluation of transdermal absorption, safety, and pharmacological effects after application in rats.

  Journal of pharmaceutical sciences 20120901

• Systemically alendronate was incorporated into dental tissues but did not cause morphological or mechanical changes in rats teeth.

  Microscopy research and technique 20120901

• Oral alendronate use and risk of cancer in postmenopausal women with osteoporosis: A nationwide study.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20120901

• Oral bisphosphonate-related osteonecrosis of the jaws: Clinical characteristics of a series of 20 cases in Spain.

  Medicina oral, patologia oral y cirugia bucal 20120901

• Efficacy of intravenously administered ibandronate in postmenopausal Korean women with insufficient response to orally administered bisphosphonates.

  Journal of bone and mineral metabolism 20120901

• The importance of a thorough medical and pharmacological history before dental implant placement.

  Australian dental journal 20120901

• Whole body vibration exercise improves body balance and walking velocity in postmenopausal osteoporotic women treated with alendronate: Galileo and Alendronate Intervention Trail (GAIT).

  Journal of musculoskeletal & neuronal interactions 20120901

• Bone loss after heart transplant: effect of alendronate, etidronate, calcitonin, and calcium plus vitamin D3.

  Progress in transplantation (Aliso Viejo, Calif.) 20120901

• Improved oral bioavailability of alendronate via the mucoadhesive liposomal delivery system.

  European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20120815

• Images in clinical medicine. Halitosis and sensory loss.

  The New England journal of medicine 20120809

• Cytotoxicity of the new antimetabolite-bisphosphonate (5-FdU-alendronate) in comparison to standard therapeutics on breast and ovarian cancer cell lines in the ATP tumor chemosensitivity assay.

  Investigational new drugs 20120801

• Bisphosphonates modulate the expression of OPG and M-CSF in hMSC-derived osteoblasts.

  Clinical oral investigations 20120801

• Regional bone metabolism at the lumbar spine and hip following discontinuation of alendronate and risedronate treatment in postmenopausal women.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20120801

• The association between automatic generic substitution and treatment persistence with oral bisphosphonates.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20120801

• Effect of alendronate for reducing fracture by FRAX score and femoral neck bone mineral density: the Fracture Intervention Trial.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20120801

• Modulation of gastric pH by a buffered soluble effervescent formulation: A possible means of improving gastric tolerability of alendronate.

  International journal of pharmaceutics 20120801

• Bisphosphonate-related osteonecrosis of the jaw in patients with oral bisphosphonate exposure: clinical course and outcomes.

  Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20120801

• Understanding the influence of alendronate on the morphology and phase transformation of apatitic precursor nanocrystals.

  Journal of inorganic biochemistry 20120801

• The effect of mandatory generic substitution on the safety of alendronate and patients' adherence.

  Current medical research and opinion 20120801

• A multicenter randomized double-masked comparative study of different preparations of alendronate in osteoporosis - monthly (four weeks) intravenous versus once weekly oral administrations.

  Current medical research and opinion 20120801

• Antiosteoporotic activity of Saururus chinensis extract in ovariectomized rats.

  Phytotherapy research : PTR 20120801

• Alendronate promotes plasmin-mediated MMP-9 inactivation by exposing cryptic plasmin degradation sites within the MMP-9 catalytic domain.

  FEBS letters 20120730

• Liposomal alendronate for the treatment of restenosis.

  Journal of controlled release : official journal of the Controlled Release Society 20120720

• Heterogeneity of biological bone markers in idiopathic male osteoporosis.

  Rheumatology international 20120701

• Post-menopausal women with rheumatoid arthritis who are treated with raloxifene or alendronate or glucocorticoids have lower serum undercarboxylated osteocalcin levels.

  Journal of endocrinological investigation 20120701

• Quality of life and health status with zoledronic acid and generic alendronate--a secondary analysis of the Rapid Onset and Sustained Efficacy (ROSE) study in postmenopausal women with low bone mass.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20120701

• Bisphosphonate-induced osteonecrosis of the jaw in a rat model arises first after the bone has become exposed. No primary necrosis in unexposed bone.

  Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 20120701

• Nephrotic syndrome after oral bisphosphonate (alendronate) administration in a patient with osteoporosis.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20120701

• Potential mechanism of alendronate inhibition of osteophyte formation in the rat model of post-traumatic osteoarthritis: evaluation of elemental strontium as a molecular tracer of bone formation.

  Osteoarthritis and cartilage 20120701

• Osteoclast abnormalities in fractured bone during bisphosphonate treatment for osteoporosis: a case report.

  Skeletal radiology 20120701

• Downregulation of the inflammatory response by CORM-3 results in protective effects in a model of postmenopausal arthritis.

  Calcified tissue international 20120701

• What is the role of hyperbaric oxygen in the management of bisphosphonate-related osteonecrosis of the jaw: a randomized controlled trial of hyperbaric oxygen as an adjunct to surgery and antibiotics.

  Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20120701

• A rare case of a bisphosphonate-induced peri-prosthetic femoral fracture.

  The Journal of bone and joint surgery. British volume 20120701

• Polyostotic Paget's disease.

  Journal of the College of Physicians and Surgeons--Pakistan : JCPSP 20120701

• Influence of social competence of physicians on patient compliance with osteoporosis medications--a study on Polish postmenopausal women.

  Ginekologia polska 20120701

• Application of alternative fixatives to formalin in diagnostic pathology.

  European journal of histochemistry : EJH 20120629

• Effect of alendronate on endochondral ossification in mandibular condyles of growing rats.

  European journal of histochemistry : EJH 20120629

• Combined treatment with a traditional Chinese medicine, Hachimi-jio-gan (Ba-Wei-Di-Huang-Wan) and alendronate improves bone microstructure in ovariectomized rats.

  Journal of ethnopharmacology 20120626

• The influence of alendronate on osseointegration of nanotreated dental implants in New Zealand rabbits.

  Clinical oral implants research 20120601

• Effects of alendronate on human osteoblast-like MG63 cells and matrix metalloproteinases.

  Archives of oral biology 20120601

• Bone density around endosseous implants in patients taking alendronate: a pilot study.

  The International journal of periodontics & restorative dentistry 20120601

• Pharmacodynamic responses to combined treatment regimens with the calcium sensing receptor antagonist JTT-305/MK-5442 and alendronate in osteopenic ovariectomized rats.

  Bone 20120601

• Inhibition of cathepsin K reduces cartilage degeneration in the anterior cruciate ligament transection rabbit and murine models of osteoarthritis.

  Bone 20120601

• [Concomitant treatment of the osteoporotic drugs].

  Clinical calcium 20120601

• [Long-term combined treatment with cinacalcet and bisphosphonates in persistent primary hyperparathyroidism after surgery].

  Medicina clinica 20120526

• Bisphosphonates in the treatment of osteoporosis.

  BMJ (Clinical research ed.) 20120522

• Efficacy of alendronate in the treatment of low bone density in the pediatric and young adult population.

  The Journal of bone and joint surgery. American volume 20120516

• Successful treatment of calcific uraemic arteriolopathy with bisphosphonates.

  Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20120514

• The effect of alendronate on the expression of osteopontin and osteoprotegerin in calcified aortic tissue of the rat.

  European journal of pharmacology 20120505

• Prospective comparison of the therapeutic effect of teriparatide with that of combined vertebroplasty with antiresorptive agents for the treatment of new-onset adjacent vertebral compression fracture after percutaneous vertebroplasty.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20120501

• Osteonecrosis of femoral head treated with alendronate in a 14-year-old boy: a case report.

  Journal of pediatric orthopedics. Part B 20120501

• Low-magnitude high-frequency loading via whole body vibration enhances bone-implant osseointegration in ovariectomized rats.

  Journal of orthopaedic research : official publication of the Orthopaedic Research Society 20120501

• Up-regulation of inhibitors of DNA binding/differentiation gene during alendronate-induced osteoblast differentiation.

  Archives of gynecology and obstetrics 20120501

• Alendronate in the prevention of collapse of the femoral head in nontraumatic osteonecrosis: a two-year multicenter, prospective, randomized, double-blind, placebo-controlled study.

  Arthritis and rheumatism 20120501

• 'Atypical femoral fractures' during bisphosphonate exposure in adult hypophosphatasia.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20120501

• Effects of alendronate and risedronate on bone material properties in actively forming trabecular bone surfaces.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20120501

• Combination therapy with eldecalcitol and alendronate has therapeutic advantages over monotherapy by improving bone strength.

  Bone 20120501

• Pregnancy associated osteoporosis--a case report.

  Ginekologia polska 20120501

• Awareness and education of patients receiving bisphosphonates.

  Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery 20120401

• Oral bisphosphonate use increases the risk for inflammatory jaw disease: a cohort study.

  Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20120401

• Oral ulcers, a little known adverse effect of alendronate: review of the literature.

  Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20120401

• Comparative evaluation of isosorbide mononitrate and alendronate in management of postmenopausal osteoporosis.

  Archives of gynecology and obstetrics 20120401

• Aspiration of alendronic acid leading to localized bronchiectasis.

  European journal of clinical pharmacology 20120401

• Glucocorticoid-induced osteonecrosis.

  Endocrine 20120401

• Bone micromechanical properties are compromised during long-term alendronate therapy independently of mineralization.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20120401

• Potential effects of alendronate on fibroblast growth factor 23 levels and effective control of hypercalciuria in an adult with Jansen's metaphyseal chondrodysplasia.

  The Journal of clinical endocrinology and metabolism 20120401

• Comparison of clinical efficacy and safety between denosumab and alendronate in postmenopausal women with osteoporosis: a meta-analysis.

  International journal of clinical practice 20120401

• Cutting edge: nitrogen bisphosphonate-induced inflammation is dependent upon mast cells and IL-1.

  Journal of immunology (Baltimore, Md. : 1950) 20120401

• The effectiveness of audiometric evaluation in drug treatment for otospongiosis.

  Brazilian journal of otorhinolaryngology 20120401

• Femoral canal obliteration secondary to prolonged alendronate use: a case report.

  Journal of orthopaedic surgery (Hong Kong) 20120401

• [Simultaneous determination of alendronate, pamidronate, ibandronate and risedronate using ion chromatography with integrated pulsed amperometric detection].

  Se pu = Chinese journal of chromatography 20120401

• Design and synthesis of novel bone-targeting dual-action pro-drugs for the treatment and reversal of osteoporosis.

  Bioorganic & medicinal chemistry 20120315

• Adherence to osteoporosis medications amongst Singaporean patients.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20120301

• An epidemiological study of alendronate-related osteonecrosis of the jaws. A case series from the south-east of Scotland with attention given to case definition and prevalence.

  Journal of bone and mineral metabolism 20120301

• Comparable outcomes in fracture reduction and bone properties with RANKL inhibition and alendronate treatment in a mouse model of osteogenesis imperfecta.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20120301

• Comparison of oral alendronate versus prednisolone in treatment of infants with vitamin D intoxication.

  Acta paediatrica (Oslo, Norway : 1992) 20120301

• Prevention of glucocorticoid-induced osteoporosis in immunobullous diseases with alendronate: a randomized, double-blind, placebo-controlled study.

  Archives of dermatology 20120301

• Esophageal and gastric cancer incidence and mortality in alendronate users.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20120301

• Femoral stress fractures associated with long-term bisphosphonate treatment.

  Clinical orthopaedics and related research 20120301

• Simulated resistance training, but not alendronate, increases cortical bone formation and suppresses sclerostin during disuse.

  Journal of applied physiology (Bethesda, Md. : 1985) 20120301

• Alendronate affects osteoblast functions by crosstalk through EphrinB1-EphB.

  Journal of dental research 20120301

• Changes in intracortical microporosities induced by pharmaceutical treatment of osteoporosis as detected by high resolution micro-CT.

  Bone 20120301

• Osteoclasts derived from patients with neurofibromatosis 1 (NF1) display insensitivity to bisphosphonates in vitro.

  Bone 20120301

• Influence of socioeconomic factors on the adherence of alendronate treatment in incident users in Norway.

  Pharmacoepidemiology and drug safety 20120301

• Analysis of alendronate in human urine and plasma by magnetic solid-phase extraction and capillary electrophoresis with fluorescence detection.

  Journal of separation science 20120301

• Clinical use of bone turnover markers to monitor pharmacologic fracture prevention therapy.

  Current osteoporosis reports 20120301

• Directing mesenchymal stem cells to bone to augment bone formation and increase bone mass.

  Nature medicine 20120301

• Long-term treatment of osteoporosis in postmenopausal women: a review from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation (IOF).

  Current medical research and opinion 20120301

• [Efficacy of teriparatide in treatment of glucocorticoid-induced osteoporosis].

  Clinical calcium 20120301

• Paget disease of bone - an update.

  Australian family physician 20120301

• Practice Gaps. Improving the care of our patients who are receiving glucocorticoid therapy.

  Archives of dermatology 20120301

• Role of connexin 43 in the mechanism of action of alendronate: dissociation of anti-apoptotic and proliferative signaling pathways.

  Archives of biochemistry and biophysics 20120215

• Immediate loading in mandible full-arch: pilot study in patients with osteoporosis in bisphosphonate therapy.

  The Journal of oral implantology 20120201

• Rapid Onset and Sustained Efficacy (ROSE) study: results of a randomised, multicentre trial comparing the effect of zoledronic acid or alendronate on bone metabolism in postmenopausal women with low bone mass.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20120201

• Bisphosphonate-related osteonecrosis of jaws in 3 osteoporotic patients with history of oral bisphosphonate use treated with single yearly zoledronic acid infusion.

  Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20120201

• Osteopenia in children with cerebral palsy can be treated with oral alendronate.

  Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 20120201

• Adiponectin and leptin serum levels in osteoporotic postmenopausal women treated with raloxifene or alendronate.

  Menopause (New York, N.Y.) 20120201

• Biomimetic coating of bisphosphonate incorporated CDHA on Ti6Al4V.

  Journal of materials science. Materials in medicine 20120201

• Three-year experience with alendronate treatment in postmenopausal osteoporotic Japanese women with or without renal dysfunction: a retrospective study.

  Drugs & aging 20120201

• Painful trigeminal neuropathy induced by oral bisphosphonate-related osteonecrosis of the jaw: a new etiology for the numb-chin syndrome.

  Quintessence international (Berlin, Germany : 1985) 20120201

• Vitamin D levels: its relationship to bone mineral density response and disease activity in premenopausal Malaysian systemic lupus erythematosus patients on corticosteroids.

  International journal of rheumatic diseases 20120201

• Efficacy of glucosamine alendronate alone & in combination with dihydroquercetin for treatment of osteoporosis in animal model.

  The Indian journal of medical research 20120201

• [Clinical application of alendronate for osteoporosis/osteopenia secondary to hyperthyroidism].

  Zhongguo gu shang = China journal of orthopaedics and traumatology 20120201

• [Clinical study of oral alendronate in the treatment of pediatric osteogenesis imperfecta].

  Zhonghua yi xue za zhi 20120131

• [Treatment with bisphosphonates as a possible cause of bilateral spontaneous atypical femoral fracture].

  Ugeskrift for laeger 20120109

• Alendronate and atrial fibrillation: a meta-analysis of randomized placebo-controlled clinical trials.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20120101

• Clinical efficacy of 1% alendronate gel as a local drug delivery system in the treatment of chronic periodontitis: a randomized, controlled clinical trial.

  Journal of periodontology 20120101

• Clinical efficacy of 1% alendronate gel in adjunct to mechanotherapy in the treatment of aggressive periodontitis: a randomized controlled clinical trial.

  Journal of periodontology 20120101

• Are the results of multiple drilling and alendronate for osteonecrosis of the femoral head better than those of multiple drilling? A pilot study.

  Joint, bone, spine : revue du rhumatisme 20120101

• The effect of long-term alendronate treatment on cortical thickness of the proximal femur.

  Clinical orthopaedics and related research 20120101

• Effects of strontium ranelate and alendronate on bone microstructure in women with osteoporosis. Results of a 2-year study.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20120101

• Persistence with osteoporosis medications among postmenopausal women in the UK General Practice Research Database.

  Menopause (New York, N.Y.) 20120101

• Reduction of urinary levels of N-telopeptide correlates with treatment compliance in women with postmenopausal osteoporosis receiving alendronate.

  Menopause (New York, N.Y.) 20120101

• Final results of the DAPS (Denosumab Adherence Preference Satisfaction) study: a 24-month, randomized, crossover comparison with alendronate in postmenopausal women.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20120101

• Association of laser phototherapy with PRP improves healing of bisphosphonate-related osteonecrosis of the jaws in cancer patients: a preliminary study.

  Oral oncology 20120101

• Trimethylsilyldiazomethane derivatization coupled with solid-phase extraction for the determination of alendronate in human plasma by LC-MS/MS.

  Analytical and bioanalytical chemistry 20120101

• The effect of zoledronate-hydroxyapatite nanocomposites on osteoclasts and osteoblast-like cells in vitro.

  Biomaterials 20120101

• Femoral strength in osteoporotic women treated with teriparatide or alendronate.

  Bone 20120101

• Alendronate liposomes for antitumor therapy: activation of γδ T cells and inhibition of tumor growth.

  Advances in experimental medicine and biology 20120101

• Weak effect of strontium on early implant fixation in rat tibia.

  Bone 20120101

• Acute myocardial infarction and atherosclerosis of the coronary arteries in patients treated with drugs against osteoporosis: calcium in the vessels and not the bones?

  Calcified tissue international 20120101

• Fluorescence imaging of osteoclasts using confocal microscopy.

  Methods in molecular biology (Clifton, N.J.) 20120101

• Clinical subtypes of depression are associated with specific metabolic parameters and circadian endocrine profiles in women: the power study.

  PloS one 20120101

• Denosumab for postmenopausal osteoporosis?

  Drug and therapeutics bulletin 20120101

• Evidence to inform decision makers in Thailand: a cost-effectiveness analysis of screening and treatment strategies for postmenopausal osteoporosis.

  Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20120101

• Administration of bisphosphonates for malignant hepatic tumor with hypercalcemia.

  Hepato-gastroenterology 20120101

• Cost-utility and budget impact analysis of primary prevention with alendronate of osteoporotic hip fractures in Catalonia.

  Reumatologia clinica 20120101

• Impact of generic alendronate cost on the cost-effectiveness of osteoporosis screening and treatment.

  PloS one 20120101

• Impregnation of bone chips with alendronate and cefazolin, combined with demineralized bone matrix: a bone chamber study in goats.

  BMC musculoskeletal disorders 20120101

• Femoral fractures in osteoporotic patients on bisphosphonates. A case report.

  Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 20120101

• Bone remodeling after administration of proton pump (H+/K+-ATPase) inhibitors and alendronate in ovariectomized rats.

  Acta poloniae pharmaceutica 20120101

• Pathophysiology and medical treatment of pain in fibrous dysplasia of bone.

  Orphanet journal of rare diseases 20120101

• Effect of methylprednisolone pulse therapy with and without alendronate on biochemical markers of bone turnover in patients with Graves' ophthalmopathy.

  Polskie Archiwum Medycyny Wewnetrznej 20120101

• The novel non-steroidal selective androgen receptor modulator S-101479 has additive effects with bisphosphonate, selective estrogen receptor modulator, and parathyroid hormone on the bones of osteoporotic female rats.

  Biological & pharmaceutical bulletin 20120101

• Proton pump (H+/K+-ATPase) inhibitors weaken the protective effect of alendronate on bone mechanical properties in estrogen-deficient rats.

  Pharmacological reports : PR 20120101

• [Headache case that responded to alendronate treatment in Paget's disease].

  Agri : Agri (Algoloji) Dernegi'nin Yayin organidir = The journal of the Turkish Society of Algology 20120101

• Bisphosphonates for osteoporosis in primary biliary cirrhosis.

  The Cochrane database of systematic reviews 20111207

• Bisphosphonate fractures as a cause of painful total hip arthroplasty.

  Orthopedics 20111206

• Enhancement of subchondral bone quality by alendronate administration for the reduction of cartilage degeneration in the early phase of experimental osteoarthritis.

  Clinical and experimental medicine 20111201

• Effects of one year daily teriparatide treatment on trabecular bone material properties in postmenopausal osteoporotic women previously treated with alendronate or risedronate.

  Bone 20111201

• Comparison of local and systemic alendronate on distraction osteogenesis.

  International journal of oral and maxillofacial surgery 20111201

• Current evidence for recommendation of surgery, medical treatment and vitamin D repletion in mild primary hyperparathyroidism.

  European journal of endocrinology 20111201

• Polarized osteoclasts put marks of tartrate-resistant acid phosphatase on dentin slices--a simple method for identifying polarized osteoclasts.

  Bone 20111201

• Change in undercarboxylated osteocalcin is associated with changes in body weight, fat mass, and adiponectin: parathyroid hormone (1-84) or alendronate therapy in postmenopausal women with osteoporosis (the PaTH study).

  The Journal of clinical endocrinology and metabolism 20111201

• Letter to the editor: the effect of long-term alendronate treatment on cortical thickness of the proximal femur.

  Clinical orthopaedics and related research 20111201

• Effect of rosiglitazone on bone quality in a rat model of insulin resistance and osteoporosis.

  Diabetes 20111201

• A prospective clinical trial for assessing the efficacy of a minimally invasive protocol in patients with bisphosphonate-associated osteonecrosis of the jaws.

  Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 20111201

• Atypical fracture of the ulna associated with alendronate use.

  Acta orthopaedica 20111201

• Prosthodontic treatment of a patient taking nitrogen-containing bisphosphonates to preserve the integrity of the epithelial attachment: a clinical report.

  The Journal of prosthetic dentistry 20111201

• Atypical femoral fractures in patients taking longterm alendronate.

  The Journal of rheumatology 20111201

• Development, reliability, and validity of a new Preference and Satisfaction Questionnaire.

  Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20111201

• Alendronate-associated ulnar and tibial fractures: a case report.

  Journal of orthopaedic surgery (Hong Kong) 20111201

• Alendronate and risk of esophageal cancer: a nationwide population-based study in Taiwan.

  Journal of the American Geriatrics Society 20111201

• Determination of alendronate in low volumes of plasma by column-switching high-performance liquid chromatography method and its application to pharmacokinetic studies in human plasma.

  Archives of pharmacal research 20111201

• Gastric ulcerogenic and healing impairment effects of risedronate, a nitrogen-containing bisphosphonate in rats. Comparison with alendronate and minodronate.

  Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 20111201

• Unusual subtrochanteric femoral insufficiency fractures associated with the prolonged use of alendronate and risedronate: a report of two cases.

  Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20111201

• Serum ionic fluoride concentrations are significantly decreased after treatment with alendronate in patients with osteoporosis.

  Clinica chimica acta; international journal of clinical chemistry 20111120

• Rare localizations of bone sarcoidosis: two case reports and review of the literature.

  Rheumatology international 20111101

• Should we routinely evaluate serum alkaline phosphatase levels in patients with gout?

  Rheumatology international 20111101

• Vertebral fracture risk and alendronate effects on osteoporosis assessed by a computed tomography-based nonlinear finite element method.

  Journal of bone and mineral metabolism 20111101

• rhBMP-2 not alendronate combined with HA-TCP biomaterial and distraction osteogenesis enhance bone formation.

  Archives of orthopaedic and trauma surgery 20111101

• Novel mineral contrast agent for magnetic resonance studies of bone implants grown on a chick chorioallantoic membrane.

  Magnetic resonance imaging 20111101

• Efficacy of different therapeutic regimens on hepatic osteodystrophy in chronic viral liver disease.

  European journal of gastroenterology & hepatology 20111101

• Hip and subtrochanteric or diaphyseal femoral fractures in alendronate users: a 10-year, nationwide retrospective cohort study in Taiwanese women.

  Clinical therapeutics 20111101

• Identifying multiple reports from the same study.

  Orthopedics 20111101

• Comparison of alendronate and pamidronate on bone loss in kidney transplant patients for the first 6 months of transplantation.

  Iranian journal of kidney diseases 20111101

• Discontinuation of unnecessary medications in older adults.

  The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists 20111101

• Persistence with biologic therapies in the Medicare coverage gap.

  The American journal of managed care 20111101

• Uncommon transient osteoporosis of pregnancy at multiple sites associated with cytomegalovirus infection: is there a link?

  The Israel Medical Association journal : IMAJ 20111101

• Biomimetic gelatin-octacalcium phosphate core-shell microspheres.

  Journal of colloid and interface science 20111015

• Alendronate is more effective than elcatonin in improving pain and quality of life in postmenopausal women with osteoporosis.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20111001

• Bioavailability of alendronate and vitamin D(3) in an alendronate/vitamin D(3) combination tablet.

  Journal of clinical pharmacology 20111001

• Ten-year follow-up of avascular necrosis of femoral head treated with alendronate for 3 years.

  The Journal of arthroplasty 20111001

• Chondroprotective effect of alendronate in a rabbit model of osteoarthritis.

  Journal of orthopaedic research : official publication of the Orthopaedic Research Society 20111001

• The effect of vitamin D receptor BsmI genotype on the response to osteoporosis treatment in postmenopausal women: a pilot study.

  The journal of obstetrics and gynaecology research 20111001

• Risk of newly diagnosed type 2 diabetes is reduced in users of alendronate.

  Calcified tissue international 20111001

• Prolonged bisphosphonate release after treatment in women with osteoporosis. Relationship with bone turnover.

  Bone 20111001

• Effect of alendronate on healing of extraction sockets and healing around implants.

  Oral diseases 20111001

• Binding affinity of surface functionalized gold nanoparticles to hydroxyapatite.

  Journal of biomedical materials research. Part A 20111001

• Modifications of bone material properties in postmenopausal osteoporotic women long-term treated with alendronate.

  European journal of endocrinology 20111001

• Changes in macrophage inhibitory factor correlate with changes in bone mineral density in glucocorticoid-treated patients with rheumatoid arthritis.

  Rheumatology (Oxford, England) 20111001

• Effects of pharmaceutical care on adherence and persistence to bisphosphonates in postmenopausal osteoporotic women.

  Journal of clinical pharmacy and therapeutics 20111001

• Analysis of the comparative effectiveness of 3 oral bisphosphonates in a large managed care organization: adherence, fracture rates, and all-cause cost.

  Journal of managed care pharmacy : JMCP 20111001

• [New therapy using bisphosphonate for urolithiasis].

  Clinical calcium 20111001

• Bioavailability and short-term tolerability of alendronate in glucocorticoid-treated children.

  Clinical therapeutics 20111001

• [Inflammation of the jaws during treatment with bisphosphonates].

  Deutsche medizinische Wochenschrift (1946) 20111001

• Atypical femoral fractures and bone turnover.

  The New England journal of medicine 20110929

• Effect of heparin and alendronate coating on titanium surfaces on inhibition of osteoclast and enhancement of osteoblast function.

  Biochemical and biophysical research communications 20110923

• [Alendronate and resorptive hypercalciuria].

  Medicina clinica 20110917

• Differential expression of cxcl-14 during eruptive movement of rat molar germs.

  Journal of experimental zoology. Part B, Molecular and developmental evolution 20110915

• Drug intercalation in layered double hydroxide clay: application in the development of a nanocomposite film for guided tissue regeneration.

  International journal of pharmaceutics 20110915

• Application of accelerator mass spectrometry to macromolecules: preclinical pharmacokinetic studies on a polybisphosphonate.

  Rapid communications in mass spectrometry : RCM 20110915

• Cancellous bone formation response to simulated resistance training during disuse is blunted by concurrent alendronate treatment.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20110901

• Development of polyethylene glycol-conjugated alendronate, a novel nitrogen-containing bisphosphonate derivative: evaluation of absorption, safety, and effects after intrapulmonary administration in rats.

  Journal of pharmaceutical sciences 20110901

• Efficacy of serotonin inhibition in mouse models of bone loss.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20110901

• Defect in mevalonate pathway induces pyroptosis in Raw 264.7 murine monocytes.

  Apoptosis : an international journal on programmed cell death 20110901

• Gastrointestinal tolerability and patterns of switching in patients treated for primary osteoporosis: the Swedish Adherence Register Analysis (SARA).

  Calcified tissue international 20110901

• Increased bone formation and bone mass induced by sclerostin antibody is not affected by pretreatment or cotreatment with alendronate in osteopenic, ovariectomized rats.

  Endocrinology 20110901

• The effect of alendronate sodium on human erythrocytes.

  Environmental toxicology and pharmacology 20110901

• Alendronate and raloxifene use related to cardiovascular diseases: differentiation by different dosing regimens of alendronate.

  Clinical therapeutics 20110901

• What is the optimal duration of bisphosphonate therapy?

  Cleveland Clinic journal of medicine 20110901

• Efficacy and safety of monthly 150 mg oral ibandronate in women with postmenopausal osteoporosis: a systematic review and meta-analysis of randomized controlled trials.

  The Korean journal of internal medicine 20110901

• The influence of alendronate on spine fusion in an osteoporotic animal model.

  Spine 20110815

• Small interfering RNA knocks down the molecular target of alendronate, farnesyl pyrophosphate synthase, in osteoclast and osteoblast cultures.

  Molecular pharmaceutics 20110801

• Role of prostaglandin pathway and alendronate-based carriers to enhance statin-induced bone.

  Molecular pharmaceutics 20110801

• Effect of alendronate and vitamin D₃ on fractional calcium absorption in a double-blind, randomized, placebo-controlled trial in postmenopausal osteoporotic women.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20110801

• The bone architecture is enhanced with combined PTH and alendronate treatment compared to monotherapy while maintaining the state of surface mineralization in the OVX rat.

  Bone 20110801

• Three-year experience with alendronate treatment in postmenopausal osteoporotic Japanese women with or without type 2 diabetes.

  Diabetes research and clinical practice 20110801

• Antiangiogenic antitumor activity of HPMA copolymer-paclitaxel-alendronate conjugate on breast cancer bone metastasis mouse model.

  Molecular pharmaceutics 20110801

• The effects of ronacaleret, a calcium-sensing receptor antagonist, on bone mineral density and biochemical markers of bone turnover in postmenopausal women with low bone mineral density.

  The Journal of clinical endocrinology and metabolism 20110801

• Fourier transform infrared imaging analysis of cancellous bone in alendronate- and raloxifene-treated osteopenic sheep.

  Cells, tissues, organs 20110801

• Dendritic poly(ethylene glycol) bearing paclitaxel and alendronate for targeting bone neoplasms.

  Molecular pharmaceutics 20110801

• [Does application time of alendronate sodium effect the spinal fusion in ovariectomized rats?].

  Eklem hastaliklari ve cerrahisi = Joint diseases & related surgery 20110801

• Dental sinus tracts mimicking scrofuloderma: cutaneous presentation of underlying bisphosphonate-related osteonecrosis of the jaw.

  Clinical and experimental dermatology 20110801

• Denosumab: an update.

  Drugs of today (Barcelona, Spain : 1998) 20110801

• Bisphosphonate-induced osteonecrosis of the jaw.

  The Journal of the Association of Physicians of India 20110801

• Bilateral pathologic hip fractures associated with antiretroviral therapy: a case report.

  The Journal of bone and joint surgery. American volume 20110720

• Low concentrations of alendronate increase the local invasive potential of osteoblastic sarcoma cell lines via connexin 43 activation.

  Pathology, research and practice 20110715

• A comparison of the effects of alendronate and alfacalcidol on bone mineral density around the femoral implant and in the lumbar spine after total hip arthroplasty.

  The Journal of bone and joint surgery. American volume 20110706

• Non-traumatic fracture of the femoral shaft in a patient taking long-term bisphosphonate therapy.

  Rheumatology international 20110701

• Greater magnitude of turnover suppression occurs earlier after treatment initiation with risedronate than alendronate.

  Bone 20110701

• Hip structure analysis of bisphosphonate-treated Japanese postmenopausal women with osteoporosis.

  Journal of bone and mineral metabolism 20110701

• Femoral shaft fractures in the elderly--role of prior bisphosphonate therapy.

  Injury 20110701

• Enhanced anti-tumor activity and safety profile of targeted nano-scaled HPMA copolymer-alendronate-TNP-470 conjugate in the treatment of bone malignances.

  Biomaterials 20110701

• The farnesyltransferase inhibitors tipifarnib and lonafarnib inhibit cytokines secretion in a cellular model of mevalonate kinase deficiency.

  Pediatric research 20110701

• Alendronate adherence and its impact on hip-fracture risk in patients with established osteoporosis in Taiwan.

  Clinical pharmacology and therapeutics 20110701

• Osteoporosis: yesterday, today and tomorrow.

  Rheumatology (Oxford, England) 20110701

• Alendronate induced femur fracture complicated with secondary hyperparathyroidism.

  Mymensingh medical journal : MMJ 20110701

• [Resistant ovary syndrome. Case report].

  Ginecologia y obstetricia de Mexico 20110701

• Formulation and in vivo evaluation of sodium alendronate spray-dried microparticles intended for lung delivery.

  Journal of controlled release : official journal of the Controlled Release Society 20110630

• Proton pump inhibitor use and the antifracture efficacy of alendronate.

  Archives of internal medicine 20110613

• Opportunities to decrease inappropriate uses of proton pump inhibitors: Comment on 'Proton pump inhibitor use and the antifracture efficacy of alendronate'.

  Archives of internal medicine 20110613

• Inverse association between duration of use of acid-suppressive medications and fracture risk.

  Archives of internal medicine 20110613

• A multimodal magnetic resonance imaging nanoplatform for cancer theranostics.

  Physical chemistry chemical physics : PCCP 20110607

• Adherence, preference, and satisfaction of postmenopausal women taking denosumab or alendronate.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20110601

• Effects of raloxifene and alendronate on bone turnover as assessed by procollagen type I N-terminal propeptide.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20110601

• Comparison of alendronate and raloxifene in postmenopausal women with osteoporosis.

  Climacteric : the journal of the International Menopause Society 20110601

• Teriparatide, vitamin D, and calcium healed bilateral subtrochanteric stress fractures in a postmenopausal woman with a 13-year history of continuous alendronate therapy.

  The Journal of clinical endocrinology and metabolism 20110601

• Cinacalcet hydrochloride in combination with alendronate normalizes hypercalcemia and improves bone mineral density in patients with primary hyperparathyroidism.

  Endocrine 20110601

• Synthesis and in vivo bioactivity of lipophilic alendronate derivatives against osteoporosis.

  Drug development and industrial pharmacy 20110601

• Bisphosphonate-related subtrochanteric femoral fractures.

  The American journal of geriatric pharmacotherapy 20110601

• Randomized trial of alendronate plus vitamin D3 versus standard care in osteoporotic postmenopausal women with vitamin D insufficiency.

  Calcified tissue international 20110601

• N⁴-[Alkyl-(hydroxyphosphono)phosphonate]-cytidine-new drugs covalently linking antimetabolites (5-FdU, araU or AZT) with bone-targeting bisphosphonates (alendronate or pamidronate).

  Bioorganic & medicinal chemistry 20110601

• Effects of alendronate plus alfacalcidol in osteoporosis patients with a high risk of fracture: the Japanese Osteoporosis Intervention Trial (JOINT) - 02.

  Current medical research and opinion 20110601

• Bisphosphonate-associated atypical fracture of the femur: Spontaneous healing with drug holiday and re-appearance after resumed drug therapy with bilateral simultaneous displaced fractures--a case report.

  Acta orthopaedica 20110601

• Denosumab. Limited efficacy in fracture prevention, too many adverse effects.

  Prescrire international 20110601

• Esophageal stenosis caused by alendronate.

  Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva 20110601

• [Effect of alendronate sodium on torque-out testing on implant-bone interfaces in estrogen-deficient rabbits with alendronate systemic administration].

  Hua xi kou qiang yi xue za zhi = Huaxi kouqiang yixue zazhi = West China journal of stomatology 20110601

• The effects of discontinuing long term alendronate therapy in a clinical practice setting.

  Arquivos brasileiros de endocrinologia e metabologia 20110601

• Effects of amines on percutaneous absorption of alendronate.

  Drug development and industrial pharmacy 20110501

• A case of esophageal ulcer caused by alendronate sodium tablets.

  Gastrointestinal endoscopy 20110501

• Vitamin D status and response to daily 400 IU vitamin D3 and weekly alendronate 70 mg in men and women with osteoporosis.

  The Annals of pharmacotherapy 20110501

• Incurred sample accuracy assessment: design of experiments based on standard addition.

  Bioanalysis 20110501

• Metastatic malignant melanoma and dermatomyositis: A paraneoplastic phenomenon.

  The Australasian journal of dermatology 20110501

• Esophageal stricture associated with alendronate use.

  CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20110419

• Fluorimetric quantification of clodronate and alendronate in aqueous samples and in serum.

  Talanta 20110415

• A systematic review assessing the effectiveness of alendronate in reducing periprosthetic bone loss after cementless primary THA.

  Orthopedics 20110411

• Stroke in relation to use of raloxifene and other drugs against osteoporosis.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20110401

• The relationship between bisphosphonate adherence and fracture: is it the behavior or the medication? Results from the placebo arm of the fracture intervention trial.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20110401

• 'PROFOX'--the post HRT nightmare.

  Climacteric : the journal of the International Menopause Society 20110401

• Does alendronate disturb the healing process of posterior lumbar interbody fusion? A prospective randomized trial.

  Journal of neurosurgery. Spine 20110401

• Alendronate and fusion.

  Journal of neurosurgery. Spine 20110401

• Osteoporosis medication and reduced mortality risk in elderly women and men.

  The Journal of clinical endocrinology and metabolism 20110401

• The effect of SLActive surface in guided bone formation in osteoporotic-like conditions.

  Clinical oral implants research 20110401

• Reduced osteoclastogenesis and RANKL expression in marrow from women taking alendronate.

  Calcified tissue international 20110401

• Effects of the systemic administration of alendronate on bone formation in a porous hydroxyapatite/collagen composite and resorption by osteoclasts in a bone defect model in rabbits.

  The Journal of bone and joint surgery. British volume 20110401

• Alendronate-associated femoral insufficiency fractures and femoral stress reactions.

  Journal of orthopaedic surgery (Hong Kong) 20110401

• 99mTc(CO)3-labeled pamidronate and alendronate for bone imaging.

  Dalton transactions (Cambridge, England : 2003) 20110328

• [Application of guidelines for secondary prevention of fracture and the FRAX index in patients with fragility fracture].

  Medicina clinica 20110319

• Teriparatide therapy for osteonecrosis of the jaw.

  The New England journal of medicine 20110317

• Efficacy, side effects and route of administration are more important than frequency of dosing of anti-osteoporosis treatments in determining patient adherence: a critical review of published articles from 1970 to 2009.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20110301

• Cost-effectiveness of Denosumab for the treatment of postmenopausal osteoporosis.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20110301

• The effect of oestrogen and alendronate therapies on postmenopausal bone loss around osseointegrated titanium implants.

  Clinical oral implants research 20110301

• Longitudinal evaluation of the effects of alendronate on MRI bone microarchitecture in postmenopausal osteopenic women.

  Bone 20110301

• Protein isoprenylation regulates osteogenic differentiation of mesenchymal stem cells: effect of alendronate, and farnesyl and geranylgeranyl transferase inhibitors.

  British journal of pharmacology 20110301

• Effect of oral phosphate and alendronate on bone mineral density when given as adjunctive therapy to growth hormone replacement in adult growth hormone deficiency.

  The Journal of clinical endocrinology and metabolism 20110301

• Synthesis, characterization and osteoconductivity properties of bone fillers based on alendronate-loaded poly(ε-caprolactone)/hydroxyapatite microspheres.

  Journal of materials science. Materials in medicine 20110301

• Additive impact of alfacalcidol on bone mineral density and bone strength in alendronate treated postmenopausal women with reduced bone mass.

  Journal of musculoskeletal & neuronal interactions 20110301

• Secondary prophylaxis of osteoporotic fractures in an orthogeriatric service.

  Australasian journal on ageing 20110301

• Effect of alendronate on early bone loss of renal transplant recipients.

  Transplantation proceedings 20110301

• Alendronate therapy in polyostotic fibrous dysplasia presenting with pathologic fracture.

  American journal of orthopedics (Belle Mead, N.J.) 20110301

• Positively-charged microemulsion for improving the oral bioavailability of alendronate: in-vitro and in-vivo assessment.

  The Journal of pharmacy and pharmacology 20110301

• Osteonecrosis of the jaw and the role of macrophages.

  Journal of the National Cancer Institute 20110202

• Intravenous zoledronic acid and oral alendronate in patients with a low trauma fracture: experience from an osteoporosis clinic.

  Internal medicine journal 20110201

• [Incidence of hip fractures due to osteoporosis in relation to the prescription of drugs for their prevention and treatment in Galicia, Spain].

  Atencion primaria 20110201

• Alendronate regulates cytokine production induced by lipid A through nuclear factor-κB and Smad3 activation in human gingival fibroblasts.

  Journal of periodontal research 20110201

• Effects of the combination treatment of raloxifene and alendronate on the biomechanical properties of vertebral bone.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20110201

• Effect of bisphosphonates on human gingival fibroblast production of mediators of osteoclastogenesis: RANKL, osteoprotegerin and interleukin-6.

  Journal of periodontal research 20110201

• Demineralization removes residual alendronate in allograft bone procured from donors with a history of bisphosphonate use.

  Journal of periodontology 20110201

• Cathepsin K inhibitors prevent bone loss in estrogen-deficient rabbits.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20110201

• Association between bisphosphonates and jaw osteonecrosis: a study in Wistar rats.

  Head & neck 20110201

• Breast cancer cells inhibit spontaneous and bisphosphonate-induced osteoclast apoptosis.

  Bone 20110201

• The societal burden of poor persistence to treatment of osteoporosis in Sweden.

  Bone 20110201

• Investigation of alendronate-doped apatitic cements as a potential technology for the prevention of osteoporotic hip fractures: critical influence of the drug introduction mode on the in vitro cement properties.

  Acta biomaterialia 20110201

• Targeting RANKL for reduction of bone loss around unstable implants: OPG-Fc compared to alendronate in a model for mechanically induced loosening.

  Bone 20110201

• Use of bisphosphonates to treat severe idiopathic hypercalcaemia in a young Ragdoll cat.

  Journal of feline medicine and surgery 20110201

• Alendronate for the treatment of pediatric osteogenesis imperfecta: a randomized placebo-controlled study.

  The Journal of clinical endocrinology and metabolism 20110201

• Diaphyseal femoral fatigue fracture associated with bisphosphonate therapy - 3 more cases.

  Acta orthopaedica 20110201

• Effect of denosumab on bone mineral density and biochemical markers of bone turnover: six-year results of a phase 2 clinical trial.

  The Journal of clinical endocrinology and metabolism 20110201

• [Alendronate treatment of osteoporosis secondary to Duchenne muscular dystrophy].

  Anales de pediatria (Barcelona, Spain : 2003) 20110201

• Zenker's diverticulitis secondary to alendronate ingestion: a rare cause of recurrent dysphagia.

  Gastrointestinal endoscopy 20110201

• Evaluation of bone remodelling parameters after one year treatment with alendronate in postmenopausal women with osteoporosis.

  Bosnian journal of basic medical sciences 20110201

• Atypical femoral fractures: a complication of prolonged bisphosphonate therapy?

  The Medical journal of Australia 20110117

• Alendronate and raloxifene affect the osteoprotegerin/RANKL system in human osteoblast primary cultures from patients with osteoporosis and osteoarthritis.

  European journal of pharmacology 20110115

• Metabolic bone disease: atypical femoral fractures.

  Journal of biomechanics 20110111

• Comparison of the effects of alendronate sodium and calcitonin on bone-prosthesis osseointegration in osteoporotic rats.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20110101

• Pathological fracture due to vertebral osteonecrosis associated with pancreatitis.

  Archives of orthopaedic and trauma surgery 20110101

• The cost effectiveness of a randomized controlled trial to establish the relative efficacy of vitamin K1 compared with alendronate.

  Medical decision making : an international journal of the Society for Medical Decision Making 20110101

• Unusual case of a conservatively treated pathological fracture after sequestrectomy in a patient with long-term oral bisphosphonate use.

  Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery 20110101

• Design of a pragmatic approach to evaluate the effectiveness of concurrent treatment for the prevention of osteoporotic fractures: rationale, aims and organization of a Japanese Osteoporosis Intervention Trial (JOINT) initiated by the Research Group of Adequate Treatment of Osteoporosis (A-TOP).

  Journal of bone and mineral metabolism 20110101

• Alendronate-loaded microparticles for improvement of intestinal cellular absorption.

  Journal of drug targeting 20110101

• An open-label trial comparing alendronate and alphacalcidol in reducing falls and hip fractures in disabled stroke patients.

  Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 20110101

• Comparison between nuclear magnetic resonance profiling and the source/sink approach for characterizing drug diffusion in hydrogel matrices.

  Pharmaceutical development and technology 20110101

• Retrospective study of two biochemical markers for the risk assessment of oral bisphosphonate-related osteonecrosis of the jaws: can they be utilized as risk markers?

  Clinical oral implants research 20110101

• Consistency of bone turnover marker and calcium responses to parathyroid hormone (1-84) therapy in postmenopausal osteoporosis.

  Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 20110101

• Denosumab: a review of its use in the treatment of postmenopausal osteoporosis.

  Drugs & aging 20110101

• [Measurement of bone mineral density is necessary for monitoring of bisphosphonate treatment].

  Clinical calcium 20110101

• Multicentric reticulohistiocytosis with dermatomyositis-like features: a more common disease presentation than previously thought.

  Dermatology (Basel, Switzerland) 20110101

• Ineffectiveness of tumor necrosis factor-alpha inhibition in association with bisphosphonates for the treatment of cherubism.

  Clinical and experimental rheumatology 20110101

• [Effect of alendronate on interleukin-1beta induced chondrocytes of rat in vitro].

  Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery 20110101

• Risk reduction of falls and fractures, reduction of back pain and safety in elderly high risk patients receiving combined therapy with alfacalcidol and alendronate: a prospective study.

  Arzneimittel-Forschung 20110101

• Switching from one generic alendronate to another--a common procedure in Poland in the years 2001-2005.

  Endokrynologia Polska 20110101

• Alendronate 70 therapy in elderly women with post-menopausal osteoporosis: the problem of compliance.

  Endokrynologia Polska 20110101

• Current indications for prevention and therapy of steroid-iduced osteoporosis in men and women.

  Endokrynologia Polska 20110101

• Atypical subtrochanteric fractures after long-term bisphosphonate therapy.

  Endokrynologia Polska 20110101

• Osteonecrosis of the jaw.

  Endokrynologia Polska 20110101

• Bisphosphonates and the risk of atrial fibrillation.

  Endokrynologia Polska 20110101

• Potency of a combined alfacalcidol-alendronate therapy to reduce the risk of falls and fractures in elderly patients with glucocorticoid-induced osteoporosis.

  Arzneimittel-Forschung 20110101

• Prominent bone loss mediated by RANKL and IL-17 produced by CD4+ T cells in TallyHo/JngJ mice.

  PloS one 20110101

• Oral bisphosphonate-related osteonecrosis of the jaws in rheumatoid arthritis patients: a critical discussion and two case reports.

  Head & face medicine 20110101

• [Influence of mineral water on absorption of oral alendronate in rats].

  Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20110101

• Fracture prevention in postmenopausal women.

  BMJ clinical evidence 20110101

• Gastric ulcerogenic and healing impairment actions of alendronate, a nitrogen-containing bisphosphonate - prophylactic effects of rebamipide.

  Current pharmaceutical design 20110101

• The safety and efficacy of early-stage bi-weekly alendronate to improve bone mineral density and bone turnover in chinese post-menopausal women at risk of osteoporosis.

  The Journal of international medical research 20110101

• A preliminary study on the morphological and release properties of hydroxyapatite-alendronate composite materials.

  Journal of microencapsulation 20110101

• Alendronate (ALN) combined with osteoprotegerin (OPG) significantly improves mechanical properties of long bone than the single use of ALN or OPG in the ovariectomized rats.

  Journal of orthopaedic surgery and research 20110101

• Teriparatide vs. alendronate as a treatment for osteoporosis: changes in biochemical markers of bone turnover, BMD and quality of life.

  Medical science monitor : international medical journal of experimental and clinical research 20110101

• [Effect of alendronate on bone tissue status of senescence-accelerated OXYS rats].

  Advances in gerontology = Uspekhi gerontologii 20110101

• Massive osteolysis in a dog resembling Gorham's disease in humans.

  Veterinary and comparative orthopaedics and traumatology : V.C.O.T 20110101

• Evaluation of the relative efficacy of an alloplast used alone and in conjunction with an osteoclast inhibitor in the treatment of human periodontal infrabony defects: a clinical and radiological study.

  Indian journal of dental research : official publication of Indian Society for Dental Research 20110101

• Multiple miliary osteoma cutis of the face after initiation of alendronate therapy for osteoporosis.

  Skinmed 20110101

• Going on a drug holiday?

  Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 20110101

• Atypical fractures on long term bisphosphonates therapy.

  Irish medical journal 20110101

• Adherence to bisphosphonate therapy in postmenopausal osteoporotic women.

  Folia medica 20110101

• Combined treatment of alendronate and low-intensity pulsed ultrasound (LIPUS) increases bone mineral density at the cancellous bone osteotomy site in aged rats: a preliminary study.

  JNMA; journal of the Nepal Medical Association 20110101

• Teriparatide for bone loss in the jaw.

  The New England journal of medicine 20101216

• Teriparatide therapy for alendronate-associated osteonecrosis of the jaw.

  The New England journal of medicine 20101216

• Differential effects of alendronate and losartan therapy on osteopenia and aortic aneurysm in mice with severe Marfan syndrome.

  Human molecular genetics 20101215

• The synthesis of a multiblock osteotropic polyrotaxane by copper(I)-catalyzed huisgen 1,3-dipolar cycloaddition.

  Macromolecular bioscience 20101208

• [Osteoporosis. Improving bone and muscle performance].

  MMW Fortschritte der Medizin 20101202

• Effects of bisphosphonate administration on the bone mass in immune thrombocytopenic purpura patients under treatment with steroids.

  Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 20101201

• Histomorphometric changes by teriparatide in alendronate-pretreated women with osteoporosis.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20101201

• Possible beneficial effect of bisphosphonates in osteonecrosis of the knee.

  Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA 20101201

• Comment on Xue et al.: Alendronate treatment improves bone-pedicle screw interface fixation in posterior lateral spine fusion: an experimental study in a porcine model.

  International orthopaedics 20101201

• Development of a novel transdermal patch of alendronate, a nitrogen-containing bisphosphonate, for the treatment of osteoporosis.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20101201

• A longitudinal HR-pQCT study of alendronate treatment in postmenopausal women with low bone density: Relations among density, cortical and trabecular microarchitecture, biomechanics, and bone turnover.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20101201

• Oral ulcer associated with alendronate: a case report.

  Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 20101201

• Chronic inhibition of farnesyl pyrophosphate synthase improves endothelial function in spontaneously hypertensive rats.

  Biochemical pharmacology 20101201

• Route of administration-dependent anti-inflammatory effect of liposomal alendronate.

  Journal of controlled release : official journal of the Controlled Release Society 20101201

• Cumulative alendronate dose and the long-term absolute risk of subtrochanteric and diaphyseal femur fractures: a register-based national cohort analysis.

  The Journal of clinical endocrinology and metabolism 20101201

• Bone morphology in response to alendronate as seen by high-resolution computed tomography: Through a glass darkly.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20101201

• The effects of topical application of bisphosphonates on replanted rat molars.

  Dental traumatology : official publication of International Association for Dental Traumatology 20101201

• Response of postpoliomyelitis patients to bisphosphonate treatment.

  PM & R : the journal of injury, function, and rehabilitation 20101201

• Outcome of patients with early breast cancer receiving nitrogen-containing bisphosphonates: a comparative analysis from the Metropolitan Detroit Cancer Surveillance System.

  Clinical breast cancer 20101201

• [Prosthetic rehabilitation after osteonecrosis of the jaws due to histiocytosis X and treatment with bisphosphonates apropos of a case].

  Odonto-stomatologie tropicale = Tropical dental journal 20101201

• Pro-IL-1β accumulation in macrophages by alendronate and its prevention by clodronate.

  Toxicology letters 20101130

• Absorption and safety of alendronate, a nitrogen-containing bisphosphonate, after intrapulmonary administration in rats.

  International journal of pharmaceutics 20101115

• Stem cells and osteoporosis therapy.

  Cell stem cell 20101105

• Inhibition of Sca-1-positive skeletal stem cell recruitment by alendronate blunts the anabolic effects of parathyroid hormone on bone remodeling.

  Cell stem cell 20101105

• Alendronate induces mineralization in mouse osteoblastic MC3T3-E1 cells: regulation of mineralization-related genes.

  Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 20101101

• Pathological mandibular fracture after simple molar extraction in a patient with osteogenesis imperfecta treated with alendronate.

  Medicina oral, patologia oral y cirugia bucal 20101101

• Bone-targeted doxorubicin-loaded nanoparticles as a tool for the treatment of skeletal metastases.

  Current cancer drug targets 20101101

• Effects of 1 year of daily teriparatide treatment on iliacal bone mineralization density distribution (BMDD) in postmenopausal osteoporotic women previously treated with alendronate or risedronate.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20101101

• The effect of the local delivery of alendronate on human adipose-derived stem cell-based bone regeneration.

  Biomaterials 20101101

• Nonexposed variant of bisphosphonate-associated osteonecrosis of the jaw: a case series.

  The American journal of medicine 20101101

• Biocompatibility of alendronate-loaded acrylic cement for vertebroplasty.

  European cells & materials 20101005

• Alendronate reduces osteoclast precursors in osteoporosis.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20101001

• Efficacy and safety of a once-yearly i.v. Infusion of zoledronic acid 5 mg versus a once-weekly 70-mg oral alendronate in the treatment of male osteoporosis: a randomized, multicenter, double-blind, active-controlled study.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20101001

• In situ fabrication of alendronate-loaded calcium phosphate microspheres: controlled release for inhibition of osteoclastogenesis.

  Journal of controlled release : official journal of the Controlled Release Society 20101001

• Functionalization of biomimetic calcium phosphate bone cements with alendronate.

  Journal of inorganic biochemistry 20101001

• Validity of prevention of glucocorticoid-induced alveolar bone loss in rat by either calcitonin or alendronate administration.

  Archives of oral biology 20101001

• Risk of upper gastrointestinal tract events in risedronate users switched to alendronate.

  Calcified tissue international 20101001

• Skeletal integrity and visceral transplantation.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20101001

• Effects of alendronate on bone healing after tooth extraction in rats.

  Oral diseases 20101001

• Boerhaave's syndrome - rapidly evolving pleural effusion; a radiographic clue.

  Minerva anestesiologica 20101001

• Ocular side effects of bisphosphonates: A case report and literature review.

  Canadian family physician Medecin de famille canadien 20101001

• [Biphosphonate treatment can cause stress fracture. But treatment benefits significantly overweight the risk].

  Lakartidningen 20101001

• Risk of atypical femoral fracture with long-term use of alendronate (bisphosphonates) : a systemic review of literature.

  Acta orthopaedica Belgica 20101001

• Bisphosphonates and atypical femoral fractures.

  The New England journal of medicine 20100909

• Bisphosphonates and atypical femoral fractures.

  The New England journal of medicine 20100909

• Are osteoclasts needed for the bone anabolic response to parathyroid hormone? A study of intermittent parathyroid hormone with denosumab or alendronate in knock-in mice expressing humanized RANKL.

  The Journal of biological chemistry 20100903

• Effect of alendronate on bone metabolic indices and bone mineral density in patients treated with high-dose glucocorticoid: a prospective study.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20100901

• Effect of alendronate on pseudomembrane cytokine expression in patients with aseptic osteolysis.

  The Journal of arthroplasty 20100901

• High level of serum undercarboxylated osteocalcin in patients with incident fractures during bisphosphonate treatment.

  Journal of bone and mineral metabolism 20100901

• In vivo microfocal computed tomography and micro-magnetic resonance imaging evaluation of antiresorptive and antiinflammatory drugs as preventive treatments of osteoarthritis in the rat.

  Arthritis and rheumatism 20100901

• Bisphosphonate protonation states, conformations, and dynamics on bone mineral probed by solid-state NMR without isotope enrichment.

  European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20100901

• Charcot's foot: newest findings on its pathophysiology, diagnosis and treatment.

  Diabetes & metabolism 20100901

• Intramural hematoma of the esophagus presenting as chest pain.

  Journal of hospital medicine 20100901

• Acute effects of intravenous administration of pamidronate in patients with osteoporosis.

  Journal of Korean medical science 20100901

• [Jaw osteonecrosis induced by oral biphosphonates: 12 cases].

  Revue de stomatologie et de chirurgie maxillo-faciale 20100901

• Gastroresistant microparticles containing sodium alendronate prevent the bone loss in ovariectomized rats.

  European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20100811

• Evaluation of a novel osteoporotic drug delivery system in vitro: alendronate-loaded calcium phosphate cement.

  Orthopedics 20100811

• The role of alendronate in mitigating perimenopausal bone loss: a double-blind randomized controlled pilot study.

  Fertility and sterility 20100801

• Sol-gel derived titania coating with immobilized bisphosphonate enhances screw fixation in rat tibia.

  Journal of biomedical materials research. Part A 20100801

• Microarchitectural deterioration of cortical and trabecular bone: differing effects of denosumab and alendronate.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20100801

• One year of alendronate treatment lowers microstructural stresses associated with trabecular microdamage initiation.

  Bone 20100801

• Low 24-hour adiponectin and high nocturnal leptin concentrations in a case-control study of community-dwelling premenopausal women with major depressive disorder: the Premenopausal, Osteopenia/Osteoporosis, Women, Alendronate, Depression (POWER) study.

  The Journal of clinical psychiatry 20100801

• Strontium ranelate and alendronate have differing effects on distal tibia bone microstructure in women with osteoporosis.

  Rheumatology international 20100801

• Histology of an undisplaced femoral fatigue fracture in association with bisphosphonate treatment. Frozen bone with remodelling at the crack.

  Acta orthopaedica 20100801

• Bone mineral density and fracture rate in response to intravenous and oral bisphosphonates in adult osteogenesis imperfecta.

  Calcified tissue international 20100801

• Bisphosphonate inhibits bone turnover in OPG(-/-) mice via a depressive effect on both osteoclasts and osteoblasts.

  Calcified tissue international 20100801

• Oral bisphosphonate use and breast cancer incidence in postmenopausal women.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100801

• Parathyroid hormone and bisphosphonate have opposite effects on stress fracture repair.

  Bone 20100801

• The influence of alendronate on the healing of extraction sockets of ovariectomized rats assessed by in vivo micro-computed tomography.

  Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 20100801

• Osteoporosis and venous thromboembolism: a retrospective cohort study in the UK General Practice Research Database.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20100701

• Case reports: subtrochanteric femoral stress fractures after prolonged alendronate therapy.

  Clinical orthopaedics and related research 20100701

• The effects of local and systemic alendronate delivery on wear debris-induced osteolysis in vivo.

  Journal of orthopaedic research : official publication of the Orthopaedic Research Society 20100701

• Effects of combination treatment with alendronate and vitamin K(2) on bone mineral density and strength in ovariectomized mice.

  Journal of bone and mineral metabolism 20100701

• Use of bisphosphonates for the treatment of osteonecrosis as a complication of therapy for childhood acute lymphoblastic leukaemia (ALL).

  Pediatric blood & cancer 20100701

• The inhibition of mevalonate pathway induces upregulation of NALP3 expression: new insight in the pathogenesis of mevalonate kinase deficiency.

  European journal of human genetics : EJHG 20100701

• Effect of alendronate on vascular calcification in CKD stages 3 and 4: a pilot randomized controlled trial.

  American journal of kidney diseases : the official journal of the National Kidney Foundation 20100701

• Role of genetic pattern on bone mineral density in thalassemic patients.

  Clinical biochemistry 20100701

• Treatment outcomes in patients with bisphosphonate-related osteonecrosis of the jaws: a prospective study.

  Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 20100701

• The effects of high-dose, long-term alendronate treatment on microarchitecture and bone mineral density of compact and trabecular bone in the proximal femur of adult male rabbits.

  Archives of orthopaedic and trauma surgery 20100701

• Atraumatic bilateral femur fracture in long-term bisphosphonate use.

  Orthopedics 20100701

• [Comparison of effects of Wujia Bugu decoction) and alendronate sodium on protection the bone loss of hindlimb unloaded rats].

  Zhongguo gu shang = China journal of orthopaedics and traumatology 20100701

• Importance of microcracks in etiology of bisphosphonate-related osteonecrosis of the jaw: a possible pathogenetic model of symptomatic and non-symptomatic osteonecrosis of the jaw based on scanning electron microscopy findings.

  Clinical oral investigations 20100601

• Longitudinal change in clinical fracture incidence after initiation of bisphosphonates.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20100601

• Birefringence of the secretory-stage enamel organic extracellular matrix from rats submitted to successive injections of bisphosphonates.

  Connective tissue research 20100601

• Dramatic increase in cortical thickness induced by femoral marrow ablation followed by a 3-month treatment with PTH in rats.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20100601

• Effects of alendronate and strontium ranelate on cancellous and cortical bone mass in glucocorticoid-treated adult rats.

  Calcified tissue international 20100601

• Subtrochanteric femoral fractures in patients receiving long-term alendronate therapy: imaging features.

  AJR. American journal of roentgenology 20100601

• [Bone and joint diseases in children. Bisphosphonates in osteogenesis imperfecta].

  Clinical calcium 20100601

• Effective dosage and administration schedule of oral alendronate for non-nociceptive symptoms in rats with chronic constriction injury.

  Journal of Korean medical science 20100601

• Rebamipide: a gastrointestinal protective drug with pleiotropic activities.

  Expert review of gastroenterology & hepatology 20100601

• Effect of alendronate on alveolar bone resorption and angiogenesis in rats with experimental periapical lesions.

  International endodontic journal 20100601

• Low acceptance of treatment in the elderly for the secondary prevention of osteoporotic fracture in the acute rehabilitation setting.

  Aging clinical and experimental research 20100601

• [New proposal concerning alendronate reimbursement].

  Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20100520

• 188Re(CO)3-dipicolylamine-alendronate: a new bisphosphonate conjugate for the radiotherapy of bone metastases.

  Bioconjugate chemistry 20100519

• Cost-effectiveness of fracture prevention in men who receive androgen deprivation therapy for localized prostate cancer.

  Annals of internal medicine 20100518

• Bisphosphonates and fractures of the subtrochanteric or diaphyseal femur.

  The New England journal of medicine 20100513

• Evolving data about subtrochanteric fractures and bisphosphonates.

  The New England journal of medicine 20100513

• Atypical femoral fractures and bisphosphonate use.

  The New England journal of medicine 20100513

• Estimating long-term effects of treatment from placebo-controlled trials with an extension period, using virtual twins.

  Statistics in medicine 20100510

• An in vitro assay to measure targeted drug delivery to bone mineral.

  ChemMedChem 20100503

• Relationships between serum adiponectin, leptin concentrations and bone mineral density, and bone biochemical markers in Chinese women.

  Clinica chimica acta; international journal of clinical chemistry 20100502

• Calcitonin, sodium alendronate and high intensity laser in the treatment of traumatized teeth: a preliminary study.

  Lasers in medical science 20100501

• Effects of alendronate on bone formation and osteoclastic resorption after implantation of beta-tricalcium phosphate.

  Journal of biomedical materials research. Part A 20100501

• Preference and satisfaction with a 6-month subcutaneous injection versus a weekly tablet for treatment of low bone mass.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20100501

• The effects of weekly alendronate therapy in Taiwanese males with osteoporosis.

  Journal of bone and mineral metabolism 20100501

• Ultra-short echo-time MRI detects changes in bone mineralization and water content in OVX rat bone in response to alendronate treatment.

  Bone 20100501

• Inhibition of necrotic actions of nitrogen-containing bisphosphonates (NBPs) and their elimination from bone by etidronate (a non-NBP): a proposal for possible utilization of etidronate as a substitution drug for NBPs.

  Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20100501

• Microencapsulation of sodium alendronate reduces drug mucosal damage in rats.

  Drug delivery 20100501

• Efficacy of continued alendronate for fractures in women with and without prevalent vertebral fracture: the FLEX trial.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20100501

• Pharmacokinetic characteristics of formulated alendronate transdermal delivery systems in rats and humans.

  Drug delivery 20100501

• Use of cone-beam computerized tomography for evaluation of bisphosphonate-associated osteonecrosis of the jaws.

  Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 20100501

• Risk of atrial fibrillation associated with use of bisphosphonates and other drugs against osteoporosis: a cohort study.

  Calcified tissue international 20100501

• Resolution of oral bisphosphonate and steroid-related osteonecrosis of the jaw--a serial case analysis.

  Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20100501

• Alendronate affects cartilage resorption by regulating vascular endothelial growth factor expression in rats.

  Anatomical record (Hoboken, N.J. : 2007) 20100501

• A rational approach to management of alendronate-related subtrochanteric fractures.

  The Journal of bone and joint surgery. British volume 20100501

• How patients' lack of knowledge about oral bisphosphonates can interfere with medical and dental care.

  Journal of the American Dental Association (1939) 20100501

• Bilateral atypical femoral fractures after long-term alendronate therapy: a case report.

  Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20100501

• Lichenoid dermatosis induced by alendronate: an unusual skin drug reaction.

  Acta dermato-venereologica 20100501

• Alendronate-related femoral diaphysis fracture--what should be done to predict and prevent subsequent fracture of the contralateral side?

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20100401

• Comparison of effects of alfacalcidol and alendronate on mechanical properties and bone collagen cross-links of callus in the fracture repair rat model.

  Bone 20100401

• Bone formation markers in patients with glucocorticoid-induced osteoporosis treated with teriparatide or alendronate.

  Bone 20100401

• Correlations between biochemical markers of bone turnover and bone density responses in patients with glucocorticoid-induced osteoporosis treated with teriparatide or alendronate.

  Bone 20100401

• Risedronate versus alendronate in older patients with osteoporosis at high risk of fracture: an Italian cost-effectiveness analysis.

  Aging clinical and experimental research 20100401

• Effects of teriparatide, alendronate, or both in women with postmenopausal osteoporosis.

  The Journal of clinical endocrinology and metabolism 20100401

• Insufficiency femoral fractures in patients undergoing prolonged alendronate therapy.

  Eklem hastaliklari ve cerrahisi = Joint diseases & related surgery 20100401

• Taking PET for a walk - an unusual cause of bilateral leg claudication.

  The Journal of rheumatology 20100401

• The effect of the alendronate on OPG/RANKL system in differentiated primary human osteoblasts.

  Endocrine 20100401

• Alendronate treatment improves bone-pedicle screw interface fixation in posterior lateral spine fusion: an experimental study in a porcine model.

  International orthopaedics 20100301

• Effect of alendronate on bone mineral density and bone turnover markers in post-gastrectomy osteoporotic patients.

  Journal of bone and mineral metabolism 20100301

• Bisphosphonate treatment modifies canine bone mineral and matrix properties and their heterogeneity.

  Bone 20100301

• Atypical insufficiency fracture of the tibia associated with long-term bisphosphonate therapy.

  Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 20100301

• Response to oral bisphosphonates in subgroups of younger and older postmenopausal women.

  Journal of women's health (2002) 20100301

• Characteristics of implant failures in patients with a history of oral bisphosphonate therapy.

  Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20100301

• [Effects of SERMs on bone health. Combination therapy with raloxifene].

  Clinical calcium 20100301

• [Osteodensitometry and duration of treatment in osteoporosis].

  Deutsche medizinische Wochenschrift (1946) 20100301

• Intravenous zoledronic acid: what are the indications for male osteoporosis?

  Current osteoporosis reports 20100301

• Thighbone fractures in women taking bisphosponate drugs.

  Harvard women's health watch 20100301

• FPIN's clinical inquiries. Combination therapy for postmenopausal osteoporosis.

  American family physician 20100215

• Unusual mid-shaft fractures during long-term bisphosphonate therapy.

  Clinical endocrinology 20100201

• A simple and rapid high-performance liquid chromatography method for determination of alendronate sodium in beagle dog plasma with application to preclinical pharmacokinetic study.

  Biomedical chromatography : BMC 20100201

• Prevalence of osteonecrosis of the jaw in patients with oral bisphosphonate exposure.

  Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20100201

• Chronic inhibition of farnesyl pyrophosphate synthase attenuates cardiac hypertrophy and fibrosis in spontaneously hypertensive rats.

  Biochemical pharmacology 20100201

• Conservative treatment of a pathologic fracture in a patient with Gorham-Stout disease.

  Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 20100201

• Rapid analysis of alkylphosphonate drugs by capillary zone electrophoresis using indirect ultraviolet detection.

  Journal of separation science 20100201

• The effect of the alendronate on OPG/RANKL system in differentiated primary human osteoblasts.

  Endocrine 20100201

• Cocktail therapy for femoral head necrosis of the hip.

  Archives of orthopaedic and trauma surgery 20100101

• Effects of alendronate treatment on serum levels of osteoprotegerin and total receptor activator of nuclear factor kappaB in women with postmenopausal osteoporosis.

  Menopause (New York, N.Y.) 20100101

• Mineralization density distribution of postmenopausal osteoporotic bone is restored to normal after long-term alendronate treatment: qBEI and sSAXS data from the fracture intervention trial long-term extension (FLEX).

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20100101

• Effects of denosumab on bone mineral density and bone turnover in postmenopausal women transitioning from alendronate therapy.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20100101

• Impact of bisphosphonate wash-out prior to teriparatide therapy in clinical practice.

  Journal of bone and mineral metabolism 20100101

• Osteoporosis treatment and atrial fibrillation: alendronate versus raloxifene.

  Menopause (New York, N.Y.) 20100101

• Biomechanical effects of teriparatide in women with osteoporosis treated previously with alendronate and risedronate: results from quantitative computed tomography-based finite element analysis of the vertebral body.

  Bone 20100101

• Bisphosphonates do not inhibit periosteal bone formation in estrogen deficient animals and allow enhanced bone modeling in response to mechanical loading.

  Bone 20100101

• The impact of fewer hip fractures with risedronate versus alendronate in the first year of treatment: modeled German cost-effectiveness analysis.

  Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20100101

• Baseline glucocorticoid dose and bone mineral density response with teriparatide or alendronate therapy in patients with glucocorticoid-induced osteoporosis.

  The Journal of rheumatology 20100101

• Bisphosphonates and atypical femoral fractures: a time for reflection.

  Maturitas 20100101

• Do estrogen and alendronate improve metaphyseal fracture healing when applied as osteoporosis prophylaxis?

  Calcified tissue international 20100101

• Morphological assessment of basic multicellular unit resorption parameters in dogs shows additional mechanisms of bisphosphonate effects on bone.

  Calcified tissue international 20100101

• Vibrational bone characteristics versus bone density for the assessment of osteoporosis in ovariectomized rats.

  Journal of medical engineering & technology 20100101

• Cost-effectiveness of osteoporosis screening followed by treatment: the impact of medication adherence.

  Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20100101

• [Diagnosis and treatment of osteoporosis in persons aged more than 75 years].

  Revista espanola de geriatria y gerontologia 20100101

• A scoping review of strategies for the prevention of hip fracture in elderly nursing home residents.

  PloS one 20100101

• Adverse events, bone mineral density and discontinuation associated with generic alendronate among postmenopausal women previously tolerant of brand alendronate: a retrospective cohort study.

  BMC musculoskeletal disorders 20100101

• High incidence rate of vertebral fractures during chronic prednisone treatment, in spite of bisphosphonate or alfacalcidol use. Extension of the alendronate or alfacalcidol in glucocorticoid-induced osteoporosis-trial.

  Clinical and experimental rheumatology 20100101

• Bisphosphonate-associated osteonecrosis of the jaw, with healing after teriparatide: a review of the literature and a case report.

  Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry 20100101

• Alendronate improves QOL of postmenopausal women with osteoporosis.

  Clinical interventions in aging 20100101

• Alendronate reduces periprosthetic bone loss after uncemented primary total hip arthroplasty - a 5-year follow-up of 16 patients.

  Scandinavian journal of surgery : SJS : official organ for the Finnish Surgical Society and the Scandinavian Surgical Society 20100101

• In vitro osteogenesis of synovium mesenchymal cells induced by controlled release of alendronate and dexamethasone from a sintered microspherical scaffold.

  Journal of biomaterials science. Polymer edition 20100101

• Efficacy of strontium ranelate on bone mineral density in men with osteoporosis.

  Arzneimittel-Forschung 20100101

• Osteogenic activity of locally applied small molecule drugs in a rat femur defect model.

  Journal of biomedicine & biotechnology 20100101

• [Anabolic therapy of induced osteoporosis in beta-thalassaemia major: case report and literature review].

  Reumatismo 20100101

• [A toxic reaction of the oral mucosa to alendronate (Fosamax)].

  Nederlands tijdschrift voor tandheelkunde 20100101

• Influence of bisphosphonates on alveolar bone density: a histomorphometric analysis.

  Brazilian oral research 20100101

• [The role of rank-ligand inhibition in the treatment of postmenopausal osteoporosis].

  Reumatismo 20100101

• Adverse events and intravenous versus oral bisphosphonate use in patients with osteoporosis and cancer in the U.S.

  General dentistry 20100101

• Bisphosphonates in calcific aortic stenosis: association with slower progression in mild disease--a pilot retrospective study.

  Cardiology 20100101

• Sclerotic metaphyseal lines in children and adolescents treated with alendronate.

  Revista brasileira de reumatologia 20100101

• Oral erosive mucositis associated with improper administration of a drug.

  Journal (Canadian Dental Association) 20100101

• Migrating bone marrow edema syndrome: a cause of recurring knee pain.

  Acta orthopaedica et traumatologica turcica 20100101

• A rare complication with a single dose of alendronate.

  BMJ case reports 20100101

• Alendronate enhances osteogenic differentiation of bone marrow stromal cells: a preliminary study.

  Clinical orthopaedics and related research 20091201

• Teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: an analysis by gender and menopausal status.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20091201

• Differences in persistence, safety and efficacy of generic and original branded once weekly bisphosphonates in patients with postmenopausal osteoporosis: 1-year results of a retrospective patient chart review analysis.

  Rheumatology international 20091201

• Teriparatide reduces bone microdamage accumulation in postmenopausal women previously treated with alendronate.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20091201

• Alendronate decreases the fracture risk in patients with prostate cancer on androgen-deprivation therapy and with severe osteopenia or osteoporosis.

  BJU international 20091201

• Correlation between serum C-terminal cross-linking telopeptide of type I collagen and staging of oral bisphosphonate-related osteonecrosis of the jaws.

  Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20091201

• Bone loss in patients with HIV infection.

  Joint, bone, spine : revue du rhumatisme 20091201

• Effect of alendronate on orthodontic tooth movement in rats.

  American journal of orthodontics and dentofacial orthopedics : official publication of the American Association of Orthodontists, its constituent societies, and the American Board of Orthodontics 20091201

• Time-of-flight secondary ion mass spectrometry study on the distribution of alendronate sodium in drug-loaded ultra-high molecular weight polyethylene.

  Biomedical materials (Bristol, England) 20091201

• Complex regional pain syndrome type 1. Some treatments assessed versus placebo, limited efficacy.

  Prescrire international 20091201

• Factors affecting discontinuation of alendronate treatment in postmenopausal Japanese women with osteoporosis.

  Journal of the Chinese Medical Association : JCMA 20091201

• Bisphosphonates: atypical fractures. Femur most often involved.

  Prescrire international 20091201

• [In vitro effect of alendronate on chondrocytes and articular cartilage and subchondral bone in rabbit anterior cruciate ligament transection model].

  Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery 20091201

• Review of osteoporosis pharmacotherapy for geriatric patients.

  The American journal of geriatric pharmacotherapy 20091201

• Serum cathepsin K as a marker of bone metabolism in postmenopausal women treated with alendronate.

  Maturitas 20091120

• Alendronate treatment does not inhibit bone formation within biphasic calcium phosphate ceramics in posterolateral spinal fusion: an experimental study in porcine model.

  Chinese medical journal 20091120

• [Osteoprotegerin gene polymorphism and therapeutic response to alendronate in postmenopausal women with osteoporosis].

  Zhonghua yi xue za zhi 20091117

• [Risks associated with drug therapy. What do patients need to know? What can they do].

  Medizinische Klinik (Munich, Germany : 1983) 20091115

• Overcoming resistance to bisphosphonates through the administration of alfacalcidol: results of a 1-year, open follow-up study.

  Rheumatology international 20091101

• FRAX and risk of vertebral fractures: the fracture intervention trial.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20091101

• Minimum required vitamin D level for optimal increase in bone mineral density with alendronate treatment in osteoporotic women.

  Calcified tissue international 20091101

• Effects of alendronate on bone metabolism in glucocorticoid-induced osteoporosis measured by 18F-fluoride PET: a prospective study.

  Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20091101

• A retrospective clinical and radiographic study on healing of periradicular lesions in patients taking oral bisphosphonates.

  Journal of endodontics 20091101

• Effects of teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: thirty-six-month results of a randomized, double-blind, controlled trial.

  Arthritis and rheumatism 20091101

• Bilateral low-energy simultaneous or sequential femoral fractures in patients on long-term alendronate therapy.

  The Journal of bone and joint surgery. American volume 20091101

• Positive effect of alendronate on subchondral bone healing and subsequent cartilage repair in a rabbit osteochondral defect model.

  The American journal of sports medicine 20091101

• Comparative gastrointestinal safety of weekly oral bisphosphonates.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20091001

• Effects of 1 to 3 years' treatment with alendronate on mechanical properties of the femoral shaft in a canine model: implications for subtrochanteric femoral fracture risk.

  Journal of orthopaedic research : official publication of the Orthopaedic Research Society 20091001

• Bilateral fractures of the femur diaphysis in a patient with rheumatoid arthritis on long-term treatment with alendronate: clues to the mechanism of increased bone fragility.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20091001

• Effects of teriparatide in postmenopausal women with osteoporosis on prior alendronate or raloxifene: differences between stopping and continuing the antiresorptive agent.

  The Journal of clinical endocrinology and metabolism 20091001

• In vitro determination of the release of alendronic acid from alendronate tablets of different brands during deglutition.

  Journal of pharmaceutical sciences 20091001

• Effects of bisphosphonate on the endochondral bone formation of the mandibular condyle.

  Anatomia, histologia, embryologia 20091001

• Biofunctional alendronate-Hydroxyapatite thin films deposited by Matrix Assisted Pulsed Laser Evaporation.

  Biomaterials 20091001

• Treatment with a potent cathepsin K inhibitor preserves cortical and trabecular bone mass in ovariectomized monkeys.

  Calcified tissue international 20091001

• Femur bone repair in ovariectomized rats under the local action of alendronate, hydroxyapatite and the association of alendronate and hydroxyapatite.

  International journal of experimental pathology 20091001

• Mineral complexes and vascular calcification.

  Kidney international 20091001

• Inhibition of farnesylpyrophosphate synthase prevents angiotensin II-induced hypertrophic responses in rat neonatal cardiomyocytes: involvement of the RhoA/Rho kinase pathway.

  FEBS letters 20090917

• Enhanced bone morphogenetic protein-2 performance on hydroxyapatite ceramic surfaces.

  Journal of biomedical materials research. Part A 20090915

• Comparison of direct health care costs related to the pharmacological treatment of osteoporosis and to the management of osteoporotic fractures among compliant and noncompliant users of alendronate and risedronate: a population-based study.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20090901

• Spontaneous femoral shaft fracture after long-term alendronate.

  Age and ageing 20090901

• The preparation of sugar polymer-coated nanocapsules by the layer-by-layer deposition on the liposome.

  Langmuir : the ACS journal of surfaces and colloids 20090901

• Antral ulcers induced by alendronate, a nitrogen-containing biphophonate, in rat stomachs - prophylactic effect of rebamipide.

  Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 20090901

• Comparison of the effects of alendronate and alfacalcidol on hip bone mineral density and bone turnover in Japanese men having osteoporosis or osteopenia with clinical risk factors for fractures.

  Yonsei medical journal 20090831

• Battle over popular bone drug Fosamax bursts into court.

  BMJ (Clinical research ed.) 20090806

• US judge rules Merck won't face 'punitive damages' in first Fosamax case.

  BMJ (Clinical research ed.) 20090806

• Which water for alendronate administration?

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20090801

• Differences in persistence among different weekly oral bisphosphonate medications.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20090801

• Potential of alfacalcidol for reducing increased risk of falls and fractures.

  Rheumatology international 20090801

• Activation of Src kinase by protein-tyrosine phosphatase-PEST in osteoclasts: comparative analysis of the effects of bisphosphonate and protein-tyrosine phosphatase inhibitor on Src activation in vitro.

  Journal of cellular physiology 20090801

• In-vitro osteogenesis of synovium stem cells induced by controlled release of bisphosphate additives from microspherical mesoporous silica composite.

  Biomaterials 20090801

• Once-weekly oral alendronate 70 mg in patients with glucocorticoid-induced bone loss: a 12-month randomized, placebo-controlled clinical trial.

  The Journal of rheumatology 20090801

• Mouse macrophages primed with alendronate down-regulate monocyte chemoattractant protein-1 (MCP-1) and macrophage inflammatory protein-1alpha (MIP-1alpha) production in response to Toll-like receptor (TLR) 2 and TLR4 agonist via Smad3 activation.

  International immunopharmacology 20090801

• Mandibular necrosis in beagle dogs treated with bisphosphonates.

  Orthodontics & craniofacial research 20090801

• [Biochemical markers of bone turnover. New aspect. Bone metabolic markers in prostatic carcinoma].

  Clinical calcium 20090801

• [Biochemical markers of bone turnover. New aspect. Biochemical markers of bone turnover in long term treatment with bisphosphonate].

  Clinical calcium 20090801

• The use of alendronate in the treatment of avascular necrosis of the femoral head: follow-up to eight years.

  The Journal of bone and joint surgery. British volume 20090801

• Corticosteroids: no drug prevention of fractures needed.

  Prescrire international 20090801

• Upper gastrointestinal tolerability of alendronate sodium monohydrate 10 mg once daily in postmenopausal women: a 12-week, randomized, double-blind, placebo-controlled, exploratory study.

  Clinical therapeutics 20090801

• [Skeletal biomechanical effectiveness of retinoic acid on induction of osteoporotic rats treated by alendronate and qianggu capsules].

  Zhonghua yi xue za zhi 20090721

• Vitamin D insufficiency does not affect response of bone mineral density to alendronate.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20090701

• Case reports: two femoral insufficiency fractures after long-term alendronate therapy.

  Clinical orthopaedics and related research 20090701

• Effect of eicosapentaenoic acid on bone changes due to methylprednisolone in rats.

  Basic & clinical pharmacology & toxicology 20090701

• Systemic mastocytosis presenting as osteoporosis--a case report.

  Clinical rheumatology 20090701

• Rho GTPase signaling and PTH 3-34, but not PTH 1-34, maintain the actin cytoskeleton and antagonize bisphosphonate effects in mouse osteoblastic MC3T3-E1 cells.

  Bone 20090701

• Effects of teriparatide retreatment in osteoporotic men and women.

  The Journal of clinical endocrinology and metabolism 20090701

• Denosumab update.

  Current opinion in rheumatology 20090701

• Intravenous bisphosphonate-related osteonecrosis of the jaw: bone scintigraphy as an early indicator.

  Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20090701

• Low serum levels of undercarboxylated osteocalcin in postmenopausal osteoporotic women receiving an inhibitor of bone resorption.

  The Tohoku journal of experimental medicine 20090701

• [Hormones and osteoporosis update. Glucocorticoids and bone].

  Clinical calcium 20090701

• Studies on the formation of hydrophobic ion-pairing complex of alendronate.

  Archives of pharmacal research 20090701

• Bilateral atypical femoral diaphyseal fractures in a patient treated with alendronate sodium.

  International journal of rheumatic diseases 20090701

• [Meta-analysis of alendronate preventing hip fracture risk of postmenopausal women].

  Zhonghua yi xue za zhi 20090616

• Ab initio structure determination of anhydrous sodium alendronate from laboratory powder X-ray diffraction data.

  Journal of pharmaceutical sciences 20090601

• DXA-based hip structural analysis of once-weekly bisphosphonate-treated postmenopausal women with low bone mass.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20090601

• Changes in non-enzymatic glycation and its association with altered mechanical properties following 1-year treatment with risedronate or alendronate.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20090601

• RisedronatE and ALendronate Intervention over Three Years (REALITY): minimal differences in fracture risk reduction.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20090601

• Effect of alendronate in elderly patients after low trauma hip fracture repair.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20090601

• Retreatment with teriparatide one year after the first teriparatide course in patients on continued long-term alendronate.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20090601

• Subtrochanteric and diaphyseal femur fractures in patients treated with alendronate: a register-based national cohort study.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20090601

• A double-blinded head-to-head trial of minodronate and alendronate in women with postmenopausal osteoporosis.

  Bone 20090601

• The anabolic action of intermittent PTH in combination with cathepsin K inhibitor or alendronate differs depending on the remodeling status in bone in ovariectomized mice.

  Bone 20090601

• Osteoprotegerin abrogated cortical porosity and bone marrow fibrosis in a mouse model of constitutive activation of the PTH/PTHrP receptor.

  The American journal of pathology 20090601

• Clinical investigation of C-terminal cross-linking telopeptide test in prevention and management of bisphosphonate-associated osteonecrosis of the jaws.

  Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20090601

• Pathological fractures in patients caused by bisphosphonate-related osteonecrosis of the jaws: report of 3 cases.

  Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20090601

• Why are physicians reluctant to use estrogens for anything--or do they prefer 'PROFOX'?

  Menopause international 20090601

• Safety of bisphosphonates in women of child bearing age.

  Alimentary pharmacology & therapeutics 20090601

• Synergistic action of statins and nitrogen-containing bisphosphonates in the development of rhabdomyolysis in L6 rat skeletal myoblasts.

  The Journal of pharmacy and pharmacology 20090601

• Alendronate inhibits growth of high-grade chondrosarcoma cells.

  Anticancer research 20090601

• [Effect of alendronate on glucocorticoid-induced osteoporosis].

  Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences 20090601

• Impact of alendronate and VEGF-antisense combined treatment on highly VEGF-expressing A431 cells.

  Biochemical pharmacology 20090515

• Theoretical analysis of alendronate and risedronate effects on canine vertebral remodeling and microdamage.

  Journal of biomechanics 20090511

• Effect of low-power gallium-aluminum-arsenium laser therapy (830 nm) in combination with bisphosphonate treatment on osteopenic bone structure: an experimental animal study.

  Lasers in medical science 20090501

• Spectroscopic markers of bone quality in alendronate-treated postmenopausal women.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20090501

• Assessment of vertebral fracture risk and therapeutic effects of alendronate in postmenopausal women using a quantitative computed tomography-based nonlinear finite element method.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20090501

• Alendronate and indapamide alone or in combination in the management of hypercalciuria associated with osteoporosis: a randomized controlled trial of two drugs and three treatments.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20090501

• Alendronate treatment of the brtl osteogenesis imperfecta mouse improves femoral geometry and load response before fracture but decreases predicted material properties and has detrimental effects on osteoblasts and bone formation.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20090501

• Efficacy and safety of pharmacological agents in managing osteoporosis in the old old: review of the evidence.

  Bone 20090501

• Atrial fibrillation in fracture patients treated with oral bisphosphonates.

  Journal of internal medicine 20090501

• Fully phosphorylated fetuin-A forms a mineral complex in the serum of rats with adenine-induced renal failure.

  Kidney international 20090501

• Improved GI tolerability with monthly ibandronate in women previously using weekly bisphosphonates.

  Southern medical journal 20090501

• Outcome of surgical management of bisphosphonate-related osteonecrosis of the jaws: review of 33 surgical cases.

  Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20090501

• A compounded diagnosis: maxillary osteochemonecrosis in the setting of low dose radiotherapy.

  Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20090501

• The efficacy of alendronate in wheelchair-bound patients: a 1-year prospective study.

  Journal of pediatric orthopedics. Part B 20090501

• A fractured service: will NOGG mend it?

  The British journal of general practice : the journal of the Royal College of General Practitioners 20090501

• Experimental results of combining bisphosphonates with allograft in a rat model.

  The Journal of bone and joint surgery. British volume 20090501

• Oral bisphosphonates.

  Journal of the American Dental Association (1939) 20090501

• Osteoporosis and thyrotropin-suppressive therapy: reduced effectiveness of alendronate.

  Thyroid : official journal of the American Thyroid Association 20090501

• Modulation of murine bone marrow-derived CFU-F and CFU-OB by in vivo bisphosphonate and fluoride treatments.

  Orthodontics & craniofacial research 20090501

• [Bone quality].

  Nihon rinsho. Japanese journal of clinical medicine 20090501

• [Prediction of vertebral strength using a CT based finite element method--clinical application in evaluation of the efficacy of alendronate].

  Nihon rinsho. Japanese journal of clinical medicine 20090501

• [Alendronate for treatment of osteoporoses].

  Nihon rinsho. Japanese journal of clinical medicine 20090501

• [Drug therapy of secondary osteoporosis: glucocorticoid-induced osteoporosis].

  Nihon rinsho. Japanese journal of clinical medicine 20090501

• [A-TOP research group/JOINT program].

  Nihon rinsho. Japanese journal of clinical medicine 20090501

• Optimal increase in bone mass by continuous local infusion of alendronate during distraction osteogenesis in rabbits.

  Bone 20090501

• Bioavailability and bioequivalence of two oral formulations of alendronate sodium 70 mg: an open-label, randomized, two-period crossover comparison in healthy Korean adult male volunteers.

  Clinical therapeutics 20090501

• By the way, doctor. I'm 69 and have taking Fosamax for 10 years. My doctor has approved a 'drug holiday,' provided we use a CTX test to monitor my bones. Can you explain?

  Harvard women's health watch 20090501

• More on reports of esophageal cancer with oral bisphosphonate use.

  The New England journal of medicine 20090423

• Giant osteoclast formation and long-term oral bisphosphonate therapy.

  The New England journal of medicine 20090416

• Alendronate treatment results in similar levels of trabecular bone remodeling in the femoral neck and vertebra.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20090401

• Marked reduction of bone turnover by alendronate attenuates the acute response of bone resorption marker to endogenous parathyroid hormone.

  Bone 20090401

• Effects of alendronate on a disintegrin and metalloproteinase with thrombospondin motifs expression in the developing epiphyseal cartilage in rats.

  Anatomia, histologia, embryologia 20090401

• Alendronate/vitamin D3 70 mg/2800 IU with and without additional 2800 IU vitamin D3 for osteoporosis: results from the 24-week extension of a 15-week randomized, controlled trial.

  Bone 20090401

• Biocompatibility evaluation of alendronate paste in rat's subcutaneous tissue.

  Dental traumatology : official publication of International Association for Dental Traumatology 20090401

• Genistein aglycone reverses glucocorticoid-induced osteoporosis and increases bone breaking strength in rats: a comparative study with alendronate.

  British journal of pharmacology 20090401

• Bisphosphonate-related osteonecrosis of the jaws: a single-center study of 101 patients.

  Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20090401

• Risk of severe gastrointestinal events in women treated with monthly ibandronate or weekly alendronate and risedronate.

  The Annals of pharmacotherapy 20090401

• The marketing of osteoporosis.

  The American journal of nursing 20090401

• Comparison of radiographic fracture healing in the distal radius for patients on and off bisphosphonate therapy.

  The Journal of hand surgery 20090401

• Synthesis and assessment of 99mTc chelate-conjugated alendronate for development of specific radiopharmaceuticals.

  Cancer biotherapy & radiopharmaceuticals 20090401

• Oral bisphosphonate-related osteonecrosis of the jaws: favorable outcome after bisphosphonate holiday.

  Quintessence international (Berlin, Germany : 1985) 20090401

• [Combination treatment in osteoporosis. Basic treatment plus specific osteoporosis medication].

  Medizinische Monatsschrift fur Pharmazeuten 20090401

• Efficacy and tolerability of once-monthly oral ibandronate (150 mg) and once-weekly oral alendronate (70 mg): additional results from the Monthly Oral Therapy With Ibandronate For Osteoporosis Intervention (MOTION) study.

  Clinical therapeutics 20090401

• [Postmenopausal osteoporosis. Bisphosphonates are not all equal].

  MMW Fortschritte der Medizin 20090312

• [Patient compliance program aids therapy success].

  MMW Fortschritte der Medizin 20090312

• [Alendronate for the prevention and treatment of postmenopausal osteoporosis. A survey of a Cochrane review].

  Ugeskrift for laeger 20090309

• [Atrial fibrillation during bisphosphonate therapy. side effects or coincidental finding?].

  MMW Fortschritte der Medizin 20090305

• The effects of alendronate in the treatment of experimental osteonecrosis of the hip in adult rabbits.

  Osteoarthritis and cartilage 20090301

• Oral mucosal irritation with incorrect use of alendronate.

  The British journal of oral & maxillofacial surgery 20090301

• Variability in pharmacy interpretations of physician prescriptions.

  Medical care 20090301

• Bisphosphonates for postmenopausal osteoporosis: determining duration of treatment.

  Current osteoporosis reports 20090301

• Glucocorticoid-induced osteoporosis.

  Current osteoporosis reports 20090301

• Alendronate-induced asthma.

  The Annals of pharmacotherapy 20090301

• Preparation and characterisation of alendronate-loaded chitosan microparticles obtained through the spray drying technique.

  Medicinal chemistry (Shariqah (United Arab Emirates)) 20090301

• Effect of alendronate and intermittent parathyroid hormone on implant fixation in ovariectomized rats.

  Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association 20090301

• Once-weekly oral medication with alendronate does not prevent migration of knee prostheses: A double-blind randomized RSA study.

  Acta orthopaedica 20090226

• Clinical trial: comparison of alendronate and alfacalcidol in glucocorticoid-associated osteoporosis in patients with ulcerative colitis.

  Alimentary pharmacology & therapeutics 20090215

• Alendronate augments interleukin-1beta release from macrophages infected with periodontal pathogenic bacteria through activation of caspase-1.

  Toxicology and applied pharmacology 20090215

• BMP/Wnt antagonists are upregulated by dexamethasone in osteoblasts and reversed by alendronate and PTH: potential therapeutic targets for glucocorticoid-induced osteoporosis.

  Biochemical and biophysical research communications 20090206

• Prevention of distortion of vascular deprivation-induced osteonecrosis of the rat femoral head by treatment with alendronate.

  Archives of orthopaedic and trauma surgery 20090201

• Initiation of anti-osteoporotic therapy in patients with recent fractures: a nationwide analysis of prescription rates and persistence.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20090201

• Vitamin D status and response to treatment in post-menopausal osteoporosis.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20090201

• Local bisphosphonate treatment increases fixation of hydroxyapatite-coated implants inserted with bone compaction.

  Journal of orthopaedic research : official publication of the Orthopaedic Research Society 20090201

• Changes of femoral periprosthetic bone mineral density 6 years after treatment with alendronate following total hip arthroplasty.

  Journal of orthopaedic research : official publication of the Orthopaedic Research Society 20090201

• Massive proteinuria and acute renal failure after oral bisphosphonate (alendronate) administration in a patient with focal segmental glomerulosclerosis.

  Clinical and experimental nephrology 20090201

• Peritoneal macrophage depletion by liposomal bisphosphonate attenuates endometriosis in the rat model.

  Human reproduction (Oxford, England) 20090201

• Enhancing alendronate release from a novel PLGA/hydroxyapatite microspheric system for bone repairing applications.

  Pharmaceutical research 20090201

• Comparison of effects of the bisphosphonate alendronate versus the RANKL inhibitor denosumab on murine fracture healing.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20090201

• [Bisphosphonates and other new therapeutic agents for the treatmednt of osteogenesis imperfecta].

  Clinical calcium 20090201

• Efficacy of bisphosphonates in reducing fracture risk in postmenopausal osteoporosis.

  The American journal of medicine 20090201

• In vitro disintegration studies of weekly generic alendronate sodium tablets (70 mg) available in the US.

  Current medical research and opinion 20090201

• A novel biomaterial for osteotropic drug nanocarriers: synthesis and biocompatibility evaluation of a PLGA-ALE conjugate.

  Nanomedicine (London, England) 20090201

• Postmarketing surveillance rates of uveitis and scleritis with bisphosphonates among a national veteran cohort.

  Retina (Philadelphia, Pa.) 20090201

• Using the osteoporosis self-assessment tool for referring older men for bone densitometry: a decision analysis.

  Journal of the American Geriatrics Society 20090201

• Higher incidence of Osteonecrosis of the Jaw (ONJ) in patients with metastatic castration resistant prostate cancer treated with anti-angiogenic agents.

  Cancer investigation 20090201

• Transport evaluation of alendronate across Caco-2 cell monolayers.

  Die Pharmazie 20090201

• [Osteonecrosis of the jaw secondary to oral alendronate: Report of three cases].

  Revista medica de Chile 20090201

• A new double emulsion solvent diffusion technique for encapsulating hydrophilic molecules in PLGA nanoparticles.

  Journal of controlled release : official journal of the Controlled Release Society 20090119

• A new method for preventing restenosis: a single IV injection of drug-loaded nanoparticles.

  Journal of controlled release : official journal of the Controlled Release Society 20090119

• Randomized, active-controlled study of once-weekly alendronate 280 mg high dose oral buffered solution for treatment of Paget's disease.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20090101

• Alendronate lowers cholesterol synthesis in the central nervous system of rats - a preliminary study.

  Physiological research 20090101

• Comparison of the effect of denosumab and alendronate on BMD and biochemical markers of bone turnover in postmenopausal women with low bone mass: a randomized, blinded, phase 3 trial.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20090101

• Identification of novel biphenyl carboxylic acid derivatives as novel antiresorptive agents that do not impair parathyroid hormone-induced bone formation.

  Endocrinology 20090101

• The potential effects on fracture outcomes of improvements in persistence and compliance with bisphosphonates.

  QJM : monthly journal of the Association of Physicians 20090101

• Quantitative ultrasound at the phalanges in monitoring alendronate therapy.

  Ultrasound in medicine & biology 20090101

• Alendronate and Pamidronate calcium phosphate bone cements: setting properties and in vitro response of osteoblast and osteoclast cells.

  Journal of inorganic biochemistry 20090101

• Active comparator trial of teriparatide vs alendronate for treating glucocorticoid-induced osteoporosis: results from the Hispanic and non-Hispanic cohorts.

  Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 20090101

• Bisphosphonate-induced osteonecrosis of the jaws, bone markers, and a hypothesized candidate gene.

  Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20090101

• Giant osteoclast formation and long-term oral bisphosphonate therapy.

  The New England journal of medicine 20090101

• The deceiving appearances of osteoclasts.

  The New England journal of medicine 20090101

• Reports of esophageal cancer with oral bisphosphonate use.

  The New England journal of medicine 20090101

• Oral bisphosphonate use and the prevalence of osteonecrosis of the jaw: an institutional inquiry.

  Journal of the American Dental Association (1939) 20090101

• [New development in bisphosphonate treatment. Fracture prevention by bisphosphonates].

  Clinical calcium 20090101

• [New development in bisphosphonate treatment. Characteristics and effectiveness of intermittent bisphophonates].

  Clinical calcium 20090101

• [New development in bisphosphonate treatment. When and how long should patients take bisphosphonates for osteoporosis?].

  Clinical calcium 20090101

• [New development in bisphosphonate treatment. Review of effect on bone metabolism by minodronic acid in primary osteoporosis].

  Clinical calcium 20090101

• A brown tumor after biliopancreatic diversion for severe obesity.

  Endocrine journal 20090101

• Bilateral stress fractures of the distal fibula in a woman with osteoporosis: a case report.

  Journal of the American Podiatric Medical Association 20090101

• Two years adherence to anti-osteoporotic medications in postmenopausal Israeli women.

  Archives of gerontology and geriatrics 20090101

• Peripheral quantitative computed tomography is useful to monitor response to alendronate therapy in postmenopausal women.

  Journal of bone and mineral metabolism 20090101

• New bisphosphonates and trends in drug therapy for osteoporosis: preface.

  Clinical calcium 20090101

• Comparison of the analgesic effects of bisphosphonates: etidronate, alendronate and risedronate by electroalgometry utilizing the fall of skin impedance.

  Journal of bone and mineral metabolism 20090101

• Evidence-based dentistry and the concept of harm.

  Dental clinics of North America 20090101

• The effect of alendronate sodium on carotid artery intima-media thickness and lipid profile in women with postmenopausal osteoporosis.

  Menopause (New York, N.Y.) 20090101

• Bisphosphonates and low-impact femoral fractures: current evidence on alendronate-fracture risk.

  Geriatrics 20090101

• The prognosis for dental implants placed in patients taking oral bisphosphonates.

  Journal of the California Dental Association 20090101

• Oral bisphosphonates and risk of atrial fibrillation and flutter in women: a self-controlled case-series safety analysis.

  PloS one 20090101

• [Mouth sores caused by alendronate].

  Actas dermo-sifiliograficas 20090101

• Targeting bone metastases with a bispecific anticancer and antiangiogenic polymer-alendronate-taxane conjugate.

  Angewandte Chemie (International ed. in English) 20090101

• Controlled release of alendronate from polymeric films.

  Journal of biomaterials science. Polymer edition 20090101

• Bisphosphonates are not associated with vertebral osteonecrosis.

  Journal of bone and mineral metabolism 20090101

• The efficacy and tolerability of once-weekly alendronate 70 mg on bone mineral density and bone turnover markers in postmenopausal Chinese women with osteoporosis.

  Journal of bone and mineral metabolism 20090101

• Imaging findings of bisphosphonate-related osteonecrosis of the jaw with emphasis on early magnetic resonance imaging findings.

  Journal of computer assisted tomography 20090101

• Images, lipoproteins, drugs, and atherothrombotic events.

  Menopause (New York, N.Y.) 20090101

• Postpartum depression co-occurring with lactation-related osteoporosis.

  Psychosomatics 20090101

• Effects of alendronate on the proliferation and osteogenic differentiation of MG-63 cells.

  The Journal of international medical research 20090101

• Drug-induced esophagitis.

  Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus 20090101

• Compliance with alendronate 10 treatment in elderly women with postmenopausal osteoporosis.

  Endokrynologia Polska 20090101

• RANKL increases the level of Mcl-1 in osteoclasts and reduces bisphosphonate-induced osteoclast apoptosis in vitro.

  Arthritis research & therapy 20090101

• Bisphosphonate administration prior to tooth extraction delays initial healing of the extraction socket in rats.

  Journal of bone and mineral metabolism 20090101

• Development and validation of a Markov microsimulation model for the economic evaluation of treatments in osteoporosis.

  Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20090101

• Alendronate improves low bone mineral density induced by steroid therapy in Crohn's disease.

  Internal medicine (Tokyo, Japan) 20090101

• Value of routine monitoring of bone mineral density after starting bisphosphonate treatment: secondary analysis of trial data.

  BMJ (Clinical research ed.) 20090101

• Additional beneficial effects of recombinant growth hormone in alendronate-treated patients with idiopathic osteoporosis.

  Endocrine journal 20090101

• [Osteoporosis treatment evaluation with desoxypiridinoline urine detection in postmenopause patients].

  Revista medica del Instituto Mexicano del Seguro Social 20090101

• Alendronate therapy in men with primary hyperparathyroidism.

  Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 20090101

• Low-energy femoral fractures associated with the long-term use of bisphosphonates: a case series from a Swiss university hospital.

  Drug safety 20090101

• A woman with progressive thinning of the skull.

  Internal medicine (Tokyo, Japan) 20090101

• Cost-effectiveness of using clinical risk factors with and without DXA for osteoporosis screening in postmenopausal women.

  Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20090101

• Alendronate binds to tooth root surfaces and inhibits progression of feline tooth resorption: a pilot proof-of-concept study.

  Journal of veterinary dentistry 20090101

• Identification of secondary targets of N-containing bisphosphonates in mammalian cells via parallel competition analysis of the barcoded yeast deletion collection.

  Genome biology 20090101

• Alendronate reduces the excretion of risk factors for calcium phosphate stone formation in postmenopausal women with osteoporosis.

  Urologia internationalis 20090101

• [Using parathyroid hormone 1-84 in the treatment of osteoporosis: presentation and comments of main clinical trial].

  La Clinica terapeutica 20090101

• Truncated area under the urinary excretion rate curve in the evaluation of alendronate bioequivalence after a single dose in healthy volunteers.

  Arzneimittel-Forschung 20090101

• Alendronate affects calcium dynamics in cardiomyocytes in vitro.

  Vascular pharmacology 20090101

• Two-way crossover bioequivalence study of alendronate sodium tablets in healthy, non-smoking male volunteers under fasted conditions.

  Arzneimittel-Forschung 20090101

• Effects of alendronate and alfacalcidol on the femoral bone mass and bone strength in orchidectomized rats.

  The Chinese journal of physiology 20081231

• Opposing effects of bisphosphonates and advanced glycation end-products on osteoblastic cells.

  European journal of pharmacology 20081214

• [Osteoporotic fracture in menopausal women: alendronate reduces the risk].

  Revue medicale suisse 20081210

• Alendronate enhances antibiotic-impregnated bone grafts in the treatment of osteomyelitis.

  International orthopaedics 20081201

• A case report: pregnancy-induced severe osteoporosis with eight vertebral fractures.

  Rheumatology international 20081201

• Femoral bone strength and its relation to cortical and trabecular changes after treatment with PTH, alendronate, and their combination as assessed by finite element analysis of quantitative CT scans.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20081201

• Bisphosphonates in children with hypercalciuria and reduced bone mineral density.

  Pediatric nephrology (Berlin, Germany) 20081201

• Isosorbide mononitrate versus alendronate for postmenopausal osteoporosis.

  International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 20081201

• Preparation of alendronate liposomes for enhanced stability and bioactivity: in vitro and in vivo characterization.

  The AAPS journal 20081201

• A comparison of calcium, calcitriol, and alendronate in corticosteroid-treated premenopausal patients with systemic lupus erythematosus.

  The Journal of rheumatology 20081201

• [New therapeutic approach in glucocorticoid-induce osteoporosis].

  Der Internist 20081201

• Alendronate is effective to treat bone loss in renal transplantation recipients.

  Transplantation proceedings 20081201

• Alendronate, osteoporosis, and atherosclerosis.

  Archives of internal medicine 20081124

• Update: A 64-year-old woman with primary hyperparathyroidism.

  JAMA 20081105

• Management of atrophic maxilla in severe osteoporosis treated with bisphosphonates: a case report.

  Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 20081101

• Bone resorption inhibitor alendronate normalizes the reduced bone thickness of TRPV5(-/-) mice.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20081101

• Connexin 43 is required for the anti-apoptotic effect of bisphosphonates on osteocytes and osteoblasts in vivo.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20081101

• Statin suppresses apoptosis in osteoblastic cells: role of transforming growth factor-beta-Smad3 pathway.

  Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 20081101

• Effects of genistein aglycone in osteoporotic, ovariectomized rats: a comparison with alendronate, raloxifene and oestradiol.

  British journal of pharmacology 20081101

• Vertebral strength changes in rheumatoid arthritis patients treated with alendronate, as assessed by finite element analysis of clinical computed tomography scans: a prospective randomized clinical trial.

  Arthritis and rheumatism 20081101

• Use of high-dose oral bisphosphonate therapy for symptomatic fibrous dysplasia of the skull.

  Journal of neurosurgery 20081101

• Vertebral fracture in a pilot during centrifuge training: finding of osteopenia.

  Aviation, space, and environmental medicine 20081101

• Therapeutic effects of alendronate on bone erosion and atrophy in a patient with rheumatoid arthritis and hepatitis C virus infection.

  The Journal of rheumatology 20081101

• Alendronate protects premenopausal women from bone loss and fracture associated with high-dose glucocorticoid therapy.

  The Journal of rheumatology 20081101

• What's the story with Fosamax? Recent reports have women wondering if they should stop taking this widely prescribed osteoporosis drug.

  Harvard women's health watch 20081101

• Is your knowledge up-to-date? Bisphosphonate-related osteonecrosis of the jaw.

  International journal of dental hygiene 20081101

• The effect of alendronate on progression of spinal osteophytes and disc-space narrowing.

  Annals of the rheumatic diseases 20081001

• Differential effects of biologic versus bisphosphonate inhibition of wear debris-induced osteolysis assessed by longitudinal micro-CT.

  Journal of orthopaedic research : official publication of the Orthopaedic Research Society 20081001

• Recovery of trabecular and cortical bone turnover after discontinuation of risedronate and alendronate therapy in ovariectomized rats.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20081001

• Identification of material parameters based on Mohr-Coulomb failure criterion for bisphosphonate treated canine vertebral cancellous bone.

  Bone 20081001

• Suppression of CYP2B induction by alendronate-mediated farnesyl diphosphate synthase inhibition in primary cultured rat hepatocytes.

  Drug metabolism and disposition: the biological fate of chemicals 20081001

• Alendronate once weekly for the prevention and treatment of bone loss in Canadian adult cystic fibrosis patients (CFOS trial).

  Chest 20081001

• Bisphosphonates for osteoarthritis prevention: 'Holy Grail' or not?

  Annals of the rheumatic diseases 20081001

• Low incidence of anti-osteoporosis treatment after hip fracture.

  The Journal of bone and joint surgery. American volume 20081001

• [Alendronate].

  Clinical calcium 20081001

• Paget disease of bone: therapeutic options.

  Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 20081001

• Effects of alendronate on rate of distraction in rabbit mandibles.

  Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20081001

• [Treatment of osteoporosis in the elderly: what is the evidence?].

  Tijdschrift voor gerontologie en geriatrie 20081001

• Effect of bisphosphonate treatment on bone mineral density in patients with thalassaemia major.

  Pediatric endocrinology reviews : PER 20081001

• Do not use bisphosphonate therapy indefinitely for fracture prevention.

  Prescrire international 20081001

• Skeletal health after continuation, withdrawal, or delay of alendronate in men with prostate cancer undergoing androgen-deprivation therapy.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080920

• Synthesis and biological evaluation of indolyl bisphosphonates as anti-bone resorptive and anti-leishmanial agents.

  Bioorganic & medicinal chemistry 20080915

• Treatment of osteonecrosis of the hip: comparison of extracorporeal shockwave with shockwave and alendronate.

  Archives of orthopaedic and trauma surgery 20080901

• Effects of PTH and alendronate on type I collagen isomerization in postmenopausal women with osteoporosis: the PaTH study.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20080901

• Nonvertebral fracture risk reduction with nitrogen-containing bisphosphonates.

  Current osteoporosis reports 20080901

• Therapies for treatment of osteoporosis in US women: cost-effectiveness and budget impact considerations.

  The American journal of managed care 20080901

• Alendronate for fracture prevention in postmenopause.

  American family physician 20080901

• Changes in urinary NTX levels in patients with primary osteoporosis undergoing long-term bisphosphonate treatment.

  Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association 20080901

• Hip fracture protection by alendronate treatment in postmenopausal women with osteoporosis: a review of the literature.

  Clinical interventions in aging 20080901

• Teriparatide (recombinant human parathyroid hormone 1-34) in postmenopausal women with osteoporosis: systematic review.

  Sao Paulo medical journal = Revista paulista de medicina 20080901

• Osteoporosis treatment and fracture incidence: the ICARO longitudinal study.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20080801

• Natural isoprenoids are able to reduce inflammation in a mouse model of mevalonate kinase deficiency.

  Pediatric research 20080801

• Does a history of non-vertebral fracture identify women without osteoporosis for treatment?

  Journal of general internal medicine 20080801

• Development of an oral microemulsion formulation of alendronate: effects of oil and co-surfactant type on phase behaviour.

  Journal of microencapsulation 20080801

• Severely suppressed bone turnover and atypical skeletal fragility.

  The Journal of clinical endocrinology and metabolism 20080801

• Effect of denosumab on bone density and turnover in postmenopausal women with low bone mass after long-term continued, discontinued, and restarting of therapy: a randomized blinded phase 2 clinical trial.

  Bone 20080801

• Electrospray tandem mass spectrometry of alendronate analogues: fingerprints for characterization of new potential prodrugs.

  Rapid communications in mass spectrometry : RCM 20080801

• Maximizing effectiveness of bisphosphonate therapy for osteoporosis.

  Southern medical journal 20080801

• Potential excessive suppression of bone turnover with long-term oral bisphosphonate therapy in postmenopausal osteoporotic patients.

  Climacteric : the journal of the International Menopause Society 20080801

• Calcium, vitamin D supplements with or without alendronate and supragingival calculus formation in osteoporotic women: a preliminary study.

  Expert opinion on pharmacotherapy 20080801

• Occupational rhinitis to sodium alendronate.

  Allergy 20080801

• [Chronic mouth ulcer due to inadequate ingestion of alendronate].

  Atencion primaria 20080801

• Subtrochanteric displaced insufficiency fracture after long-term alendronate therapy--a case report.

  Acta orthopaedica 20080801

• Therapeutic effects of one-year alendronate treatment in three cases of osteoporosis with parietal thinning of skull.

  The journal of medical investigation : JMI 20080801

• Bisphosphonates and atrial fibrillation.

  Prescrire international 20080801

• More on atypical fractures of the femoral diaphysis.

  The New England journal of medicine 20080717

• [Alendronate prevents steroid-induced osteoporosis in patients with rheumatic diseases].

  Zhonghua yi xue za zhi 20080715

• Effects of teriparatide on serum calcium in postmenopausal women with osteoporosis previously treated with raloxifene or alendronate.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20080701

• Efficacy of intravenous alendronate for the treatment of glucocorticoid-induced osteoporosis in children with autoimmune diseases.

  Clinical rheumatology 20080701

• The population of health economic models is critical.

  Bone 20080701

• Impact of noncompliance with alendronate and risedronate on the incidence of nonvertebral osteoporotic fractures in elderly women.

  British journal of clinical pharmacology 20080701

• Stimulation of osteogenic differentiation and inhibition of adipogenic differentiation in bone marrow stromal cells by alendronate via ERK and JNK activation.

  Bone 20080701

• The effects of bisphosphonates on osteoblasts in vitro.

  Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 20080701

• The effects of systemic alendronate with or without intraalveolar collagen sponges on postextractive bone resorption: a single masked randomized clinical trial.

  The Journal of craniofacial surgery 20080701

• Changes in bone markers after once-weekly low-dose alendronate in postmenopausal women with moderate bone loss.

  Maturitas 20080620

• The effects of fatty acids in propylene glycol on the percutaneous absorption of alendronate across the excised hairless mouse skin.

  International journal of pharmaceutics 20080605

• Review of comparative effectiveness of treatments to prevent fractures.

  Annals of internal medicine 20080603

• Adherence to bisphosphonates therapy and hip fracture risk in osteoporotic women.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20080601

• The cost-effectiveness of the treatment of high risk women with osteoporosis, hypertension and hyperlipidaemia in Sweden.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20080601

• Onion decreases the ovariectomy-induced osteopenia in young adult rats.

  Bone 20080601

• Clinical concerns of alendronate use.

  Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20080601

• Alendronate may enhance implant osseointegration, study finds.

  Journal of the American Dental Association (1939) 20080601

• Efficacy of alendronate in the treatment of the SAPHO syndrome.

  Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 20080601

• The effects of alendronate treatment in osteoporotic patients affected by monoclonal gammopathy of undetermined significance.

  Calcified tissue international 20080601

• Postmarketing surveillance rates of uveitis and scleritis with bisphosphonates among a national veteran cohort.

  Retina (Philadelphia, Pa.) 20080601

• Adsorption and conformational change of myoglobin on biomimetic hydroxyapatite nanocrystals functionalized with alendronate.

  Langmuir : the ACS journal of surfaces and colloids 20080506

• Summaries for patients. Drug therapy for osteoporosis.

  Annals of internal medicine 20080506

• Relative effectiveness of osteoporosis drugs for preventing nonvertebral fracture.

  Annals of internal medicine 20080506

• Greater first year effectiveness drives favorable cost-effectiveness of brand risedronate versus generic or brand alendronate: modeled Canadian analysis.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20080501

• Treatment preference for monthly oral ibandronate and weekly oral alendronate in women with postmenopausal osteoporosis: A randomized, crossover study (BALTO II).

  Joint, bone, spine : revue du rhumatisme 20080501

• Persistence of weekly alendronate: a real-world study in Croatia.

  Clinical rheumatology 20080501

• Visualizing mineral binding and uptake of bisphosphonate by osteoclasts and non-resorbing cells.

  Bone 20080501

• Determinants of non-compliance with bisphosphonates in women with postmenopausal osteoporosis.

  Current medical research and opinion 20080501

• Mandible matrix necrosis in beagle dogs after 3 years of daily oral bisphosphonate treatment.

  Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20080501

• Bisphosphonate related osteonecrosis of the palate: report of a case managed with free tissue transfer.

  Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 20080501

• Enhanced gap filling and osteoconduction associated with alendronate-calcium phosphate-coated porous tantalum.

  The Journal of bone and joint surgery. American volume 20080501

• Alendronate reduces bone toughness of ribs without significantly increasing microdamage accumulation in dogs following 3 years of daily treatment.

  Calcified tissue international 20080501

• Esophageal transit and in vivo disintegration of branded risedronate sodium tablets and two generic formulations of alendronic acid tablets: a single-center, single-blind, six-period crossover study in healthy female subjects.

  Clinical therapeutics 20080501

• Osteoporotic fracture management in India: a survey of orthopaedic surgeons.

  Journal of the Indian Medical Association 20080501

• [Experiment study of alendronate in the prevention and treatment of aseptic loosening of prosthesis].

  Zhongguo gu shang = China journal of orthopaedics and traumatology 20080501

• Considering competing risks . . . Not all black and white.

  Archives of internal medicine 20080428

• Use of alendronate and risk of incident atrial fibrillation in women.

  Archives of internal medicine 20080428

• Biocompatibility of poly(D,L-lactide-co-glycolide) nanoparticles conjugated with alendronate.

  Biomaterials 20080401

• Effects of alendronate and pamidronate on cultured rat metatarsal bones: failure to prevent dexamethasone-induced growth retardation.

  Bone 20080401

• Long-term effects of local pretreatment with alendronate on healing of replanted rat teeth.

  Journal of periodontal research 20080401

• A comparison of the effect of alendronate and risedronate on bone mineral density in postmenopausal women with osteoporosis: 24-month results from FACTS-International.

  International journal of clinical practice 20080401

• In vitro disintegration and dissolution studies of once-weekly copies of alendronate sodium tablets (70 mg) and in vivo implications.

  Current medical research and opinion 20080401

• Intragastric alendronate therapy in two infants with vitamin D intoxication: a new method.

  Clinical toxicology (Philadelphia, Pa.) 20080401

• Effect of preoperative combined treatment with alendronate and calcitriol on fixation of hydroxyapatite-coated implants in ovariectomized rats.

  The Journal of bone and joint surgery. American volume 20080401

• Osteonecrosis of the jaw: new developments in an old disease.

  The Journal of rheumatology 20080401

• Effects of bisphosphonates on lipid metabolism.

  Neuro endocrinology letters 20080401

• Increase in bone mass after correction of vitamin D insufficiency in bisphosphonate-treated patients.

  Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 20080401

• Local action of sodium alendronate in bone repair of spontaneously hypertensive rat (SHR).

  Arquivos brasileiros de cardiologia 20080401

• Oral bisphosphonate prevents bone loss in androgen deprivation therapy for nonmetastatic prostate cancer.

  Hinyokika kiyo. Acta urologica Japonica 20080401

• Osteodensitometry in healthy postmenopausal women.

  Prescrire international 20080401

• Paget's disease of bone in a patient on hemodialysis.

  Iranian journal of kidney diseases 20080401

• Teriparatide or alendronate in glucocorticoid-induced osteoporosis.

  The New England journal of medicine 20080320

• Atypical fractures of the femoral diaphysis in postmenopausal women taking alendronate.

  The New England journal of medicine 20080320

• Teriparatide or alendronate in glucocorticoid-induced osteoporosis.

  The New England journal of medicine 20080320

• Bone turnover and bone collagen maturation in osteoporosis: effects of antiresorptive therapies.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20080301

• Adherence to alendronate in male veterans.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20080301

• Renal function and bisphosphonate safety.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20080301

• Alendronate-hydroxyapatite nanocomposites and their interaction with osteoclasts and osteoblast-like cells.

  Biomaterials 20080301

• Bisphosphonates alter trabecular bone collagen cross-linking and isomerization in beagle dog vertebra.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20080301

• Alendronate-induced synovitis.

  The Journal of rheumatology 20080301

• Cost-effectiveness of a fixed dose combination of alendronate and cholecalciferol in the treatment and prevention of osteoporosis in the United Kingdom and The Netherlands.

  Current medical research and opinion 20080301

• Discontinuity and failures of therapy with bisphosphonates: joint assessment of predictors with multi-state models.

  Pharmacoepidemiology and drug safety 20080301

• Comment on: Bisphosphonates and osteonecrosis of the jaw.

  Rheumatology (Oxford, England) 20080301

• Interaction between IGF-1, inflammation, and neuropathy in the pathogenesis of acute charcot neuroarthropathy: lessons from alendronate therapy and future perspectives of medical therapy.

  Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 20080301

• Aminobisphosphonates cause osteoblast apoptosis and inhibit bone nodule formation in vitro.

  Calcified tissue international 20080301

• Prevention of bone loss after withdrawal of tamoxifen.

  Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 20080301

• [Assessment of bone quality. Effects of osteoporosis medications on structural and mechanical integrity of bone].

  Clinical calcium 20080301

• Chronic kidney disease--a disease domain complex.

  Geriatrics 20080301

• Treatment trial of multicentric reticulohistiocytosis with a combination of predonisolone, methotrexate and alendronate.

  The Journal of dermatology 20080301

• Effect of inappropriate and continuous therapy with alendronate for ten years on skeletal integrity - observations in two elderly patients.

  Journal of endocrinological investigation 20080301

• [Osteonecrosis of the jaw developing during bisphosphonate treatment].

  Magyar onkologia 20080301

• Bisphosphonate-related osteonecrosis of the jaws--report of 2 cases and strategies on prevention and management.

  Quintessence international (Berlin, Germany : 1985) 20080301

• Comparison of effects of alendronate and raloxifene on lumbar bone mineral density, bone turnover, and lipid metabolism in elderly women with osteoporosis.

  Yonsei medical journal 20080227

• Use of weekly alendronate to treat osteoporosis in boys with muscular dystrophy.

  American journal of physical medicine & rehabilitation 20080201

• Alendronate for the treatment of osteoporosis in men.

  Expert opinion on pharmacotherapy 20080201

• An emerging pattern of subtrochanteric stress fractures: a long-term complication of alendronate therapy?

  Injury 20080201

• Influence of estrogen deficiency and its treatment with alendronate and estrogen on bone density around osseointegrated implants: radiographic study in female rats.

  Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 20080201

• Beneficial effects of combined administration of alendronate and alfacalcidol on cancellous bone mass of the tibia in orchidectomized rats: a bone histomorphometry study.

  Journal of nutritional science and vitaminology 20080201

• NMR investigations of the static and dynamic structures of bisphosphonates on human bone: a molecular model.

  Journal of the American Chemical Society 20080130

• Alendronate decreases TRACP 5b activity in osteoarthritic bone.

  European journal of medical research 20080123

• Alendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women.

  The Cochrane database of systematic reviews 20080123

• [Long term effects of raloxifen on the bones].

  Ugeskrift for laeger 20080121

• Changes in vertebral strength-density and energy absorption-density relationships following bisphosphonate treatment in beagle dogs.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20080101

• Treatment of immobilization hypercalciuria using weekly alendronate in two quadriplegic patients.

  International urology and nephrology 20080101

• Evaluation of a fully automated serum assay for total N-terminal propeptide of type I collagen in postmenopausal osteoporosis.

  Clinical chemistry 20080101

• Once-monthly oral ibandronate compared with weekly oral alendronate in postmenopausal osteoporosis: results from the head-to-head MOTION study.

  Current medical research and opinion 20080101

• Alendronate treatment promotes bone formation with a less anisotropic microstructure during intramembranous ossification in rats.

  Journal of bone and mineral metabolism 20080101

• A significant improvement in lower limb pain after treatment with alendronate in two cases of Camurati-Engelmann disease.

  Journal of bone and mineral metabolism 20080101

• The cost-effectiveness of alendronate in the management of osteoporosis.

  Bone 20080101

• The effects of bone remodeling inhibition by alendronate on three-dimensional microarchitecture of subchondral bone tissues in guinea pig primary osteoarthrosis.

  Calcified tissue international 20080101

• AAOMP case challenge: pain in the right posterior mandible.

  The journal of contemporary dental practice 20080101

• Treatment of renal transplant recipients with low bone mineral density: a randomized prospective trial of alendronate, alfacalcidol, and alendronate combined with alfacalcidol.

  Transplantation proceedings 20080101

• Effects of bisphosphonates on fracture incidence and bone metabolism in rheumatoid arthritis patients in general practice taking long-term corticosteroid therapy: a retrospective study.

  Clinical drug investigation 20080101

• No increased bone formation around alendronate or omeprazole loaded bioactive bone cements in a femoral defect.

  Tissue engineering. Part A 20080101

• Latent hypoparathyroidism in an osteoporotic patient with multiple endocrinopathies and secondary hemochromatosis due to multiple blood transfusions, unmasked by alendronate and glucocorticoid at adrenal crisis.

  Internal medicine (Tokyo, Japan) 20080101

• Alendronate decreases orthotopic PC-3 prostate tumor growth and metastasis to prostate-draining lymph nodes in nude mice.

  BMC cancer 20080101

• In vitro and in vivo assays to analyze the contribution of Rho kinase in angiogenesis.

  Methods in enzymology 20080101

• Effect of alendronate on glucocorticoid-induced osteoporosis in Japanese women with systemic autoimmune diseases: versus alfacalcidol.

  Modern rheumatology 20080101

• Low-energy femoral shaft fractures associated with alendronate use.

  Journal of orthopaedic trauma 20080101

• Response of serum carboxylated and undercarboxylated osteocalcin to alendronate monotherapy and combined therapy with vitamin K2 in postmenopausal women.

  Journal of bone and mineral metabolism 20080101

• Effect of ovariectomy and alendronate on implant osseointegration in rat maxillary bone.

  The Journal of oral implantology 20080101

• The absorption of (99m)Tc-alendronate given by rectal route in rabbits.

  Pharmaceutical development and technology 20080101

• Effects of denosumab on the geometry of the proximal femur in postmenopausal women in comparison with alendronate.

  Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 20080101

• Biodistribution and pharmacokinetic studies of bone-targeting N-(2-hydroxypropyl)methacrylamide copolymer-alendronate conjugates.

  Molecular pharmaceutics 20080101

• Nodular scleritis following alendronate therapy.

  Ocular immunology and inflammation 20080101

• Application of UV-derivative spectrophotometry for determination of some bisphosphonates drugs in pharmaceutical formulations.

  Acta poloniae pharmaceutica 20080101

• [Non-hormonal treatments of postmenopausal osteoporosis].

  Gynecologie, obstetrique & fertilite 20080101

• Treatment of postmenopausal osteoporosis in women: a systematic review.

  Cadernos de saude publica 20080101

• Prolyl-hydroxyproline dipeptide in non-hydrolyzed morning urine and its value in postmenopausal osteoporosis.

  Clinical chemistry and laboratory medicine 20080101

• Alendronate-induced esophagitis: possible pathogenic role of hypersensitivity to alendronate.

  Internal medicine (Tokyo, Japan) 20080101

• Clinical performance of six different serum tartrate-resistant acid phosphatase assays for monitoring alendronate treatment.

  Clinical laboratory 20080101

• Medical treatment of otosclerosis: rationale for use of bisphosphonates.

  The international tinnitus journal 20080101

• Cost effectiveness of ultrasound and bone densitometry for osteoporosis screening in post-menopausal women.

  Applied health economics and health policy 20080101

• Cocktail therapy for hip necrosis in SARS patients.

  Chang Gung medical journal 20080101

• Fosamax and osteonecrosis of the jaw--important questions and answers.

  General dentistry 20080101

• Actin polymerization modulates CD44 surface expression, MMP-9 activation, and osteoclast function.

  Journal of cellular physiology 20071201

• Improving the outcome of established therapies for osteoporosis by adding the active D-hormone analog alfacalcidol.

  Rheumatology international 20071201

• Two-year treatment with denosumab (AMG 162) in a randomized phase 2 study of postmenopausal women with low BMD.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20071201

• Hip fractures in users of first- vs. second-generation bisphosphonates.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20071201

• Effects of alendronate on tooth eruption and molar root formation in young growing rats.

  Cell and tissue research 20071201

• [Damage to the respiratory tract due to aspirated alendronate].

  Pneumologie (Stuttgart, Germany) 20071201

• [Osteoporosis and bisphosphonates].

  Zeitschrift fur Rheumatologie 20071201

• Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment.

  Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20071201

• The effects of daily alendronate, daily calcitonin and alendronate every other day on bone mineral density in osteoporotic men.

  The aging male : the official journal of the International Society for the Study of the Aging Male 20071201

• Antiangiogenic effects of bisphosphonates on laser-induced choroidal neovascularization in mice.

  Investigative ophthalmology & visual science 20071201

• Sequential non-traumatic femoral shaft fractures in a patient on long-term alendronate.

  Hong Kong medical journal = Xianggang yi xue za zhi 20071201

• [Parathyroid and bone. Role of parathyroid hormone in the treatment of osteoporosis].

  Clinical calcium 20071201

• [Parathyroid and bone. Evidence and perspective of parathyroid therapy for patients with osteoporosis].

  Clinical calcium 20071201

• Strategy of aggressive steroid weaning and routine alendronate therapy to reduce bone loss after cardiac transplantation.

  Transplantation proceedings 20071201

• Evidence based medicine and effective interventions of pharmacological therapy for the prevention of osteoporotic fractures.

  Minerva endocrinologica 20071201

• Alendronate treatment in the revision setting, with and without controlled implant motion: an experimental study in dogs.

  Acta orthopaedica 20071201

• Alendronate with calcium and vitamin D supplementation is safe and effective for the treatment of decreased bone mineral density in HIV.

  AIDS (London, England) 20071130

• [FACT study].

  Nihon rinsho. Japanese journal of clinical medicine 20071128

• [Bisphosphonates for osteoporosis].

  Nihon rinsho. Japanese journal of clinical medicine 20071128

• [Combination therapy for osteoporosis].

  Nihon rinsho. Japanese journal of clinical medicine 20071128

• [Evidence of alendronate treatment for osteoporosis].

  Nihon rinsho. Japanese journal of clinical medicine 20071128

• [Influence on atherosclerosis of improvement of bone mineral density after medication for osteoporosis].

  Nihon rinsho. Japanese journal of clinical medicine 20071128

• [Efficacy and tolerability of once-weekly administration of 35 mg alendronate and 17.5 mg risedronate].

  Nihon rinsho. Japanese journal of clinical medicine 20071128

• [Diagnosis, clinical feature and treatment of glucocorticoid-induced osteoporosis in patients with rheumatoid arthritis].

  Nihon rinsho. Japanese journal of clinical medicine 20071128

• [Bisphosphonate treatment in osteonecrosis of the femoral head].

  Nihon rinsho. Japanese journal of clinical medicine 20071128

• Conjugation of poorly absorptive drugs with mucoadhesive polymers for the improvement of oral absorption of drugs.

  Journal of controlled release : official journal of the Controlled Release Society 20071120

• Teriparatide or alendronate in glucocorticoid-induced osteoporosis.

  The New England journal of medicine 20071115

• Anabolic therapy in glucocorticoid-induced osteoporosis.

  The New England journal of medicine 20071115

• Bone densitometry and treatment for osteoporosis in older men.

  JAMA 20071114

• Simulation-based cost-utility analysis of population screening-based alendronate use in Switzerland.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20071101

• Three years of alendronate treatment results in similar levels of vertebral microdamage as after one year of treatment.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20071101

• Patient compliance with alendronate, risedronate and raloxifene for the treatment of osteoporosis in postmenopausal women.

  Current medical research and opinion 20071101

• Cognitive effects of short-term use of raloxifene: a randomized clinical trial.

  The International journal of neuroscience 20071101

• Effects of antifracture drugs in postmenopausal, male and glucocorticoid-induced osteoporosis--usefulness of alendronate and risedronate.

  Expert opinion on pharmacotherapy 20071101

• Effect of an estrogen-deficient state and alendronate therapy on bone loss resulting from experimental periapical lesions in rats.

  Journal of endodontics 20071101

• Metaphyseal sclerosis associated with bisphosphonate therapy.

  Journal of pediatric endocrinology & metabolism : JPEM 20071101

• By the way, doctor. I take Fosamax with vitamin D and a multivitamin that contains vitamin D. Now I see my calcium tablets also have vitamin D in them. Am I getting too much of this vitamin?

  Harvard women's health watch 20071101

• Osteoporosis--from hormonal replacement therapy to bisphosphonates and beyond: a review.

  East African medical journal 20071101

• Collapsing focal segmental glomerulosclerosis in a liver transplant recipient on alendronate.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20071001

• Re: 'A single zoleledronic acid infusion reduces bone resorption markers more rapidly than weekly oral alendronate in postmenopausal women with low bone mineral density' by Saag et al.

  Bone 20071001

• Alendronate has an anabolic effect on bone through the differentiation of mesenchymal stem cells.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20071001

• Soaking morselized allograft in bisphosphonate can impair implant fixation.

  Clinical orthopaedics and related research 20071001

• Effect of local delivery of alendronate on bone formation in bioactive glass grafting in rats.

  Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 20071001

• Alendronate therapy in cyclosporine-induced alveolar bone loss in rats.

  Journal of periodontal research 20071001

• Osteoporosis: non-hormonal treatment.

  Climacteric : the journal of the International Menopause Society 20071001

• Iontophoresis significantly increases the trans-dentinal delivery of osteoprotegerin, alendronate, and calcitonin.

  Journal of endodontics 20071001

• [Osteoporosis in the patients with rheumatoid arthritis (3) : the efficacy and the selection of the osteoporosis therapeutic drug].

  Clinical calcium 20071001

• Effect of RANKL-specific denosumab on osteoclast number and function: a potential friend or foe?

  Current opinion in investigational drugs (London, England : 2000) 20071001

• [Pharmacological and clinical profile of once weekly alendronate for the treatment of osteoporosis (Fosamac 35 mg/Bonalon 35 mg)].

  Nihon yakurigaku zasshi. Folia pharmacologica Japonica 20071001

• Prophylactic effect of rebamipide against the irritative and healing impairment actions of alendronate in rat stomachs.

  Inflammopharmacology 20071001

• Ask the doctor. I am 86 years old and have been taking Fosamax to strengthen my bones for nearly 10 years. A few months ago, I suddenly fainted and was later diagnosed with atrial fibrillation. Did that happen because I was taking Fosamax?

  Harvard heart letter : from Harvard Medical School 20071001

• Modern milk alkali syndrome--a preventable serious condition.

  The New Zealand medical journal 20070921

• Design of surface-modified poly(D,L-lactide-co-glycolide) nanoparticles for targeted drug delivery to bone.

  Journal of controlled release : official journal of the Controlled Release Society 20070911

• Novel biomineral-binding cyclodextrins for controlled drug delivery in the oral cavity.

  Journal of controlled release : official journal of the Controlled Release Society 20070911

• The effects of combination of alendronate and human parathyroid hormone(1-34) on bone strength are synergistic in the lumbar vertebra and additive in the femur of C57BL/6J mice.

  Endocrinology 20070901

• Low bone mineral density is associated with bone microdamage accumulation in postmenopausal women with osteoporosis.

  Bone 20070901

• Alendronate PLGA microspheres with high loading efficiency for dental applications.

  Journal of microencapsulation 20070901

• Osteoporosis medication profile preference: results from the PREFER-US study.

  Health expectations : an international journal of public participation in health care and health policy 20070901

• Implant placement with or without simultaneous tooth extraction in patients taking oral bisphosphonates: postoperative healing, early follow-up, and the incidence of complications in two private practices.

  Journal of periodontology 20070901

• Denture-related osteonecrosis of the maxilla associated with oral bisphosphonate treatment.

  Journal of the American Dental Association (1939) 20070901

• Bisphosphonate therapy for reduced bone mineral density during treatment of acute lymphoblastic leukemia in childhood and adolescence: a report of preliminary experience.

  Journal of pediatric hematology/oncology 20070901

• [The treatment of renal lithiasis with biphosphonates].

  Archivos espanoles de urologia 20070901

• Yearly zoledronic acid in postmenopausal osteoporosis.

  The New England journal of medicine 20070816

• Development and application of a high-performance liquid chromatography-mass spectrometry method to determine alendronate in human urine.

  Journal of chromatography. A 20070810

• [Diphosphonate therapy and osteonecrosis of the jaw].

  Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20070809

• Cost-effectiveness of bone densitometry followed by treatment of osteoporosis in older men.

  JAMA 20070808

• The effect of pregnancy on pre-existing osteopenia: a case report.

  Archives of gynecology and obstetrics 20070801

• Cost-effectiveness of alendronate in the treatment of postmenopausal women in 9 European countries--an economic evaluation based on the fracture intervention trial.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20070801

• Impairment of gastric ulcer healing by alendronate, a nitrogen-containing bisphosphonate, in rats.

  Digestive diseases and sciences 20070801

• Effect of short-term treatment with alendronate on ulnar bone adaptation to cyclic fatigue loading in rats.

  Journal of orthopaedic research : official publication of the Orthopaedic Research Society 20070801

• Individual and combined effects of exercise and alendronate on bone mass and strength in ovariectomized rats.

  Bone 20070801

• Comparative in vitro study of oesophageal adhesiveness of different commercial formulations containing alendronate.

  European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20070801

• Age-related changes in marmoset trabecular and cortical bone and response to alendronate therapy resemble human bone physiology and architecture.

  Anatomical record (Hoboken, N.J. : 2007) 20070801

• Adverse cutaneous drug reaction to alendronate.

  Contact dermatitis 20070801

• Morphometric and microscopic evaluation of the effect of a solution of alendronate as an intracanal therapeutic agent in rat teeth submitted to late reimplantation.

  Dental traumatology : official publication of International Association for Dental Traumatology 20070801

• Alendronate inhibits cell invasion and MMP-2 secretion in human chondrosarcoma cell line.

  Acta pharmacologica Sinica 20070801

• Additive-free albumin nanoparticles of alendronate for attenuating inflammation through monocyte inhibition.

  Nanomedicine (London, England) 20070801

• [Glucocorticoid-induced osteoporosis].

  Polskie Archiwum Medycyny Wewnetrznej 20070801

• Oral bisphosphonate associated osteonecrosis of the jaws: three case reports.

  British dental journal 20070728

• Hetereogeneity in skeletal response to full-length parathyroid hormone in the treatment of osteoporosis.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20070701

• Is cortical bone hip? What determines cortical bone properties?

  Bone 20070701

• Intravenous zoledronic acid 5 mg in the treatment of postmenopausal women with low bone density previously treated with alendronate.

  Bone 20070701

• Effect of 17beta-estradiol and alendronate on the removal torque of osseointegrated titanium implants in ovariectomized rats.

  Journal of periodontology 20070701

• Locally administered low-dose alendronate increases bone mineral density during distraction osteogenesis in a rabbit model.

  The Journal of bone and joint surgery. British volume 20070701

• Malignancy-related hypercalcemia developing on a bisphosphonate but responding to calcitonin.

  Clinical lung cancer 20070701

• Efficacy of bisphosphonates for the control of alveolar bone loss in periodontitis.

  Journal of the International Academy of Periodontology 20070701

• [Osteoporosis treatment: choices and options].

  Polskie Archiwum Medycyny Wewnetrznej 20070701

• Bisphosphonates: are they standard of care for the treatment of breast cancer?

  British journal of cancer 20070618

• Hepatotoxicity induced by alendronate therapy.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20070601

• Systemic alendronate treatment improves fixation of press-fit implants: a canine study using nonloaded implants.

  Journal of orthopaedic research : official publication of the Orthopaedic Research Society 20070601

• Pretreatment with anticatabolic agents blunts but does not eliminate the skeletal anabolic response to parathyroid hormone in oophorectomized mice.

  Endocrinology 20070601

• Characterizing early prescribers of newly marketed drugs in Canada: a population-based study.

  European journal of clinical pharmacology 20070601

• Natural calcium isotopic composition of urine as a marker of bone mineral balance.

  Clinical chemistry 20070601

• Treatment with alendronate plus calcium, alendronate alone, or calcium alone for postmenopausal low bone mineral density.

  Current medical research and opinion 20070601

• Pharmacological treatment of osteoporosis for people over 70.

  Aging clinical and experimental research 20070601

• Contrast agent may aid cancer detection.

  JAMA 20070509

• Use of alendronate after 5 years of treatment.

  JAMA 20070509

• Use of alendronate after 5 years of treatment.

  JAMA 20070509

• Use of alendronate after 5 years of treatment.

  JAMA 20070509

• Alendronate induces anti-migratory effects and inhibition of neutral phosphatases in UMR106 osteosarcoma cells.

  European journal of pharmacology 20070507

• [Practical guidelines for the management of osteoporosis--evidence-based and cost-effective].

  Deutsche medizinische Wochenschrift (1946) 20070504

• Alendronate and atrial fibrillation.

  The New England journal of medicine 20070503

• Bisphosphonate treatment in ochronotic osteoporotic patients.

  Clinical rheumatology 20070501

• A single zoledronic acid infusion reduces bone resorption markers more rapidly than weekly oral alendronate in postmenopausal women with low bone mineral density.

  Bone 20070501

• The bisphosphonate alendronate improves the damage associated with trinitrobenzenesulfonic acid-induced colitis in rats.

  British journal of pharmacology 20070501

• Prevention of glucocorticoid induced osteoporosis with alendronate or alfacalcidol: relations of change in bone mineral density, bone markers, and calcium homeostasis.

  The Journal of rheumatology 20070501

• Bisphosphonates. A cornerstone of osteoporosis treatment.

  Mayo Clinic women's healthsource 20070501

• Secondary hyperparathyroidism due to hypovitaminosis D affects bone mineral density response to alendronate in elderly women with osteoporosis: a randomized controlled trial.

  Journal of the American Geriatrics Society 20070501

• Comparison of testosterone, alendronate, and a combination of both therapies in men with low bone mineral density.

  Journal of investigative medicine : the official publication of the American Federation for Clinical Research 20070501

• [Persistent polyarticular synovitis after treatment with alendronate].

  Ugeskrift for laeger 20070423

• Interventions for the treatment of decreased bone mineral density associated with HIV infection.

  The Cochrane database of systematic reviews 20070418

• [Progress in diagnosis and therapy: Hypercalcemia due to primary hyperparathyroidism].

  Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine 20070410

• Local alendronate increases fixation of implants inserted with bone compaction: 12-week canine study.

  Journal of orthopaedic research : official publication of the Orthopaedic Research Society 20070401

• Comparative effects of raloxifene and alendronate on fracture outcomes in postmenopausal women with low bone mass.

  Bone 20070401

• Alendronate prevents bone loss and improves tendon-to-bone repair strength in a canine model.

  Journal of orthopaedic research : official publication of the Orthopaedic Research Society 20070401

• Alendronate prevents bone loss in patients with acute spinal cord injury: a randomized, double-blind, placebo-controlled study.

  The Journal of clinical endocrinology and metabolism 20070401

• Risedronate and alendronate suppress osteocyte apoptosis following cyclic fatigue loading.

  Bone 20070401

• Alendronate treatment in women with normal to severely impaired renal function: an analysis of the fracture intervention trial.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20070401

• Reduced bone formation and relatively increased bone resorption in absorptive hypercalciuria.

  Kidney international 20070401

• Pathological effects of drugs on the gastrointestinal tract: a review.

  Human pathology 20070401

• [Secondary osteoporosis. Evidence of treatment efficacy in patients with glucocorticoid-induced osteoporosis].

  Clinical calcium 20070401

• Meds hiatus won't hurt your hips. Five years on, five years off: taking a break from Fosamax won't result in broken bones.

  DukeMedicine healthnews 20070401

• Effect of bisphosphonates on bone mineral density after renal transplantation as assessed by bone mineral densitometry.

  Transplantation proceedings 20070401

• Amino-bisphosphonates decrease hTERT gene expression in breast cancer in vitro.

  Aging clinical and experimental research 20070401

• Alendronic acid: synovitis, myalgia and arthralgia.

  Prescrire international 20070401

• [Mouth ulcers].

  Annales de dermatologie et de venereologie 20070401

• Therapeutic management of bone demineralization in the HIV-infected population.

  AIDS (London, England) 20070330

• [Osteoporosis compounds in general practice. That is REAL: in routine practice the better choice].

  MMW Fortschritte der Medizin 20070329

• Summaries for patients. Preventing bone loss in men with prostate cancer.

  Annals of internal medicine 20070320

• Effect of once-weekly oral alendronate on bone loss in men receiving androgen deprivation therapy for prostate cancer: a randomized trial.

  Annals of internal medicine 20070320

• Alendronate suppresses tumor angiogenesis by inhibiting Rho activation of endothelial cells.

  Biochemical and biophysical research communications 20070309

• Elevations in serum and urinary calcium with parathyroid hormone (1-84) with and without alendronate for osteoporosis.

  The Journal of clinical endocrinology and metabolism 20070301

• Superiority of a combined treatment of Alendronate and Alfacalcidol compared to the combination of Alendronate and plain vitamin D or Alfacalcidol alone in established postmenopausal or male osteoporosis (AAC-Trial).

  Rheumatology international 20070301

• Inhibitory effect of alendronate on bone resorption of autogenous free bone grafts in rats.

  Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20070301

• Resolution of bisphosphonate-associated osteonecrosis of the mandible: possible application for intermittent low-dose parathyroid hormone [rhPTH(1-34)].

  Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20070301

• Prevention and treatment of glucocorticoid-induced osteoporosis.

  Current osteoporosis reports 20070301

• Effect of long-term oral bisphosphonates on implant wound healing: literature review and a case report.

  Journal of periodontology 20070301

• Gaps in treatment among users of osteoporosis medications: the dynamics of noncompliance.

  The American journal of medicine 20070301

• A claims database analysis of persistence with alendronate therapy and fracture risk in post-menopausal women with osteoporosis.

  Current medical research and opinion 20070301

• Subtrochanteric insufficiency fractures in patients on alendronate therapy: a caution.

  The Journal of bone and joint surgery. British volume 20070301

• [Prevention of glucocorticoid induced osteoporosis with alendronate or alfacalcidol].

  Medizinische Monatsschrift fur Pharmazeuten 20070301

• [Questions and answers about bisphosphonates].

  Presse medicale (Paris, France : 1983) 20070301

• Oral bisphosphonate treatment for osteogenesis imperfecta--an Indian perspective.

  Annals of tropical paediatrics 20070301

• Osteochemonecrosis of jaws and bisphosphonates.

  Irish medical journal 20070301

• [Recent topics in the treatment of osteoporosis in Japan].

  Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics 20070301

• Nanosuspensions of alendronate with gallium or gadolinium attenuate neointimal hyperplasia in rats.

  Journal of controlled release : official journal of the Controlled Release Society 20070226

• Application of a semi-automated 96-well format solid-phase extraction, column-switching, fluorescence detection protocol for the determination of alendronate in human urine samples obtained from a bioequivalence study.

  Journal of pharmaceutical and biomedical analysis 20070219

• Differential effects of bisphosphonates on breast cancer cell lines.

  Cancer letters 20070208

• Comparison of the effect of alendronate on lumbar bone mineral density and bone turnover in men and postmenopausal women with osteoporosis.

  Clinical rheumatology 20070201

• Potential for bone turnover markers to cost-effectively identify and select post-menopausal osteopenic women at high risk of fracture for bisphosphonate therapy.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20070201

• Histidine decarboxylase-stimulating and inflammatory effects of alendronate in mice: involvement of mevalonate pathway, TNFalpha, macrophages, and T-cells.

  International immunopharmacology 20070201

• Clinical concerns of alendronate use.

  Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20070201

• Comparison of alendronate vs alendronate plus mechanical loading as prophylaxis for osteoporosis in lung transplant recipients: a pilot study.

  The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20070201

• Differences of therapeutic effects on regional bone mineral density and markers of bone mineral metabolism between alendronate and alfacalcidol in Japanese osteoporotic women.

  The journal of medical investigation : JMI 20070201

• Co-treatment of PTH with osteoprotegerin or alendronate increases its anabolic effect on the skeleton of oophorectomized mice.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20070101

• Effects of teriparatide and alendronate on vertebral strength as assessed by finite element modeling of QCT scans in women with osteoporosis.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20070101

• Bisphosphonates may also be effective in the management of non-skeletal metastases in hormone receptor positive breast cancer.

  Medical hypotheses 20070101

• Differential effects of statins and alendronate on cholinesterases in serum and brain of rats.

  Physiological research 20070101

• Effectiveness of bisphosphonates on nonvertebral and hip fractures in the first year of therapy: the risedronate and alendronate (REAL) cohort study.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20070101

• Bisphosphonate-associated osteonecrosis of the jaw in patients with multiple myeloma and breast cancer.

  Acta haematologica 20070101

• Brand versus generic alendronate: gastrointestinal effects measured by resource utilization.

  The Annals of pharmacotherapy 20070101

• Matrix metalloproteinases, tissue inhibitor of matrix metalloproteinase-1, and laminin-5 gamma2 chain immunolocalization in gingival tissue of endotoxin-induced periodontitis in rats: effects of low-dose doxycycline and alendronate.

  Journal of periodontology 20070101

• Alendronate improves screw fixation in osteoporotic bone.

  The Journal of bone and joint surgery. American volume 20070101

• How long should patients take medications for postmenopausal osteoporosis?

  Joint, bone, spine : revue du rhumatisme 20070101

• Comparison of raloxifene and bisphosphonates based on adherence and treatment satisfaction in postmenopausal Asian women.

  Journal of bone and mineral metabolism 20070101

• Changes in bone resorption markers among Japanese patients with postmenopausal osteoporosis treated with alendronate and risedronate.

  Journal of bone and mineral metabolism 20070101

• [Bilateral fracture of the femoral neck following transient osteoporosis in pregnancy].

  Zeitschrift fur Orthopadie und ihre Grenzgebiete 20070101

• [The histopathological evaluation of the local tolerance of alendronate containing medicines].

  Endokrynologia Polska 20070101

• [Severe osteoporosis with vertebral crushes in juvenile dermatomyositis. Effect of oral alendronate therapy].

  Medicina 20070101

• Relative effects of exercise training and alendronate treatment on skeletal muscle function of ovariectomized rats.

  Menopause (New York, N.Y.) 20070101

• Cost-effectiveness of preventative therapies for postmenopausal women with osteopenia.

  BMC women's health 20070101

• Alendronate inhibits periprosthetic bone loss around uncemented femoral components.

  Journal of bone and mineral metabolism 20070101

• Idiopathic sporadic tumoral calcinosis of the hip: successful oral bisphosphonate therapy.

  Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 20070101

• The effect of alendronate, risedronate, and raloxifene on renal functions, based on the Cockcroft and Gault method, in postmenopausal women.

  Renal failure 20070101

• Corticosteroid-induced osteoporosis in children: outcome after two-year follow-up, risk factors, densitometric predictive cut-off values for vertebral fractures.

  Clinical and experimental rheumatology 20070101

• Rapid determination of bisphosphonates by ion chromatography with indirect UV detection.

  Journal of chromatographic science 20070101

• Effects of alendronate sodium therapy on carotid intima media thickness in postmenopausal women with osteoporosis.

  Advances in therapy 20070101

• Bisphosphonates and osteonecrosis of the jaw: a retrospective study.

  Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 20070101

• Rolipram, a phosphodiesterase 4 inhibitor, prevented cancellous and cortical bone loss by inhibiting endosteal bone resorption and maintaining the elevated periosteal bone formation in adult ovariectomized rats.

  Journal of musculoskeletal & neuronal interactions 20070101

• Common musculoskeletal adverse effects of oral treatment with once weekly alendronate and risedronate in patients with osteoporosis and ways for their prevention.

  Journal of musculoskeletal & neuronal interactions 20070101

• Combined therapies in osteoporosis: bisphosphonates and vitamin D-hormone analogs.

  Journal of musculoskeletal & neuronal interactions 20070101

• Hypocalcemia after alendronate therapy in a patient with celiac disease.

  Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 20070101

• Factors affecting long-term compliance of osteoporotic patients with bisphosphonate treatment and QOL assessment in actual practice: alendronate and risedronate.

  Journal of bone and mineral metabolism 20070101

• Pelvic insufficiency fracture associated with severe suppression of bone turnover by alendronate therapy.

  Journal of bone and mineral metabolism 20070101

• Osteotropic Peptide that differentiates functional domains of the skeleton.

  Bioconjugate chemistry 20070101

• The influence of ovariectomy, simvastatin and sodium alendronate on alveolar bone in rats.

  Brazilian oral research 20070101

• Safety considerations with bisphosphonates for the treatment of osteoporosis.

  Drug safety 20070101

• Oral bisphosphonate adverse effects in 849 patients with metabolic bone diseases.

  Hormones (Athens, Greece) 20070101

• Looking beyond low bone mineral density: multiple insufficiency fractures in a woman with post-menopausal osteoporosis on alendronate therapy.

  Journal of endocrinological investigation 20070101

• Antiosteoporotic effect of Polycan, beta-glucan from Aureobasidium, in ovariectomized osteoporotic mice.

  Nutrition (Burbank, Los Angeles County, Calif.) 20070101

• Are there any alternatives to alendronate (Fosamax) for osteoporosis to avoid the risk of osteonecrosis of the jaw?

  General dentistry 20070101

• Influence of type 2 diabetes mellitus on bone mineral density response to bisphosphonates in late postmenopausal osteoporosis.

  Advances in therapy 20070101

• Radiographic and histological evaluation of bisphosphonate alendronate and metotrexate effects on rat mandibles inoculated with Walker 256 carcinosarcoma.

  Acta cirurgica brasileira 20070101

• Use of platelet-rich plasma in the management of oral biphosphonate-associated osteonecrosis of the jaw: a report of 2 cases.

  The Journal of oral implantology 20070101

• [Alendronate and vitamin D (Fosavance): persistence, adherence and importance of vitamin D].

  Reumatizam 20070101

• Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial.

  JAMA 20061227

• Ten vs five years of bisphosphonate treatment for postmenopausal osteoporosis: enough of a good thing.

  JAMA 20061227

• Response rate of bone mineral density to teriparatide in postmenopausal women with osteoporosis.

  Bone 20061201

• Urinary gamma-glutamyltransferase (GGT) as a potential marker of bone resorption.

  Bone 20061201

• Effects of a combined alendronate and calcitriol agent (Maxmarvil) on bone metabolism in Korean postmenopausal women: a multicenter, double-blind, randomized, placebo-controlled study.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20061201

• Cytotoxicity evaluation of sodium alendronate on cultured human periodontal ligament fibroblasts.

  Dental traumatology : official publication of International Association for Dental Traumatology 20061201

• Estrogen and alendronate therapies may prevent the influence of estrogen deficiency on the tooth-supporting alveolar bone: a histometric study in rats.

  Journal of periodontal research 20061201

• A case of polymyalgia rheumatica, microscopic polyangiitis, and B-cell lymphoma.

  Nature clinical practice. Rheumatology 20061201

• Immunohistochemical evidence of a cytokine and chemokine network in three patients with Erdheim-Chester disease: implications for pathogenesis.

  Arthritis and rheumatism 20061201

• Is the current anti-osteoporotic therapy paradigm good enough?

  Journal of the American Geriatrics Society 20061201

• NOFSA statement on generic bisphosphonates.

  South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 20061201

• European women's preference for osteoporosis treatment: influence of clinical effectiveness and dosing frequency.

  Current medical research and opinion 20061201

• By the way, doctor. I'm 60 and have osteoporosis. My doctor is recommending Fosamax, but I'm concerned about jawbone problems. Are there any other drugs I can take?

  Harvard women's health watch 20061201

• Bisphosphonates.

  Annals of the New York Academy of Sciences 20061201

• [Advances in the research of bisphosphonate-associated osteonecrosis of the jaws].

  Shanghai kou qiang yi xue = Shanghai journal of stomatology 20061201

• Images in clinical medicine. Bisphosphonate-associated contact stomatitis.

  The New England journal of medicine 20061130

• Alendronate or alfacalcidol in glucocorticoid-induced osteoporosis.

  The New England journal of medicine 20061116

• [Generic preparations--undocumented effects?].

  Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20061116

• Alendronate or alfacalcidol in glucocorticoid-induced osteoporosis.

  The New England journal of medicine 20061116

• [Correlation between studies and general practice].

  MMW Fortschritte der Medizin 20061116

• Compliance with treatment for osteoporosis.

  Lancet (London, England) 20061111

• Suppressed bone turnover during alendronate therapy for high-turnover osteoporosis.

  The New England journal of medicine 20061109

• Bisphosphonates suppress periosteal osteoblast activity independently of resorption in rat femur and tibia.

  Bone 20061101

• The outcome of pregnancy following pre-pregnancy or early pregnancy alendronate treatment.

  Reproductive toxicology (Elmsford, N.Y.) 20061101

• [Bisphosphonate-related bilateral mandibular osteochemonecrosis with pathological fracture of the horizontal ramus].

  Revue de stomatologie et de chirurgie maxillo-faciale 20061101

• Modulation of osteoclastogenesis induced by nucleoside reverse transcriptase inhibitors.

  AIDS research and human retroviruses 20061101

• NOFSA statement on generic bisphosphonates.

  South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 20061101

• [Menopause].

  La Revue du praticien 20061031

• Evaluation of multidimensional capillary electrophoretic methodologies for determination of amino bisphosphonate pharmaceuticals.

  Journal of chromatography. A 20061013

• [Generic preparations--undocumented effects?].

  Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20061005

• Agreement and validity of pharmacy data versus self-report for use of osteoporosis medications among chronic glucocorticoid users.

  Pharmacoepidemiology and drug safety 20061001

• Is the increase in osteoporosis prevention a result of the audit?

  Clinical neurology and neurosurgery 20061001

• Bisphosphonates activate nucleotide receptors signaling and induce the expression of Hsp90 in osteoblast-like cell lines.

  Bone 20061001

• Alterations in canine vertebral bone turnover, microdamage accumulation, and biomechanical properties following 1-year treatment with clinical treatment doses of risedronate or alendronate.

  Bone 20061001

• Treatment of severe osteoporosis with alendronate in a patient with lysinuric protein intolerance.

  Journal of inherited metabolic disease 20061001

• Fracture incidence and characterization in patients on osteoporosis treatment: the ICARO study.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20061001

• Prevalence of evaluation and treatment of glucocorticoid-induced osteoporosis in men.

  Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 20061001

• [Drug treatment of postmenopausal osteoporosis. What's New in 2006].

  Presse medicale (Paris, France : 1983) 20061001

• [Osteoporosis: Optimizing treatment strategy].

  Presse medicale (Paris, France : 1983) 20061001

• Antiremodeling agents influence osteoblast activity differently in modeling and remodeling sites of canine rib.

  Calcified tissue international 20061001

• Corneal graft rejection precipitated by uveitis secondary to alendronate sodium therapy.

  Cornea 20061001

• Generic alendronate in the treatment of osteoporosis.

  South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 20061001

• Severe skeletal complications in a child with acute lymphoblastic leukemia.

  Pediatric hematology and oncology 20060901

• [Current research in adequate treatment by Osteoporosis Research Group].

  Clinical calcium 20060901

• Alendronate with and without cholecalciferol for osteoporosis: results of a 15-week randomized controlled trial.

  Current medical research and opinion 20060901

• Case-only analysis of treatment-covariate interactions in clinical trials.

  Biometrics 20060901

• NOFSA statement on generic bisphosphonates.

  South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 20060901

• Alendronate or alfacalcidol in glucocorticoid-induced osteoporosis.

  The New England journal of medicine 20060817

• Assessment of DNA damage in postmenopausal women under osteoporosis therapy.

  European journal of obstetrics, gynecology, and reproductive biology 20060801

• Effects of calcitonin and alendronate on distraction osteogenesis.

  International orthopaedics 20060801

• Chemical makeup of microdamaged bone differs from undamaged bone.

  Bone 20060801

• Vitamin D intoxication and therapy with alendronate (case report and review of literature).

  European journal of pediatrics 20060801

• Antiallodynic effect of etidronate, a bisphosphonate, in rats with adjuvant-induced arthritis: involvement of ATP-sensitive K+ channels.

  Neuropharmacology 20060801

• Effects of teriparatide, alendronate, or both on bone turnover in osteoporotic men.

  The Journal of clinical endocrinology and metabolism 20060801

• Treatment persistence with once-monthly ibandronate and patient support vs. once-weekly alendronate: results from the PERSIST study.

  International journal of clinical practice 20060801

• Osteonecrosis of the jaw and oral bisphosphonate treatment.

  Journal of the American Dental Association (1939) 20060801

• Bisphosphonates and oral pathology I. General and preventive aspects.

  Medicina oral, patologia oral y cirugia bucal 20060801

• Use of generic alendronate in the treatment of osteoporosis.

  South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 20060801

• Bone necrosis of the jaws associated with bisphosphonate treatment: a report of twenty-nine cases.

  Acta bio-medica : Atenei Parmensis 20060801

• [FOSAVANCE -- alendronate plus vitamin D in a weekly tablet].

  Praxis 20060705

• Alendronate and vitamin D2 for prevention of hip fracture in Parkinson's disease: a randomized controlled trial.

  Movement disorders : official journal of the Movement Disorder Society 20060701

• Comparison of weekly treatment of postmenopausal osteoporosis with alendronate versus risedronate over two years.

  The Journal of clinical endocrinology and metabolism 20060701

• Alendronate prevents femoral periprosthetic bone loss following total hip arthroplasty: prospective randomized double-blind study.

  Journal of orthopaedic research : official publication of the Orthopaedic Research Society 20060701

• [Pregnancy-associated osteoporosis. A new case].

  La Revue de medecine interne 20060701

• Effect of alendronate on endosseous implant integration: an in vivo study in rabbits.

  Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20060701

• Osteoporotic fractures and vitamin D deficiency.

  Australian family physician 20060701

• Cost-effectiveness of alternative treatments for women with osteoporosis in Canada.

  Current medical research and opinion 20060701

• Prosthodontic treatment during active osteonecrosis related to radiation and bisphosphonate therapy: a clinical report.

  The Journal of prosthetic dentistry 20060701

• Comparative effects of alendronate and alfacalcidol on cancellous and cortical bone mass and bone mechanical properties in ovariectomized rats.

  Experimental animals 20060701

• [Very old patients with osteoporosis should be treated with alendronate].

  Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics 20060701

• [Should bisphosphonate treatment be used for super-old patients with osteoporosis?].

  Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics 20060701

• [Effects of alendronate on bone mineral density, cytokines and indices of bone metabolism in postmenopausal osteoporotic patients].

  Zhonghua nei ke za zhi 20060701

• Paget's disease of bone: experience from a centre in southern India.

  The Journal of the Association of Physicians of India 20060701

• Confinement and controlled release of bisphosphonates on ordered mesoporous silica-based materials.

  Journal of the American Chemical Society 20060628

• [Substance properties of zoledronate make it possible: bisphosphonate therapy only once yearly].

  MMW Fortschritte der Medizin 20060622

• Alendronate-loaded nanoparticles deplete monocytes and attenuate restenosis.

  Journal of controlled release : official journal of the Controlled Release Society 20060612

• The cost-effectiveness of therapy with teriparatide and alendronate in women with severe osteoporosis.

  Archives of internal medicine 20060612

• Evaluation of modal damping factor as a diagnostic tool for osteoporosis and its relation with serum osteocalcin and collagen I N-telopeptide for monitoring the efficacy of alendronate in ovariectomized rats.

  Journal of pharmaceutical and biomedical analysis 20060607

• [Adherence with daily and weekly administration of oral bisphosphonates for osteoporosis treatment].

  Deutsche medizinische Wochenschrift (1946) 20060602

• Immunocytochemical study of amelogenin deposition during the early odontogenesis of molars in alendronate-treated newborn rats.

  The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 20060601

• Effects of alendronate combined with hormone replacement therapy on osteoporotic postmenopausal Chinese women.

  Metabolism: clinical and experimental 20060601

• Synthesis and study of alendronate derivatives as potential prodrugs of alendronate sodium for the treatment of low bone density and osteoporosis.

  Journal of medicinal chemistry 20060601

• Long-term experience with alendronate in the treatment of osteoporosis.

  Expert opinion on pharmacotherapy 20060601

• Denosumab in postmenopausal women with low bone mineral density.

  The New England journal of medicine 20060601

• The prevention of bone fractures after liver transplantation: experience with alendronate treatment.

  Transplantation proceedings 20060601

• Adherence and persistence associated with the pharmacologic treatment of osteoporosis in a managed care setting.

  Southern medical journal 20060601

• [Drug therapy for prevention of falls and fractures].

  Medizinische Klinik (Munich, Germany : 1983) 20060601

• [The effect of alendronate on arterial calcification in rat model].

  Zhonghua nei ke za zhi 20060601

• Fracture prevention in postmenopausal women.

  Clinical evidence 20060601

• [Progress for patients with osteoporosis].

  MMW Fortschritte der Medizin 20060518

• Mutual augmentation of the induction of the histamine-forming enzyme, histidine decarboxylase, between alendronate and immuno-stimulants (IL-1, TNF, and LPS), and its prevention by clodronate.

  Toxicology and applied pharmacology 20060515

• Inhibitory effects of alendronate on cholinergic responses in rat lower esophageal sphincter.

  European journal of pharmacology 20060510

• Relative binding affinities of bisphosphonates for human bone and relationship to antiresorptive efficacy.

  Bone 20060501

• Cytosolic entry of bisphosphonate drugs requires acidification of vesicles after fluid-phase endocytosis.

  Molecular pharmacology 20060501

• Role of the osteoclast in cranial suture waveform patterning.

  The anatomical record. Part A, Discoveries in molecular, cellular, and evolutionary biology 20060501

• Density and structural changes in the bone of growing rats after weekly alendronate administration with and without a methotrexate challenge.

  Journal of orthopaedic research : official publication of the Orthopaedic Research Society 20060501

• Randomized active and placebo-controlled endoscopy study of a novel protected formulation of oral alendronate.

  Digestive diseases and sciences 20060501

• The effect of raloxifene on cardiac autonomic regulation in osteoporotic women.

  American journal of obstetrics and gynecology 20060501

• I was prescribed alendronate (Fosamax) for bone loss a year ago, when I was 55. I just got the results of my recent bone density scan and I'm puzzled by the results. Why would it show a good improvement in the spine but no so much on my hip? How long do I have to wait to see results on my bone density?

  Health news (Waltham, Mass.) 20060501

• Efficacy and safety of alendronate and risedronate for postmenopausal osteoporosis.

  Current medical research and opinion 20060501

• [Diphosphonates can cause necrosis of the jaw. Patients with malignant skeletal diseases are at risk].

  Lakartidningen 20060501

• Oral ibandronate in the management of postmenopausal osteoporosis: review of upper gastrointestinal safety.

  Maturitas 20060420

• Alendronate in bone cement: fatigue life degraded by liquid, not by powder.

  Clinical orthopaedics and related research 20060401

• Short-term changes in bone turnover markers and bone mineral density response to parathyroid hormone in postmenopausal women with osteoporosis.

  The Journal of clinical endocrinology and metabolism 20060401

• A study of codispensing with sodium alendronate in Australia.

  British journal of clinical pharmacology 20060401

• A comparison of the gastrointestinal effects of the nitrogen-containing bisphosphonates pamidronate, alendronate, and olpadronate in humans.

  Journal of clinical pharmacology 20060401

• Preventing osteoporosis-related fractures: an overview.

  The American journal of medicine 20060401

• Alendronate treatment in osteogenesis imperfecta.

  Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 20060401

• Effect of alendronate on bone mineral density in adult patients with Laron syndrome (primary growth hormone insensitivity).

  Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society 20060401

• Formulation and in vitro evaluation of bisphosphonate loaded microspheres for implantation in osteolysis.

  Drug development and industrial pharmacy 20060401

• [New therapeutic approaches to osteoporosis].

  Annales d'endocrinologie 20060401

• Bioequivalence and pharmacokinetics of 70 mg alendronate sodium tablets by measuring alendronate in plasma.

  Archives of pharmacal research 20060401

• Efficacy and safety of oral alendronate treatment in children and adolescents with osteoporosis.

  Journal of pediatric endocrinology & metabolism : JPEM 20060401

• Drug insight: Bisphosphonates for postmenopausal osteoporosis.

  Nature clinical practice. Endocrinology & metabolism 20060401

• Discontinuing antiresorptive therapy one year after cardiac transplantation: effect on bone density and bone turnover.

  Transplantation 20060315

• Neuropathy-induced osteopenia in rats is not due to a reduction in weight born on the affected limb.

  Bone 20060301

• The effect of raloxifene after discontinuation of long-term alendronate treatment of postmenopausal osteoporosis.

  The Journal of clinical endocrinology and metabolism 20060301

• Preservation of thoracic spine microarchitecture by alendronate: comparison of histology and microCT.

  Bone 20060301

• Effects of alendronate and hormone replacement therapy, alone and in combination, on saliva, periodontal conditions and gingival crevicular fluid matrix metalloproteinase-8 levels in women with osteoporosis.

  Oral diseases 20060301

• Effect of topical alendronate treatment on fixation of implants inserted with bone compaction.

  Clinical orthopaedics and related research 20060301

• Osteoporosis management in a Medicaid population after the Women's Health Initiative study.

  Journal of women's health (2002) 20060301

• Denosumab in postmenopausal women with low bone mineral density.

  The New England journal of medicine 20060223

• Effectiveness of alendronate and etidronate in the treatment of osteoporosis in men: a prospective observational study.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20060201

• Estriol, conjugated equine estrogens, and alendronate therapy for osteoporosis.

  International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 20060201

• Pretreatment levels of bone turnover and the antifracture efficacy of alendronate: the fracture intervention trial.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20060201

• Effects of oral alendronate on BMD in adult patients with osteogenesis imperfecta: a 3-year randomized placebo-controlled trial.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20060201

• Evaluation of the topical effect of alendronate on the root surface of extracted and replanted teeth. Microscopic analysis on rats' teeth.

  Dental traumatology : official publication of International Association for Dental Traumatology 20060201

• Strategies for the prevention and treatment of osteoporosis during early postmenopause.

  American journal of obstetrics and gynecology 20060201

• Three-year changes in bone mineral density around the knee after a six-month course of oral alendronate following total knee arthroplasty. A prospective, randomized study.

  The Journal of bone and joint surgery. American volume 20060201

• [Application of anti-resorptive drugs for the treatment of osteoporosis].

  Nihon rinsho. Japanese journal of clinical medicine 20060201

• Does alendronate prevent collapse in osteonecrosis of the femoral head?

  Clinical orthopaedics and related research 20060201

• Oral alendronate therapy for severe vitamin D intoxication of the infant with nephrocalcinosis.

  Journal of pediatric endocrinology & metabolism : JPEM 20060201

• Relationship between periodontal disease and systemic diseases.

  Texas dental journal 20060201

• [Skeletal biomechanical properties improvement in ovariectomized osteoporotic rats of teriparatide was retarded by alendronate].

  Zhonghua nei ke za zhi 20060201

• Comparative therapeutic effects of alendronate and alfacalcidol on cancellous and cortical bone mass and mechanical properties in ovariectomized osteopenic rats.

  Journal of nutritional science and vitaminology 20060201

• Determinants of persistence with bisphosphonates: a study in women with postmenopausal osteoporosis.

  Clinical therapeutics 20060201

• High-performance liquid chromatography method for determining alendronate sodium in human plasma by detecting fluorescence: application to a pharmacokinetic study in humans.

  Journal of pharmaceutical and biomedical analysis 20060123

• Comparison of the effects of alendronate and risedronate on bone mineral density and bone turnover markers in postmenopausal osteoporosis.

  Rheumatology international 20060101

• Mechanical evaluation of bone samples following alendronate therapy in healthy male dogs.

  Journal of biomedical materials research. Part B, Applied biomaterials 20060101

• Structure and mechanism of the farnesyl diphosphate synthase from Trypanosoma cruzi: implications for drug design.

  Proteins 20060101

• The use of micro-CT to evaluate cortical bone geometry and strength in nude rats: correlation with mechanical testing, pQCT and DXA.

  Bone 20060101

• Two-year clinical trial of oral alendronate versus intravenous pamidronate in children with osteogenesis imperfecta.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20060101

• The treatment of severe postmenopausal osteoporosis : a review of current and emerging therapeutic options.

  Treatments in endocrinology 20060101

• Should bisphosphonates be continued indefinitely? An unusual fracture in a healthy woman on long-term alendronate.

  Geriatrics 20060101

• Quality of life and pain in premenopausal women with major depressive disorder: the POWER Study.

  Health and quality of life outcomes 20060101

• Changes in the RANK ligand/osteoprotegerin system are correlated to changes in bone mineral density in bisphosphonate-treated osteoporotic patients.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20060101

• Positive effect of alendronate on bone mineral density and markers of bone turnover in patients with rheumatoid arthritis on chronic treatment with low-dose prednisone: a randomized, double-blind, placebo-controlled trial.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20060101

• Bisphosphonates are effective prophylactic of early bone loss after renal transplantation.

  Transplantation proceedings 20060101

• [A head-to-head comparative study for evaluation of effectiveness among drugs for osteoporosis].

  Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics 20060101

• Cost-effectiveness of osteoporosis screening and treatment with hormone replacement therapy, raloxifene, or alendronate.

  Medical decision making : an international journal of the Society for Medical Decision Making 20060101

• Drug injury in the upper gastrointestinal tract: effects of alendronate.

  Gastrointestinal endoscopy clinics of North America 20060101

• Effects of alendronate on bone mineral density and bone metabolic markers in patients with liver transplantation.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20060101

• In vitro disintegration and dissolution and in vivo bioequivalence of two alendronate once-weekly formulations.

  Arzneimittel-Forschung 20060101

• Persistence with weekly alendronate therapy among postmenopausal women.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20060101

• Channeling and adherence with alendronate and risedronate among chronic glucocorticoid users.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20060101

• Cost-effectiveness of vertebral fracture assessment to detect prevalent vertebral deformity and select postmenopausal women with a femoral neck T-score>-2.5 for alendronate therapy: a modeling study.

  Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 20060101

• The problem of low levels of vitamin D and osteoporosis: use of combination therapy with alendronic acid and colecalciferol (vitamin D3).

  Drugs & aging 20060101

• [New horizons for increased sensitivity of radionuclide imaging in primary hyperparathyroidism].

  Przeglad lekarski 20060101

• Medication persistence with weekly versus daily doses of orally administered bisphosphonates.

  Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 20060101

• A general approach for the quantitative analysis of bisphosphonates in human serum and urine by high-performance liquid chromatography/tandem mass spectrometry.

  Rapid communications in mass spectrometry : RCM 20060101

• Effects of alendronate on bone mineral density in men with prostate cancer treated with androgen deprivation therapy.

  Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 20060101

• Commentary on Mobley and Others: importance of assumptions about VTE mortality in modeling the cost-effectiveness of osteoporosis therapies.

  Medical decision making : an international journal of the Society for Medical Decision Making 20060101

• Tolerability of different dosing regimens of bisphosphonates for the treatment of osteoporosis and malignant bone disease.

  Drug safety 20060101

• Alendronic acid produces greater effects than risedronic acid on bone density and turnover in postmenopausal women with osteoporosis : results of FACTS -international.

  Clinical drug investigation 20060101

• Differences in osteoclast formation between proximal and distal tibial osteoporosis in rats with adjuvant arthritis: inhibitory effects of bisphosphonates on osteoclasts.

  Modern rheumatology 20060101

• Effects of alendronate and risedronate on bone mineral density and bone turnover markers in late postmenopausal women with osteoporosis.

  Advances in therapy 20060101

• Effects of Alendronate on bone mass in women with osteoporosis.

  Medicinski pregled 20060101

• An esophageal ulcer mimicking advanced esophageal cancer in a patient on alendronate sodium treatment for osteoporosis.

  Endoscopy 20060101

• [Current osteoporosis treatment: reasons for adding vitamin D to alendronate].

  Reumatizam 20060101

• Comparison of effect of treatment with etidronate and alendronate on lumbar bone mineral density in elderly women with osteoporosis.

  Yonsei medical journal 20051231

• Paget's disease and bisphosphonates.

  The New England journal of medicine 20051215

• Alendronate and parathyroid hormone.

  The New England journal of medicine 20051215

• [Treating with what? Therapy for how long?].

  MMW Fortschritte der Medizin 20051215

• [Reliably combined to combat osteoporosis].

  MMW Fortschritte der Medizin 20051215

• [Cost effective osteoporosis therapy. Alendronate is also immediately available as a generic drug].

  MMW Fortschritte der Medizin 20051208

• [An advantage for compliance: alendronate once weekly].

  MMW Fortschritte der Medizin 20051208

• Absorption of the oral bisphosphonate alendronate in osteoporotic patients with Crohn's disease.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20051201

• Potential cost-effective use of spine radiographs to detect vertebral deformity and select osteopenic post-menopausal women for amino-bisphosphonate therapy.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20051201

• Cytotoxicity analysis of alendronate on cultured endothelial cells and subcutaneous tissue. a pilot study.

  Dental traumatology : official publication of International Association for Dental Traumatology 20051201

• Combination therapy for osteoporosis: considerations and controversy.

  Current osteoporosis reports 20051201

• Urinary osteocalcin is a useful marker for monitoring the effect of alendronate therapy.

  Clinical chemistry 20051201

• Prevention and treatment of glucocorticoid-induced osteoporosis in 2005.

  Joint, bone, spine : revue du rhumatisme 20051201

• Alendronate for osteoporosis in men with androgen-repleted hypogonadism.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20051201

• Patient preference for once-monthly ibandronate versus once-weekly alendronate in a randomized, open-label, cross-over trial: the Boniva Alendronate Trial in Osteoporosis (BALTO).

  Current medical research and opinion 20051201

• Alendronate for treatment of renal transplant patients with osteoporosis.

  Transplantation proceedings 20051201

• Strontium: new drug. Postmenopausal osteoporosis: too many unknowns.

  Prescrire international 20051201

• Early changes in biochemical markers of bone turnover predict bone mineral density response to antiresorptive therapy in Korean postmenopausal women with osteoporosis.

  Endocrine journal 20051201

• Ghrelin against alendronate-induced gastric damage in rats.

  The Journal of endocrinology 20051201

• By the way, doctor. I've heard that taking Fosamax for a long time causes the jawbone to deteriorate. Do you know anything about this?

  Harvard women's health watch 20051201

• [Examination and treatment of orthopedic-surgery patients with osteoporosis-related fragility fractures].

  Ugeskrift for laeger 20051121

• Alendronate inhibits spine fusion in a rat model.

  Spine 20051115

• The treatment of osteoporosis in patients with rheumatoid arthritis receiving glucocorticoids: a comparison of alendronate and intranasal salmon calcitonin.

  Rheumatology international 20051101

• The effect of intravenous pamidronate versus oral alendronate on bone mineral density in patients with osteoporosis.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20051101

• Expression profiling of rat femur revealed suppression of bone formation genes by treatment with alendronate and estrogen but not raloxifene.

  Molecular pharmacology 20051101

• Cyclical alendronate treatment in postmenopausal women with osteoporosis.

  International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 20051101

• The inhibitory effect of alendronate, a nitrogen-containing bisphosphonate on the PI3K-Akt-NFkappaB pathway in osteosarcoma cells.

  British journal of pharmacology 20051101

• Are we treating women with postmenopausal osteoporosis for their low BMD or high fracture risk?

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20051101

• Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment.

  Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20051101

• The effect of hormone replacement on physical performance in community-dwelling elderly women.

  The American journal of medicine 20051101

• Effect of sodium alendronate on alveolar bone resorption in experimental periodontitis in rats.

  Journal of periodontology 20051101

• Systemic low-dose doxycycline and alendronate administration and serum interleukin-1beta, osteocalcin, and C-reactive protein levels in rats.

  Journal of periodontology 20051101

• [Antiresorptive treatment after proximal femur fracture].

  Atencion primaria 20051101

• [Alendronate and mouth ulcers: careful interrogation of the patient to start with].

  Annales de dermatologie et de venereologie 20051101

• Oral alendronate in osteogenesis imperfecta.

  Indian pediatrics 20051101

• Efficacy of alendronate in the treatment of avascular necrosis of the hip.

  Rheumatology (Oxford, England) 20051001

• Effect of osteoporosis treatments on risk of non-vertebral fractures: review and meta-analysis of intention-to-treat studies.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20051001

• Histological comparison of alendronate, calcium hydroxide and formocresol in amputated rat molar.

  Dental traumatology : official publication of International Association for Dental Traumatology 20051001

• Pilot studies of the effect of zoledronic acid (Zometa) on tumor-derived cells ex vivo in the ATP-based tumor chemosensitivity assay.

  Anti-cancer drugs 20051001

• Alendronate improves bone mineral density in primary biliary cirrhosis: a randomized placebo-controlled trial.

  Hepatology (Baltimore, Md.) 20051001

• Comparative appraisal of clodronate, aspirin and dexamethasone as agents reducing alendronate-induced inflammation in a murine model.

  Basic & clinical pharmacology & toxicology 20051001

• Universal bone densitometry screening combined with alendronate therapy for those diagnosed with osteoporosis is highly cost-effective for elderly women.

  Journal of the American Geriatrics Society 20051001

• Bisphosphonate-associated osteonecrosis of the jaws and endodontic treatment: two case reports.

  Journal of endodontics 20051001

• Enhancement of crude bone morphogenetic protein-induced new bone formation and normalization of endochondral ossification by bisphosphonate treatment in osteoprotegerin-deficient mice.

  Calcified tissue international 20051001

• The use of alendronate to prevent early collapse of the femoral head in patients with nontraumatic osteonecrosis. A randomized clinical study.

  The Journal of bone and joint surgery. American volume 20051001

• Effect of alendronate therapy in children with osteogenesis imperfecta.

  Joint, bone, spine : revue du rhumatisme 20051001

• Review of treatment modalities for postmenopausal osteoporosis.

  Southern medical journal 20051001

• The patient's page. Bone health facts.

  Southern medical journal 20051001

• Serum TRACP 5b is a useful marker for monitoring alendronate treatment: comparison with other markers of bone turnover.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20051001

• [Protocol for prevention and treatment of osteoporosis in patients with cystic fibrosis].

  Medicina clinica 20050917

• Effect of hormone replacement, alendronate, or combination therapy on hip structural geometry: a 3-year, double-blind, placebo-controlled clinical trial.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20050901

• Efficacy and tolerability of alendronate once weekly in Asian postmenopausal osteoporotic women.

  The Annals of pharmacotherapy 20050901

• Second hip fracture in elderly hip fracture patients: cost and effectiveness of fracture prevention treatment.

  Age and ageing 20050901

• Tumor necrosis factor prevents alendronate-induced osteoclast apoptosis in vivo by stimulating Bcl-xL expression through Ets-2.

  Arthritis and rheumatism 20050901

• Rapid improvement of calcinosis in juvenile dermatomyositis with alendronate therapy.

  The Journal of rheumatology 20050901

• Letter re: alendronate in anorexia nervosa.

  The Journal of clinical endocrinology and metabolism 20050901

• Alendronate and vertebral fracture risk.

  Mayo Clinic proceedings 20050901

• Alendronate and vertebral fracture risk.

  Mayo Clinic proceedings 20050901

• Compliance and persistence with bisphosphonate dosing regimens among women with postmenopausal osteoporosis.

  Current medical research and opinion 20050901

• A randomized, placebo-controlled, 6-month study of once-weekly alendronate oral solution for postmenopausal osteoporosis.

  The American journal of geriatric pharmacotherapy 20050901

• Bone remodeling at the iliac crest can predict the changes in remodeling dynamics, microdamage accumulation, and mechanical properties in the lumbar vertebrae of dogs.

  Calcified tissue international 20050901

• Rethinking early bone-loss treatment.

  Mayo Clinic health letter (English ed.) 20050901

• Bisphosphonates decrease telomerase activity and hTERT expression in MCF-7 breast cancer cells.

  Molecular and cellular endocrinology 20050830

• One year of alendronate after one year of parathyroid hormone (1-84) for osteoporosis.

  The New England journal of medicine 20050811

• Daily and cyclic parathyroid hormone in women receiving alendronate.

  The New England journal of medicine 20050811

• Combination and sequential therapy for osteoporosis.

  The New England journal of medicine 20050811

• BsmI vitamin D receptor genotypes influence the efficacy of antiresorptive treatments in postmenopausal osteoporotic women. A 1-year multicenter, randomized and controlled trial.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20050801

• Bisphosphonates stimulate an endogenous nonselective cation channel in Xenopus oocytes: potential mechanism of action.

  American journal of physiology. Cell physiology 20050801

• Are we treating women with postmenopausal osteoporosis for their low BMD or high fracture risk?

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20050801

• Alendronate in combination with calcium and vitamin D prevents bone loss after orthotopic liver transplantation: a prospective single-center study.

  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20050801

• Alendronate (Fosamax) and risedronate (Actonel) revisited.

  Obstetrics and gynecology 20050801

• Longterm reduction of back pain risk in women with osteoporosis treated with teriparatide compared with alendronate.

  The Journal of rheumatology 20050801

• Opposite bone remodeling effects of teriparatide and alendronate in increasing bone mass.

  Archives of internal medicine 20050801

• Effects of short-term alendronate on bone mineral density in haemodialysis patients.

  Nephrology (Carlton, Vic.) 20050801

• Protective effect of melatonin and omeprazole against alendronat-induced gastric damage.

  Digestive diseases and sciences 20050801

• Are oral bisphosphonates effective in improving lumbar bone mineral density in breast cancer survivors with osteopenia or osteoporosis?

  Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC 20050801

• Appropriate intervention through fracture risk assessment.

  Managed care (Langhorne, Pa.) 20050801

• The role of managed care in the management of osteoporosis.

  Managed care (Langhorne, Pa.) 20050801

• Osteonecrosis of the jaw and bisphosphonates.

  The New England journal of medicine 20050707

• Risk of fracture among women who lose bone density during treatment with alendronate. The Fracture Intervention Trial.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20050701

• Single-dose pharmacokinetics and tolerability of alendronate 35- and 70-milligram tablets in children and adolescents with osteogenesis imperfecta type I.

  The Journal of clinical endocrinology and metabolism 20050701

• Differential effects of teriparatide and alendronate on bone remodeling in postmenopausal women assessed by histomorphometric parameters.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20050701

• The use of bisphosphonates in the treatment of osteoporosis.

  Current opinion in rheumatology 20050701

• Bisphosphonate therapy improves the outcome of conventional periodontal treatment: results of a 12-month, randomized, placebo-controlled study.

  Journal of periodontology 20050701

• Effect of alendronate administration on bone mineral density and bone strength in castrated rats.

  Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 20050701

• Response of diffuse sclerosing osteomyelitis of the mandible to alendronate: follow-up study by 99mTc scintigraphy.

  International journal of oral and maxillofacial surgery 20050701

• Bisphosphonate-associated scleritis: a case report and review.

  Southern medical journal 20050701

• Effects of alendronate on bone mass in patients with primary biliary cirrhosis and osteoporosis: preliminary results after one year.

  Scandinavian journal of gastroenterology 20050701

• [Osteonecrosis of the jaws as a possible adverse effect of the use of bisphosphonates].

  Mund-, Kiefer- und Gesichtschirurgie : MKG 20050701

• [In vitro study of combination rhOPG-Fc and alendronate on inhibition osteoclast].

  Zhonghua wai ke za zhi [Chinese journal of surgery] 20050615

• Effects of once-weekly oral alendronate on bone in children on glucocorticoid treatment.

  Rheumatology (Oxford, England) 20050601

• Effect of alendronate on bone mineral density in spinal cord injury patients: a pilot study.

  Spinal cord 20050601

• Alendronate for the treatment of osteopenia in anorexia nervosa: a randomized, double-blind, placebo-controlled trial.

  The Journal of clinical endocrinology and metabolism 20050601

• Effect of alendronate on the age-specific incidence of symptomatic osteoporotic fractures.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20050601

• The Vgamma2/Vdelta2 T-cell repertoire in Macaca fascicularis: functional responses to phosphoantigen stimulation by the Vgamma2/Jgamma1.2 subset.

  Immunology 20050601

• Inhibition of inflammatory and bone-resorption-inhibitory effects of alendronate by etidronate.

  Calcified tissue international 20050601

• A systematic review and economic evaluation of alendronate, etidronate, risedronate, raloxifene and teriparatide for the prevention and treatment of postmenopausal osteoporosis.

  Health technology assessment (Winchester, England) 20050601

• Increased renal calcium reabsorption by parathyroid hormone-related protein is a causative factor in the development of humoral hypercalcemia of malignancy refractory to osteoclastic bone resorption inhibitors.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20050601

• [Methimazole versus methimazole and diphosphonates in hyperthyroid and osteoporotic patients].

  Minerva endocrinologica 20050601

• Pill esophagitis.

  Romanian journal of gastroenterology 20050601

• [Quality of life in the treatment assessment of postmenopausal osteoporosis].

  Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences 20050601

• Effects of alendronate and calcitonin on bone mineral density in postmenopausal osteoporotic women. An observational study.

  Pharmacy world & science : PWS 20050601

• Effect of alendronate on bone mineral density in Puerto Rican males with osteoporosis.

  Puerto Rico health sciences journal 20050601

• Alendronate for steroid-induced osteopenia in children with acute lymphoblastic leukaemia or non-Hodgkin's lymphoma: results of a pilot study.

  Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 20050601

• [Marketing--alendronate versus risedronate].

  Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20050519

• The influence of alendronate treatment and bone graft volume on posterior lateral spine fusion in a porcine model.

  Spine 20050515

• The effect of menopause, hormone replacement therapy (HRT), alendronate (ALN), and calcium supplements on saliva.

  The journal of contemporary dental practice 20050515

• [To increase bone density faster and stronger].

  MMW Fortschritte der Medizin 20050505

• Summaries for patients. Cost-effectiveness of alendronate in postmenopausal women with low bone mass without osteoporosis or previous fracture.

  Annals of internal medicine 20050503

• Cost-effectiveness of alendronate therapy for osteopenic postmenopausal women.

  Annals of internal medicine 20050503

• Osteopenia: to treat or not to treat?

  Annals of internal medicine 20050503

• Meta-analysis of the efficacy of alendronate for the prevention of hip fractures in postmenopausal women.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20050501

• Early changes in biochemical markers of bone turnover are associated with long-term changes in bone mineral density in elderly women on alendronate, hormone replacement therapy, or combination therapy: a three-year, double-blind, placebo-controlled, randomized clinical trial.

  The Journal of clinical endocrinology and metabolism 20050501

• A prospective randomized study for prevention of postrenal transplantation bone loss.

  Kidney international 20050501

• Cost-effectiveness of alendronate in the prevention of osteoporotic fractures in Danish women.

  Basic & clinical pharmacology & toxicology 20050501

• Six-month treatment with alendronate in acute Charcot neuroarthropathy: a randomized controlled trial.

  Diabetes care 20050501

• New help for old bones.

  Nursing 20050501

• Bone-specific alkaline phosphatase activity is inhibited by bisphosphonates: role of divalent cations.

  Biological trace element research 20050501

• Erdheim-Chester disease: the effect of bisphosphonate treatment--a case report.

  Archives of physical medicine and rehabilitation 20050501

• Alendronate (Fosamax) and risedronate (Actonel) revisited.

  The Medical letter on drugs and therapeutics 20050425

• Bisphosphonates and avascular necrosis of the jaw: a possible association.

  The Medical journal of Australia 20050418

• [Calcium gaps in osteoporosis patients close. Blister pack simplifies comedication of calcium and bisphosphonates].

  MMW Fortschritte der Medizin 20050407

• [The efficacy of a treatment: absolute and relative risk, number of patients to be treated].

  Praxis 20050406

• Healing properties of allograft from alendronate-treated animal in lumbar spine interbody cage fusion.

  European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society 20050401

• Alendronate, vitamin D, and calcium for the treatment of osteopenia/osteoporosis associated with HIV infection.

  Journal of acquired immune deficiency syndromes (1999) 20050401

• [Increase in bone mineral density and its effect on fracture risk].

  Clinical calcium 20050401

• Alendronate in kidney transplant patients: a single-center experience.

  Transplantation proceedings 20050401

• Treatment preference and tolerability with alendronate once weekly over a 3-month period: an Israeli multi-center study.

  Aging clinical and experimental research 20050401

• Effect of whole-body vibration exercise on lumbar bone mineral density, bone turnover, and chronic back pain in post-menopausal osteoporotic women treated with alendronate.

  Aging clinical and experimental research 20050401

• Bisphosphonates induce inflammation and rupture of atherosclerotic plaques in apolipoprotein-E null mice.

  Biochemical and biophysical research communications 20050318

• Benefit period using alendronate to increase bone mineral density in women with osteoporosis?

  Chinese medical journal 20050305

• Efficacy of alendronate, a bisphosphonate, in the treatment of AVN of the hip. A prospective open-label study.

  Rheumatology (Oxford, England) 20050301

• Severely suppressed bone turnover: a potential complication of alendronate therapy.

  The Journal of clinical endocrinology and metabolism 20050301

• A randomized, phase II trial of ketoconazole plus alendronate versus ketoconazole alone in patients with androgen independent prostate cancer and bone metastases.

  The Journal of urology 20050301

• The influence of alendronate on bone formation after autogenous free bone grafting in rats.

  Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 20050301

• Upper gastrointestinal tolerability of once weekly alendronate 70 mg with concomitant non-steroidal anti-inflammatory drug use.

  Alimentary pharmacology & therapeutics 20050301

• Effect of alendronate on vertebral fracture risk in women with bone mineral density T scores of-1.6 to -2.5 at the femoral neck: the Fracture Intervention Trial.

  Mayo Clinic proceedings 20050301

• Oral antiresorptive therapy.

  Current rheumatology reports 20050301

• Rehabilitation of orthopedic and rheumatologic disorders. 1. Osteoporosis assessment, treatment, and rehabilitation.

  Archives of physical medicine and rehabilitation 20050301

• Simple computer model for calculating and reporting 5-year osteoporotic fracture risk in postmenopausal women.

  Journal of women's health (2002) 20050301

• Rapid prevention of vertebral fractures associated with osteoporosis.

  Orthopedics 20050301

• [Effects of L-threonate on bone resorption by osteoclasts in vitro].

  Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition 20050301

• Glucocorticoid-induced osteoporosis: treatment options and guidelines.

  Current osteoporosis reports 20050301

• [Pharmacological treatment of osteitis deformans (Paget's bone disease)].

  Ugeskrift for laeger 20050227

• Reversal of HIV-1-associated osteoporosis with once-weekly alendronate.

  AIDS (London, England) 20050218

• Alendronate and risedronate: reports of severe bone, joint, and muscle pain.

  Archives of internal medicine 20050214

• [Effects of teriparatide and alendronate on bone mineral density of osteoporotic rats].

  Zhonghua yi xue za zhi 20050202

• Influence of fracture history and bone mineral density testing on the treatment of osteoporosis in two non-academic community centers.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20050201

• Protective effect of taurine against alendronate-induced gastric damage in rats.

  Fundamental & clinical pharmacology 20050201

• Alendronate in the treatment of low bone mass in steroid-treated boys with Duchennes muscular dystrophy.

  Archives of physical medicine and rehabilitation 20050201

• Teriparatide: new preparation. Osteoporosis: less well evaluated than alendronic acid.

  Prescrire international 20050201

• Trabecular bone microarchitecture after alendronate treatment of osteoporotic women.

  Current medical research and opinion 20050201

• Effect of oral alendronate on net bone ingrowth into canine cementless total hips.

  The Journal of arthroplasty 20050201

• Alendronate inhibits intraperitoneal dissemination in in vivo ovarian cancer model.

  Cancer research 20050115

• [FACT study: benefits of alendronate].

  MMW Fortschritte der Medizin 20050113

• [Long-term usefulness of alendronate confirmed. Bones still benefit even after 10 years].

  MMW Fortschritte der Medizin 20050113

• Synovitis induced by alendronic acid can present as acute carpal tunnel syndrome.

  BMJ (Clinical research ed.) 20050108

• Effects of alendronate on bone mineral density and bone metabolic markers in postmenopausal asthmatic women treated with inhaled corticosteroids.

  Metabolism: clinical and experimental 20050101

• Gastroprotective effect of leukotriene receptor blocker montelukast in alendronat-induced lesions of the rat gastric mucosa.

  Prostaglandins, leukotrienes, and essential fatty acids 20050101

• Comparison of zinc excretion and biochemical markers of bone remodelling in the assessment of the effects of alendronate and calcitonin on bone in postmenopausal osteoporosis.

  Clinical biochemistry 20050101

• Weekly alendronate-induced acute pseudogout.

  Rheumatology (Oxford, England) 20050101

• Biphasic anti-osteoclastic action of intravenous alendronate therapy in multiple myeloma bone disease.

  Journal of bone and mineral metabolism 20050101

• Treatment with once-weekly alendronate 70 mg compared with once-weekly risedronate 35 mg in women with postmenopausal osteoporosis: a randomized double-blind study.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20050101

• [Human parathyroid hormone (1-34) as a new therapeutic agent for osteoporosis].

  Clinical calcium 20050101

• Osteoporosis and amenorrhea in a young patient with von Hippel-Lindau disease.

  The Israel Medical Association journal : IMAJ 20050101

• Alendronate inhibits bone resorption at the bone-screw interface.

  Clinical orthopaedics and related research 20050101

• Differential effects of alendronate treatment on bone from growing osteogenesis imperfecta and wild-type mouse.

  Bone 20050101

• A comparison of oral and intravenous bisphosphonate therapy for children with osteogenesis imperfecta.

  Journal of pediatric endocrinology & metabolism : JPEM 20050101

• A systematic review of the effect of alendronate on bone mineral density in men.

  Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 20050101

• I am in my 60s and have been taking Fosamax for osteoporosis. I was recently diagnosed with osteo arthritis in my knees. Since Fosamax helps bones, could it do something for the bones in my knees?

  Health news (Waltham, Mass.) 20050101

• [Recent progress in osteoporosis research].

  Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics 20050101

• Clinical pharmacology of potent new bisphosphonates for postmenopausal osteoporosis.

  Treatments in endocrinology 20050101

• In vitro and in vivo equivalence studies of alendronate monosodium tablets.

  Arzneimittel-Forschung 20050101

• Alendronate-induced chemical laryngitis.

  The Journal of laryngology and otology 20050101

• Interleukin-18 (IL-18) and matrix metalloproteinase-9 (MMP-9) in post-menopausal osteoporosis.

  Archives of gerontology and geriatrics 20050101

• Alendronate therapy may be effective in the prevention of bone loss around titanium implants inserted in estrogen-deficient rats.

  Journal of periodontology 20050101

• Oral bisphosphonates to treat disuse osteopenia in children with disabilities: a case series.

  Journal of pediatric orthopedics 20050101

• Early changes in urinary cross-linked N-terminal telopeptides of type I collagen level correlate with 1-year response of lumbar bone mineral density to alendronate in postmenopausal Japanese women with osteoporosis.

  Journal of bone and mineral metabolism 20050101

• False negative bone scintigraphy in a patient with primary breast cancer: a possible transient phenomenon of bisphosphonate (alendronate) treatment.

  Tumori 20050101

• Effects of trans-resveratrol from Polygonum cuspidatum on bone loss using the ovariectomized rat model.

  Journal of medicinal food 20050101

• Treatment with oral biphosphonates can increase the sensitivity of sestamibi radionuclide imaging in patients with primary hyperparathyroidism.

  International journal of clinical pharmacology research 20050101

• Chondrosarcoma in Paget's disease of bone.

  Clinical and experimental rheumatology 20050101

• [Optimal osteoporosis strategy?].

  Krankenpflege Journal 20050101

• A case study on osteoporosis in a male athlete: looking beyond the usual suspects.

  Orthopedic nursing 20050101

• Is there a role for a random measurement of 24-hour urine calcium excretion in the determination of calcium supplementation in osteoporotic postmenopausal women using alendronate?

  Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20050101

• Low dose of oral alendronate decreases bone turnover in Japanese patients with Paget's disease of bone.

  Journal of bone and mineral metabolism 20050101

• Does alendronate reduce the risk of fracture in men? A meta-analysis incorporating prior knowledge of anti-fracture efficacy in women.

  BMC musculoskeletal disorders 20050101

• Formulation and evaluation of Alendronate Sodium gel for the treatment of bone resorptive lesions in Periodontitis.

  Drug delivery 20050101

• Optimizing administration of bisphosphonates in women with postmenopausal osteoporosis.

  Treatments in endocrinology 20050101

• Similar proportions of women lose bone mineral density with raloxifene or alendronate treatment.

  Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 20050101

• Monitoring alendronate and estradiol therapy with quantitative ultrasound and bone mineral density.

  Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 20050101

• Acute granulomatous interstitial nephritis secondary to bisphosphonate alendronate sodium.

  Renal failure 20050101

• Alendronate inhibits proliferation and invasion of human epidermoid carcinoma cells in vitro.

  Anticancer research 20050101

• Modulation of bone turnover by alfacalcidol and/or alendronate does not prevent glucocorticoid-induced osteoporosis in growing minipigs.

  Journal of bone and mineral metabolism 20050101

• Effects of combined elcatonin and alendronate treatment on the architecture and strength of bone in ovariectomized rats.

  Journal of bone and mineral metabolism 20050101

• Therapeutic effects of alendronate 35 mg once weekly and 5 mg once daily in Japanese patients with osteoporosis: a double-blind, randomized study.

  Journal of bone and mineral metabolism 20050101

• Alendronate improves vitamin D-resistant osteopenia triggered by gastrectomy in patients with gastric cancer followed long term.

  Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 20050101

• Effect of Korean oriental medicine extract on bone mass as compared with alendronate in ovariectomized rats.

  Journal of medicinal food 20050101

• Efficacy of oral alendronate in children with osteogenesis imperfecta.

  Journal of pediatric orthopedics 20050101

• Impact of alendronate on quality of life in children with osteogenesis imperfecta.

  Journal of pediatric orthopedics 20050101

• [Effects of alendronate on the markers of bone metabolic activity in postmenopausal women with osteoporosis].

  Medicinski pregled 20050101

• Alendronate/colecalciferol.

  Treatments in endocrinology 20050101

• Use of alendronate in the treatment of vitamin D intoxication in infants.

  The Turkish journal of pediatrics 20050101

• [Alendronate increases bone mineral density in patients with symptomatic primary hyperparathyroidism].

  Endokrynologia Polska 20050101

• Biphosphonate-induced radiographic changes in two pediatric patients with rheumatic diseases.

  Skeletal radiology 20041201

• Effects of alendronate on restoration of biomechanical properties of periodontium in replanted rat molars.

  Journal of periodontal research 20041201

• Characterization of tumor reactivity of human V gamma 9V delta 2 gamma delta T cells in vitro and in SCID mice in vivo.

  Journal of immunology (Baltimore, Md. : 1950) 20041201

• Pharmaceutical care and community pharmacists' understanding of bisphosphonate dosing information.

  Journal of clinical pharmacy and therapeutics 20041201

• Alendronate-induced colon ulcers: case report of a new clinical entity.

  Gastrointestinal endoscopy 20041201

• Effect of treatment with alendronate in osteogenesis imperfecta type I: a case report.

  The Keio journal of medicine 20041201

• Response to therapy with once-weekly alendronate 70 mg compared to once-weekly risedronate 35 mg in the treatment of postmenopausal osteoporosis.

  Current medical research and opinion 20041201

• Effect of alendronate on periodontal disease in postmenopausal women: a randomized placebo-controlled trial.

  Journal of periodontology 20041201

• [The prize and the value of osteoporosis treatment].

  Arquivos brasileiros de endocrinologia e metabologia 20041201

• Alendronate prevents collapse in mechanically loaded osteochondral grafts: a bone chamber study in rats.

  Acta orthopaedica Scandinavica 20041201

• Oral antiresorptive therapy.

  Current osteoporosis reports 20041201

• Transient osteoporosis of the navicular bone in a runner.

  Archives of orthopaedic and trauma surgery 20041101

• The relationship of antiresorptive drug use to structural findings and symptoms of knee osteoarthritis.

  Arthritis and rheumatism 20041101

• Role of alendronate in therapy for posttraumatic complex regional pain syndrome type I of the lower extremity.

  Arthritis and rheumatism 20041101

• Effects of vitamin K2 (menatetrenone) and alendronate on bone mineral density and bone strength in rats fed a low-magnesium diet.

  Bone 20041101

• Effects of combined systemic administration of low-dose doxycycline and alendronate on endotoxin-induced periodontitis in rats.

  Journal of periodontology 20041101

• Effects of alendronate on metacarpal and lumbar bone mineral density, bone resorption, and chronic back pain in postmenopausal women with osteoporosis.

  Clinical rheumatology 20041001

• Are there differences between men and women prescribed bisphosphonate therapy in canadian subspecialty osteoporosis practices?

  The Journal of rheumatology 20041001

• Prevention of postmenopausal bone loss: six-year results from the Early Postmenopausal Intervention Cohort Study.

  The Journal of clinical endocrinology and metabolism 20041001

• Osteoporosis management: out of subspecialty practice and into primary care.

  American family physician 20041001

• Pharmacologic prevention of osteoporotic fractures.

  American family physician 20041001

• Bisphosphonate therapy in polyostotic fibrous dysplasia.

  Indian pediatrics 20041001

• Treating osteoporosis in post-menopausal women: a case approach.

  Cleveland Clinic journal of medicine 20041001

• [Who are the candidates for the treatment by raloxifen ?].

  Clinical calcium 20041001

• [Measures for osteoporosis in the dermatological field--vitamin D3 and bisphosphonate].

  Clinical calcium 20041001

• New treatments for brittle bones.

  Annals of internal medicine 20040907

• Coming to grips with bone loss.

  Science (New York, N.Y.) 20040903

• Gaucher disease: alendronate disodium improves bone mineral density in adults receiving enzyme therapy.

  Blood 20040901

• Bone cancer pain: the effects of the bisphosphonate alendronate on pain, skeletal remodeling, tumor growth and tumor necrosis.

  Pain 20040901

• Effect of discontinuation of alendronate treatment and exercise on bone mass and physical fitness: 15-month follow-up of a randomized, controlled trial.

  Bone 20040901

• [Weekly Fosamax tablet is significantly more effective than risedronate daily, as results of the Head-to-Head Study show].

  Praxis 20040901

• In vitro toxicity of bisphosphonates on human neuroblastoma cell lines.

  Anti-cancer drugs 20040901

• Bioequivalence studies on bisphosphonates: the example of alendronate.

  Arzneimittel-Forschung 20040901

• Alendronate may protect against increased periodontitis-related bone loss in estrogen-deficient rats.

  Journal of periodontology 20040901

• Clinical significance of alendronate in postmenopausal type 2 diabetes mellitus.

  Diabetes & metabolism 20040901

• Management of osteoporosis: the Indian perspective.

  Clinical calcium 20040901

• Determinants of one-year response of lumbar bone mineral density to alendronate treatment in elderly Japanese women with osteoporosis.

  Yonsei medical journal 20040831

• [Are there differences in bisphosphonates? (interview by Dr. Beate Schumacher)].

  MMW Fortschritte der Medizin 20040805

• Osteoblast proliferation and maturation by bisphosphonates.

  Biomaterials 20040801

• Change in bone turnover and hip, non-spine, and vertebral fracture in alendronate-treated women: the fracture intervention trial.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20040801

• Randomized trial of effect of alendronate continuation versus discontinuation in women with low BMD: results from the Fracture Intervention Trial long-term extension.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20040801

• Images of interest. Gastrointestinal: esophagitis caused by alendronate.

  Journal of gastroenterology and hepatology 20040801

• Treatment of osteopenia and osteoporosis in renal transplant children and adolescents.

  Pediatric transplantation 20040801

• High-dose alendronate uncouples osteoclast and osteoblast function: a study in a rat spine pseudarthrosis model.

  Clinical orthopaedics and related research 20040801

• Bone safety of long-term bisphosphonate treatment.

  Current medical research and opinion 20040801

• Postmenopausal osteoporosis and alendronate.

  Maturitas 20040715

• Patients with osteoporosis prefer once weekly to once daily dosing with alendronate.

  Maturitas 20040715

• Ten years of alendronate treatment for osteoporosis in postmenopausal women.

  The New England journal of medicine 20040708

• Ten years of alendronate treatment for osteoporosis in postmenopausal women.

  The New England journal of medicine 20040708

• Ten years of alendronate treatment for osteoporosis in postmenopausal women.

  The New England journal of medicine 20040708

• Ten years of alendronate treatment for osteoporosis in postmenopausal women.

  The New England journal of medicine 20040708

• Bisphosphonates induce apoptosis of stromal tumor cells in giant cell tumor of bone.

  Calcified tissue international 20040701

• Prevention and management of osteoporosis in women with breast cancer and men with prostate cancer.

  Current oncology reports 20040701

• Prevention of bone loss in paraplegics over 2 years with alendronate.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20040701

• Recent important clinical trials of drugs in osteoporosis.

  Expert opinion on pharmacotherapy 20040701

• Effect of alendronate on bone mineral density and biochemical markers of bone turnover in type 2 diabetic women: the fracture intervention trial.

  Diabetes care 20040701

• Alendronate in primary hyperparathyroidism: a double-blind, randomized, placebo-controlled trial.

  The Journal of clinical endocrinology and metabolism 20040701

• Comment on Disintegration/dissolution profiles of copies of Fosamax (alendronate).

  Current medical research and opinion 20040701

• Osteomalacia: recovery of bone density.

  The New Zealand medical journal 20040618

• Alendronate inhibits urinary calcium microlith formation in a three-dimensional culture model.

  Urological research 20040601

• Cost effectiveness of alendronate for the treatment of male osteoporosis in Sweden.

  Bone 20040601

• Alendronate in the prevention of osteoporosis: 7-year follow-up.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20040601

• By the way, doctor. My wife is 80. In order to increase her bone calcium, she takes calcium citrate tablets. Her doctor now wants to put her on Aredia by IV injection every three months. Since this is not FDA approved, is it a good idea?

  Harvard health letter 20040601

• Alendronate-induced auditory hallucinations and visual disturbances.

  Pharmacotherapy 20040601

• Bone anabolic agents: the unanswered queries.

  Basic & clinical pharmacology & toxicology 20040601

• Prevention of glucocorticoid-induced osteoporosis.

  Southern medical journal 20040601

• Alendronate versus calcitriol for prevention of bone loss after cardiac transplantation.

  The New England journal of medicine 20040527

• Alendronate versus calcitriol for prevention of bone loss after cardiac transplantation.

  The New England journal of medicine 20040527

• Alendronate versus calcitriol for prevention of bone loss after cardiac transplantation.

  The New England journal of medicine 20040527

• Osteoporosis screening: time to take responsibility.

  Archives of internal medicine 20040524

• Bone mineral density thresholds for pharmacological intervention to prevent fractures.

  Archives of internal medicine 20040524

• [Risk of osteoporosis in postmenopausal women. When is bone density measurement indicated?].

  MMW Fortschritte der Medizin 20040520

• Alendronate regulates cell invasion and MMP-2 secretion in human osteosarcoma cell lines.

  Pediatric blood & cancer 20040501

• Differential effects of teriparatide on BMD after treatment with raloxifene or alendronate.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20040501

• Mucosal irritative and healing impairment action of risedronate in rat stomachs: comparison with alendronate.

  Journal of gastroenterology and hepatology 20040501

• Bisphosphonate treatment affects trabecular bone apparent modulus through micro-architecture rather than matrix properties.

  Journal of orthopaedic research : official publication of the Orthopaedic Research Society 20040501

• Long-term skeletal effects of recombinant human growth hormone (rhGH) alone and rhGH combined with alendronate in GH-deficient adults: a seven-year follow-up study.

  Clinical endocrinology 20040501

• Boosting brittle bones. Fosamax fends off osteoporosis long-term.

  Health news (Waltham, Mass.) 20040501

• Upper gastrointestinal and overall tolerability of alendronate once weekly in patients with osteoporosis: results of a randomized, double-blind, placebo-controlled study.

  Current medical research and opinion 20040501

• Long-term use of Fosamax sustains or continues increases in bone density.

  Report on medical guidelines & outcomes research 20040416

• Correspondence Re S. S. Virtanen et al., Alendronate inhibits invasion of PC-3 prostate cancer cells by affecting the mevalonate pathway. Cancer Res 2002;62:2708-14. Re K. Sawada et al., Alendronate inhibits lysophosphatidic acid-induced migration of human ovarian cancer cells by attenuating the activation of Rho. Cancer Res 2002;62:6015-20.

  Cancer research 20040415

• Chronic erosive and ulcerative oral lesions caused by incorrect administration of alendronate.

  Journal of the American Academy of Dermatology 20040401

• Alendronate produces greater effects than raloxifene on bone density and bone turnover in postmenopausal women with low bone density: results of EFFECT (Efficacy of FOSAMAX versus EVISTA Comparison Trial) International.

  Journal of internal medicine 20040401

• A randomized clinical trial comparing oral alendronate and intravenous pamidronate for the treatment of Paget's disease of bone.

  Bone 20040401

• Alendronic acid for antipsychotic-related osteopenia.

  The American journal of psychiatry 20040401

• Chronic recurrent multifocal osteomyelitis of the spine and mandible: case report and review of the literature.

  Pediatrics 20040401

• Secondary prevention of hip fractures in veterans: can we do better?

  Journal of the American Geriatrics Society 20040401

• The role of subchondral bone remodeling in osteoarthritis: reduction of cartilage degeneration and prevention of osteophyte formation by alendronate in the rat anterior cruciate ligament transection model.

  Arthritis and rheumatism 20040401

• Acute polyarthritis related to once-weekly alendronate in a woman with osteoporosis.

  The Journal of rheumatology 20040401

• Does the combination of alendronate and parathyroid hormone give a greater benefit than either agent alone in osteoporosis?

  Expert opinion on pharmacotherapy 20040401

• Putting evidence-based medicine into clinical practice: comparing anti-resorptive agents for the treatment of osteoporosis.

  Current medical research and opinion 20040401

• Pharmacological treatment of osteopenia induced by gastrectomy or ovariectomy in young female rats.

  Acta orthopaedica Scandinavica 20040401

• Peri-implant bone remodeling after total hip replacement combined with systemic alendronate treatment: a finite element analysis.

  Computer methods in biomechanics and biomedical engineering 20040401

• The effect of alendronate on resorption of the alveolar bone following tooth extraction.

  International journal of oral and maxillofacial surgery 20040401

• [Clinic effect of alendronate sodium treatment in osteoporosis patients with hip fracture].

  Zhonghua wai ke za zhi [Chinese journal of surgery] 20040322

• Decimal point--osteoporosis therapy at the 10-year mark.

  The New England journal of medicine 20040318

• Ten years' experience with alendronate for osteoporosis in postmenopausal women.

  The New England journal of medicine 20040318

• [Effects of different treatments for osteoporosis on prevention of fractures: toward and individualized and economic approach].

  Praxis 20040310

• Alendronate treatment of established primary osteoporosis in men: 3-year results of a prospective, comparative, two-arm study.

  Rheumatology international 20040301

• Osteoporosis: point-of-care testing.

  The Annals of pharmacotherapy 20040301

• Neuropsychological and emotional changes during simulated microgravity: effects of triiodothyronine alendronate, and testosterone.

  Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists 20040301

• Topical, single dose bisphosphonate treatment reduced bone resorption in a rat model for prosthetic loosening.

  Journal of orthopaedic research : official publication of the Orthopaedic Research Society 20040301

• Antiresorptive treatment of postmenopausal osteoporosis: review of randomized clinical studies and rationale for the Evista alendronate comparison (EVA) trial.

  Current medical research and opinion 20040301

• Myositis ossificans circumscripta of the knee improved by alendronate.

  Joint, bone, spine : revue du rhumatisme 20040301

• Does bone resorption inhibition affect the anabolic response to parathyroid hormone?

  Trends in endocrinology and metabolism: TEM 20040301

• Two markers complement each other in identifying risk.

  Circulation 20040224

• Alendronate versus calcitriol for the prevention of bone loss after cardiac transplantation.

  The New England journal of medicine 20040219

• Bone loss after cardiac transplantation.

  The New England journal of medicine 20040219

• [Data comparison of osteoporosis patients demonstrates nasal administration is not optimal].

  MMW Fortschritte der Medizin 20040212

• The use of intermittent human parathyroid hormone as a treatment for osteoporosis.

  Current rheumatology reports 20040201

• An update on bisphosphonates.

  Current rheumatology reports 20040201

• Effects of alendronate and hormone replacement therapy, alone and in combination, on bone mass and markers of bone turnover in elderly women with osteoporosis.

  The Journal of clinical endocrinology and metabolism 20040201

• Dose reduction and discontinuation of alendronate in postmenopausal osteoporotic women who were receiving estrogen therapy.

  Fertility and sterility 20040201

• Can the increase of bone mineral density following bisphosphonates treatments be explained by biomechanical considerations?

  Clinical biomechanics (Bristol, Avon) 20040201

• [Biphosphonates and intraocular inflammation].

  Archivos de la Sociedad Espanola de Oftalmologia 20040201

• Effects of bisphosphonates on joint damage and bone loss in rat adjuvant-induced arthritis.

  Inflammation research : official journal of the European Histamine Research Society ... [et al.] 20040201

• [Treatment of osteoporosis--a new paradigm].

  Nihon rinsho. Japanese journal of clinical medicine 20040201

• [Bone mass measurement and evaluation of therapeutical response].

  Nihon rinsho. Japanese journal of clinical medicine 20040201

• [AOS-100].

  Nihon rinsho. Japanese journal of clinical medicine 20040201

• [Cross-linked N-telopeptides of type I collagen(NTX)].

  Nihon rinsho. Japanese journal of clinical medicine 20040201

• [Serum beta-CTx(beta-CrossLaps)].

  Nihon rinsho. Japanese journal of clinical medicine 20040201

• [New guideline for the treatment of osteoporosis].

  Nihon rinsho. Japanese journal of clinical medicine 20040201

• [Treatment of osteoporosis with alendronate].

  Nihon rinsho. Japanese journal of clinical medicine 20040201

• [Fracture Intervention Trial I and II(alendronate)].

  Nihon rinsho. Japanese journal of clinical medicine 20040201

• [Treatment of osteoporosis combined with a bisphosphonate and vitamin D3].

  Nihon rinsho. Japanese journal of clinical medicine 20040201

• [Combination therapy of bisphosphonate and estrogen for osteoporosis].

  Nihon rinsho. Japanese journal of clinical medicine 20040201

• Compliance and satisfaction with raloxifene versus alendronate for the treatment of postmenopausal osteoporosis in clinical practice: An open-label, prospective, nonrandomized, observational study.

  Clinical therapeutics 20040201

• Effects of clodronate and alendronate on local and systemic changes in bone metabolism in rats with adjuvant arthritis.

  Inflammation 20040201

• [Comparison of early bone histomorphometric effects of parathormone and alendronate in osteoporotic women].

  Revue medicale de la Suisse romande 20040201

• Efficacy of intermittent low dose alendronate in Thai postmenopausal osteoporosis.

  Endocrine research 20040201

• Effects of parathyroid hormone and alendronate alone or in combination in osteoporosis.

  The New England journal of medicine 20040108

• Effects of parathyroid hormone and alendronate alone or in combination in osteoporosis.

  The New England journal of medicine 20040108

• Effects of parathyroid hormone and alendronate alone or in combination in osteoporosis.

  The New England journal of medicine 20040108

• Efficacy of alendronate in adults with cystic fibrosis with low bone density.

  American journal of respiratory and critical care medicine 20040101

• Effects of weekly administrations of alendronate+clodronate on young mouse tibia: localized action at the proximal growth plate.

  Calcified tissue international 20040101

• Dysmetabolic syndrome in a man with a novel mutation of the aromatase gene: effects of testosterone, alendronate, and estradiol treatment.

  The Journal of clinical endocrinology and metabolism 20040101

• The effect of alendronate sodium on spinal fusion: a rabbit model.

  The spine journal : official journal of the North American Spine Society 20040101

• Clinical performance of immunoreactive tartrate-resistant acid phosphatase isoform 5b as a marker of bone resorption.

  Bone 20040101

• Pregnancy-associated osteoporosis with vertebral fractures and scoliosis.

  Joint, bone, spine : revue du rhumatisme 20040101

• Effect of alendronate on osteoclast differentiation and bone volume in transplanted bone.

  Experimental animals 20040101

• As drug marketing pays off, my mother pays up.

  Health affairs (Project Hope) 20040101

• Octreotide ameliorates alendronate-induced gastric injury.

  Peptides 20040101

• Gaussian process modeling in conjunction with individual patient simulation modeling: a case study describing the calculation of cost-effectiveness ratios for the treatment of established osteoporosis.

  Medical decision making : an international journal of the Society for Medical Decision Making 20040101

• Comparison of risedronate to alendronate and calcitonin for early reduction of nonvertebral fracture risk: results from a managed care administrative claims database.

  Journal of managed care pharmacy : JMCP 20040101

• Parathyroid hormone.

  The Journal of the American Academy of Orthopaedic Surgeons 20040101

• Combination therapies for osteoporosis.

  Journal of the American Pharmacists Association : JAPhA 20040101

• Effects of D-003, a mixture of high molecular weight aliphatic acids from sugar cane wax, on bones from ovariectomized rats.

  Drugs under experimental and clinical research 20040101

• Once-weekly alendronate 70 mg and raloxifene 60 mg daily in the treatment of postmenopausal osteoporosis.

  Menopause (New York, N.Y.) 20040101

• Antiresorption therapy and reduction in fracture susceptibility in the osteoporotic elderly patient: open study.

  European review for medical and pharmacological sciences 20040101

• The effect of the bisphosphonate alendronate on viability of canine osteosarcoma cells in vitro.

  In vitro cellular & developmental biology. Animal 20040101

• Alendronate reduced vertebral fracture risk in postmenopausal Japanese women with osteoporosis: a 3-year follow-up study.

  Journal of bone and mineral metabolism 20040101

• Oral alendronate treatment for polyostotic fibrous dysplasia: a case report.

  Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association 20040101

• Alendronate reduces serum TNFalpha and IL-1beta, increases neutrophil counts, and improves bone mineral density and bone metabolism indices in patients with chronic idiopathic neutropenia (CIN)-associated osteopenia/osteoporosis.

  Journal of bone and mineral metabolism 20040101

• Alendronate and risedronate for the treatment of postmenopausal osteoporosis: clinical profiles of the once-weekly and once-daily dosing formulations.

  MedGenMed : Medscape general medicine 20040101

• Changes in bone density and turnover after alendronate or estrogen withdrawal.

  Menopause (New York, N.Y.) 20040101

• [Weekly and daily intake of alendronate: comparison of tolerance in osteoporosis treatment].

  Reumatizam 20040101

• Alendronate reduces bone resorption in HIV-associated osteopenia/osteoporosis.

  HIV clinical trials 20040101

• Health-economic comparison of three recommended drugs for the treatment of osteoporosis.

  International journal of clinical pharmacology research 20040101

• Effect of concurrent administration of alendronate sodium and retinol on development of changes in histomorphometric parameters of bones induced by ovariectomy in rats.

  Polish journal of pharmacology 20040101

• Effect of administration of alendronate sodium and retinol on the mechanical properties of the femur in ovariectomized rats.

  Polish journal of pharmacology 20040101

• An ongoing six-year innovative osteoporosis disease management program: challenges and success in an IPA physician group environment.

  Disease management : DM 20040101

• [Update 2004. Osteoporosis--management--current status].

  Krankenpflege Journal 20040101

• [Routine osteoporosis therapy].

  Krankenpflege Journal 20040101

• Drug therapy increases bone density in osteonecrosis of the femoral head in canines.

  Journal of surgical orthopaedic advances 20040101

• Randomized controlled trial of alendronate in airways disease and low bone mineral density.

  Chronic respiratory disease 20040101

• Gastrointestinal side effect profile due to the use of alendronate in the treatment of osteoporosis.

  Yonsei medical journal 20031230

• Liposomal alendronate inhibits systemic innate immunity and reduces in-stent neointimal hyperplasia in rabbits.

  Circulation 20031202

• Compliance with pharmacologic therapy for osteoporosis.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20031201

• Spectrophotometric determination of some drugs for osteoporosis.

  Chemical & pharmaceutical bulletin 20031201

• An investigation of the predictors of bone mineral density and response to therapy with alendronate in osteoporotic men.

  The Journal of clinical endocrinology and metabolism 20031201

• Successful treatment of multicentric reticulohistiocytosis with alendronate: evidence for a direct effect of bisphosphonate on histiocytes.

  Arthritis and rheumatism 20031201

• Tissue mineralization is increased following 1-year treatment with high doses of bisphosphonates in dogs.

  Bone 20031201

• Compliance of osteoporotic patients with different treatment regimens.

  The Israel Medical Association journal : IMAJ 20031201

• Comparative effects of treatment with etidronate and alendronate on bone resorption, back pain, and activities of daily living in elderly women with vertebral fractures.

  The Keio journal of medicine 20031201

• An approach to postmenopausal osteoporosis treatment: a case study review.

  Journal of the American Academy of Nurse Practitioners 20031201

• Osteoporosis management in the new millennium.

  Primary care 20031201

• Mechanisms of action of antiresorptive therapies of postmenopausal osteoporosis.

  Endocrine regulations 20031201

• Use of highly potent bisphosphonates in the treatment of osteoporosis.

  Current osteoporosis reports 20031201

• Prevalence and treatment of decreased bone density in renal transplant recipients: a randomized prospective trial of calcitriol versus alendronate.

  Transplantation 20031127

• Increased bone resorption and failure to respond to antiresorptive therapy in progressive dystrophic calcification.

  Calcified tissue international 20031101

• Transient osteoporosis of the navicular bone in a runner.

  Archives of orthopaedic and trauma surgery 20031101

• Treating osteoporosis with teriparatide: many unknowns?

  Issues in emerging health technologies 20031101

• The effect of alendronate on bone mineral density in the distal part of the femur and proximal part of the tibia after total knee arthroplasty.

  The Journal of bone and joint surgery. American volume 20031101

• [Effect of alendronate on periprosthetic bone loss after cemented primary total hip arthroplasty: a prospective randomized study].

  Revue de chirurgie orthopedique et reparatrice de l'appareil moteur 20031101

• [Cost-effectiveness of alendronate treatment of osteoporosis in Denmark. An economic evaluation based on the Fracture Intervention Trial].

  Ugeskrift for laeger 20031020

• [Osteoporosis medications. Bisphosphonates exceed the others].

  MMW Fortschritte der Medizin 20031016

• Aging bone and osteoporosis: strategies for preventing fractures in the elderly.

  Archives of internal medicine 20031013

• M-CSF, TNFalpha and RANK ligand promote osteoclast survival by signaling through mTOR/S6 kinase.

  Cell death and differentiation 20031001

• Adherence to bisphosphonates and hormone replacement therapy in a tertiary care setting of patients in the CANDOO database.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20031001

• Resistance exercise training and alendronate reverse glucocorticoid-induced osteoporosis in heart transplant recipients.

  The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20031001

• Alendronate is more effective than etidronate for increasing bone mass in osteopenic patients with primary biliary cirrhosis.

  The American journal of gastroenterology 20031001

• The mevalonate synthesis pathway as a therapeutic target in cancer.

  Clinical orthopaedics and related research 20031001

• Alendronate for the prevention of bone mineral loss during gonadotropin-releasing hormone agonist therapy.

  The Journal of reproductive medicine 20031001

• Effect of alendronate on bone ingrowth into porous tantalum and carbon fiber interbody devices: an experimental study on spinal fusion in pigs.

  Acta orthopaedica Scandinavica 20031001

• Parathyroid hormone plus alendronate--a combination that does not add up.

  The New England journal of medicine 20030925

• The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis.

  The New England journal of medicine 20030925

• The effects of parathyroid hormone, alendronate, or both in men with osteoporosis.

  The New England journal of medicine 20030925

• [Osteoporosis. Don't forget the men!].

  MMW Fortschritte der Medizin 20030911

• Effect of daily hormone therapy and alendronate use on bone mineral density in postmenopausal women.

  Fertility and sterility 20030901

• Effects of hormone therapy and alendronate on C-reactive protein, E-selectin, and sex hormone-binding globulin in osteoporotic women.

  Fertility and sterility 20030901

• Alendronate has a residual effect on bone mass in postmenopausal Danish women up to 7 years after treatment withdrawal.

  Bone 20030901

• Oral bisphosphonates in polyostotic fibrous dysplasia.

  Indian pediatrics 20030901

• A histopathological investigation on the effect of systemic administration of the bisphosphonate alendronate on resorptive phase following mucoperiosteal flap surgery in the rat mandible.

  Journal of periodontology 20030901

• [Backache and palmar eczema (SAPHO syndrome)].

  Deutsche medizinische Wochenschrift (1946) 20030822

• Early discontinuation of treatment for osteoporosis.

  The American journal of medicine 20030815

• [Osteoporosis therapy compared. More solid bones with bisphosphonates].

  MMW Fortschritte der Medizin 20030807

• Bisphosphonate resistance in Paget's disease of bone.

  Arthritis and rheumatism 20030801

• By the way, doctor. Is there any advantage to taking Foxamax with distilled water? The instructions say to take it with 'plain water'. The city water where I live is loaded with phosphates and other minerals, so I'm worried that my tap water doesn't meet the definition of 'plain water'.

  Harvard health letter 20030801

• Alendronate treatment in men with primary osteoporosis: a three-year longitudinal study.

  Calcified tissue international 20030801

• Two cases of monostotic Paget's disease: effects of bisphosphonate.

  Endocrine journal 20030801

• [Evidence-based therapy of osteoporosis--comment on DMW 17/2003].

  Deutsche medizinische Wochenschrift (1946) 20030725

• [Evidence-based assessment of therapeutic agents of osteoporosis. Bisphosphonates, SERM and basic therapy in front].

  MMW Fortschritte der Medizin 20030710

• A quantitative structure-activity relationship and pharmacophore modeling investigation of aryl-X and heterocyclic bisphosphonates as bone resorption agents.

  Journal of medicinal chemistry 20030703

• Pharmacovigilance study of alendronate in England.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20030701

• Bisphosphonates: new indications and methods of administration.

  Current opinion in rheumatology 20030701

• Osteoporosis options. Choose medication based on age, health, and family history.

  Health news (Waltham, Mass.) 20030701

• How myeloma cells escape bisphosphonate-mediated killing: development of specific resistance with preserved sensitivity to conventional chemotherapeutics.

  British journal of haematology 20030701

• Inhibition of mevalonate pathway is involved in alendronate-induced cell growth inhibition, but not in cytokine secretion from macrophages in vitro.

  European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20030701

• Preventive effects of sequential treatment with alendronate and 1 alpha-hydroxyvitamin D3 on bone mass and strength in ovariectomized rats.

  Bone 20030701

• Effect of alendronate and exercise on bone and physical performance of postmenopausal women: a randomized controlled trial.

  Bone 20030701

• Biochemical markers for prediction of 4-year response in bone mass during bisphosphonate treatment for prevention of postmenopausal osteoporosis.

  Bone 20030701

• Combined local application of tetracycline and bisphosphonate reduces alveolar bone resorption in rats.

  Journal of periodontology 20030701

• [Alendronate once a week].

  Ugeskrift for laeger 20030630

• [When do men's bones become brittle. A cause can be found only in every second patient].

  MMW Fortschritte der Medizin 20030612

• Identifying the osteopenic patient and preventing worsening of the disease.

  Current women's health reports 20030601

• Superficial gyrate erythema as a cutaneous reaction to alendronate for osteoporosis.

  Journal of the American Academy of Dermatology 20030601

• Alendronate for treatment of renal transplant patients with osteoporosis.

  Transplantation proceedings 20030601

• Risk of fracture and treatment to prevent osteoporosis-related fracture in postmenopausal women. A review.

  The Journal of reproductive medicine 20030601

• Early response to alendronate after treatment with etidronate in postmenopausal women with osteoporosis.

  The Keio journal of medicine 20030601

• [Influence of biphosphonates on the integration process of endosseous implants evaluated using single photon emission computerized tomography (SPECT)].

  Minerva stomatologica 20030601

• [Alendronate. Prevention and treatment of osteoporosis].

  Revue de l'infirmiere 20030601

• Canine cancellous bone microarchitecture after one year of high-dose bisphosphonates.

  Calcified tissue international 20030601

• Combination therapy with hormone replacement and alendronate for prevention of bone loss in elderly women: a randomized controlled trial.

  JAMA 20030521

• Fourier transform infrared imaging spectroscopy (FT-IRIS) of mineralization in bisphosphonate-treated oim/oim mice.

  Calcified tissue international 20030501

• New bone formation with teriparatide [human parathyroid hormone-(1-34)] is not retarded by long-term pretreatment with alendronate, estrogen, or raloxifene in ovariectomized rats.

  Endocrinology 20030501

• Prevention and treatment of glucocorticoid-induced osteoporosis: a comparison of calcitriol, vitamin D plus calcium, and alendronate plus calcium.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20030501

• [Fragility fracture and its control].

  Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics 20030501

• Alendronate daily, weekly in conventional tablets and weekly in enteric tablets: preliminary study on the effects in bone turnover markers and incidence of side effects.

  Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology 20030501

• Once weekly alendronate.

  Drugs of today (Barcelona, Spain : 1998) 20030501

• Month 3 and month 6 measurements of bone mineral density predict the annual outcome in postmenopausal women with osteoporosis in whom alendronate was added to long-term HRT.

  Maturitas 20030425

• [Osteoporosis in men].

  Deutsche medizinische Wochenschrift (1946) 20030425

• [Rehabilitation in osteoporosis].

  Deutsche medizinische Wochenschrift (1946) 20030425

• Alendronate prevents loss of bone density associated with discontinuation of hormone replacement therapy: a randomized controlled trial.

  Archives of internal medicine 20030414

• Oral bisphosphonate therapy for vitamin D intoxication of the infant.

  Pediatrics 20030401

• A rat model for testing pharmacologic treatments of pressure-related bone loss.

  Clinical orthopaedics and related research 20030401

• Therapeutic equivalence of alendronate 35 milligrams once weekly and 5 milligrams daily in the prevention of postmenopausal osteoporosis.

  Obstetrics and gynecology 20030401

• Changes in bone mineral density following discontinuation or continuation of alendronate therapy in glucocorticoid-treated patients: a retrospective, observational study.

  Arthritis and rheumatism 20030401

• Osteoporosis in men.

  American family physician 20030401

• Canadian consensus on osteoporosis. Preventing osteoporosis among postmenopausal women.

  Canadian family physician Medecin de famille canadien 20030401

• Treatment of children with Osteogenesis imperfecta in Estonia.

  Acta paediatrica (Oslo, Norway : 1992) 20030401

• [Osteoporosis therapy. Bisphosphonates compared].

  MMW Fortschritte der Medizin 20030327

• Alendronate and etidronate do not regulate interleukin 6 and 11 synthesis in normal human osteoblasts in culture.

  Calcified tissue international 20030301

• Effectiveness of alendronate treatment in postmenopausal women with osteoporosis: relationship with BsmI vitamin D receptor genotypes.

  Clinical endocrinology 20030301

• Efficacy of teriparatide and alendronate on nonvertebral fractures.

  The Journal of clinical endocrinology and metabolism 20030301

• Alendronate affects long bone length and growth plate morphology in the oim mouse model for Osteogenesis Imperfecta.

  Bone 20030301

• No effects of bisphosphonates on the human fetus.

  Birth defects research. Part A, Clinical and molecular teratology 20030301

• Response to alendronate in osteoporotic women previously treated with pamidronate.

  Maturitas 20030225

• Effects of risedronate, alendronate, and etidronate on the viability and activity of rat bone marrow stromal cells in vitro.

  Calcified tissue international 20030201

• Diagnosis and management of treatment-related osteoporosis in men with prostate carcinoma.

  Cancer 20030201

• High Court strikes down Merck's patent on alendronate.

  BMJ (Clinical research ed.) 20030201

• Antagonistic effects of different classes of bisphosphonates in osteoclasts and macrophages in vitro.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20030201

• Oral alendronate increases bone mineral density in postmenopausal women with primary hyperparathyroidism.

  The Journal of clinical endocrinology and metabolism 20030201

• The effects of alendronate and calcitonin on cytokines in postmenopausal osteoporosis: a 6-month randomized and controlled study.

  Yonsei medical journal 20030201

• [Clinical trials of alendronate].

  Nihon rinsho. Japanese journal of clinical medicine 20030201

• [Treatment of osteoporosis provided from the orthopaedic surgeon's standpoint].

  Nihon rinsho. Japanese journal of clinical medicine 20030201

• Aggressive systemic mastocytosis.

  Joint, bone, spine : revue du rhumatisme 20030201

• Role of gastric mucosal and gastric juice cytokine concentrations in development of bisphosphonate damage to gastric mucosa.

  Digestive diseases and sciences 20030201

• Drug eruption due to alendronate sodium hydrate.

  Contact dermatitis 20030201

• Bisphosphonate mucosal injury--the end of the story?

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20030201

• In vivo rat assay: bone remodeling and steroid effects on juvenile bone by pQCT quantification in 7 days.

  American journal of physiology. Endocrinology and metabolism 20030101

• Dispensing error leading to alendronate ingestion.

  The Annals of pharmacotherapy 20030101

• A cost effectiveness analysis of calcium and vitamin D supplementation, etidronate, and alendronate in the prevention of vertebral fractures in women treated with glucocorticoids.

  The Journal of rheumatology 20030101

• Alendronate interacts with the inhibitory effect of 1,25(OH)2D3 on parathyroid hormone-related protein expression in human osteoblastic cells.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20030101

• Hadju-Cheney syndrome: response to therapy with bisphosphonates in two patients.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20030101

• The inhibitory effect of alendronate and taurine on osteoclast differentiation mediated by Porphyromonas gingivalis sonicates in vitro.

  Journal of endodontics 20030101

• Disability after clinical fracture in postmenopausal women with low bone density: the fracture intervention trial (FIT).

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20030101

• The effects of alendronate in postmenopausal women with osteoporosis.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20030101

• The influence of alendronate on bone formation and resorption in a rat ectopic bone development model.

  Journal of periodontology 20030101

• Cost effectiveness of alendronate (fosamax) for the treatment of osteoporosis and prevention of fractures.

  PharmacoEconomics 20030101

• The effect of alendronate sodium on alveolar bone loss in periodontitis (clinical trial).

  Journal of the International Academy of Periodontology 20030101

• Effects of alendronate on the removal torque of implants in rats with induced osteoporosis.

  The International journal of oral & maxillofacial implants 20030101

• Analytical and clinical evaluation of the Bio-Rad HPLC kit for measurement of type I collagen cross links.

  Journal of bone and mineral metabolism 20030101

• Therapeutic options: an evidence-based approach to prevention and treatment of osteoporosis.

  International journal of fertility and women's medicine 20030101

• Treatment of osteoporosis: combination therapies.

  International journal of fertility and women's medicine 20030101

• Direct-to-consumer marketing of osteoporosis drugs and bone densitometry.

  The Annals of pharmacotherapy 20030101

• A case of gonadal dysgenesis, breast development, Graves' disease, and low bone mass.

  Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 20030101

• Hypophosphatemic rickets and osteomalacia in polyostotic fibrous dysplasia.

  Journal of pediatric endocrinology & metabolism : JPEM 20030101

• Synthesis and evaluation of water-soluble polymeric bone-targeted drug delivery systems.

  Bioconjugate chemistry 20030101

• Comparison of change in bone resorption and bone mineral density with once-weekly alendronate and daily risedronate: a randomised, placebo-controlled study.

  Current medical research and opinion 20030101

• Monitoring response to osteoporosis therapy with alendronate by a multisite ultrasound device: a prospective study.

  Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 20030101

• [Simulation through the method of finite element of alendronate in a model of bone remodeling based on damage mechanics].

  Acta cientifica venezolana 20030101

• Effect of alendronate on bone mineral density and bone turnover in Thai postmenopausal osteoporosis.

  Journal of bone and mineral metabolism 20030101

• Modeling the annual costs of postmenopausal prevention therapy: raloxifene, alendronate, or estrogen-progestin therapy.

  Journal of managed care pharmacy : JMCP 20030101

• An opportunity for medication risk reduction, healthcare provider collaboration, and improved patient care: a retrospective analysis of osteoporosis management.

  Journal of the American Medical Directors Association 20030101

• [Bone mineralization and mineral status].

  Therapie 20030101

• Disintegration/dissolution profiles of copies of Fosamax (alendronate).

  Current medical research and opinion 20030101

• What predicts early fracture or bone loss on bisphosphonate therapy?

  Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 20030101

• Testing an intervention for preventing osteoporosis in postmenopausal breast cancer survivors.

  Journal of nursing scholarship : an official publication of Sigma Theta Tau International Honor Society of Nursing 20030101

• Combining PTH and alendronate: no advantage for boosting bone density.

  FDA consumer 20030101

• The effect of alendronate in the treatment of postmenopausal osteoporosis.

  Bratislavske lekarske listy 20030101

• [Bisphosphonates in the prevention of vertebral and non-vertebral fractures in postmenopausal women with osteoporosis].

  Reumatizam 20030101

• Hip fracture patients are not treated for osteoporosis: a call to action.

  Arthritis and rheumatism 20021215

• Significant differential effects of alendronate, estrogen, or combination therapy on the rate of bone loss after discontinuation of treatment of postmenopausal osteoporosis. A randomized, double-blind, placebo-controlled trial.

  Annals of internal medicine 20021203

• Summaries for patients. Bone loss after stopping estrogen or alendronate therapy.

  Annals of internal medicine 20021203

• Effect of alendronate on periprosthetic bone loss after total knee arthroplasty: a one-year, randomized, controlled trial of 19 patients.

  Calcified tissue international 20021201

• Bilateral acute anterior uveitis after alendronate.

  The British journal of ophthalmology 20021201

• Seizures after alendronate.

  Journal of the Royal Society of Medicine 20021201

• Raloxifene, estrogen, and alendronate affect the processes of fracture repair differently in ovariectomized rats.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20021201

• Alendronate in the prevention of bone loss after a fracture of the lower leg.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20021201

• Drug-induced prevention of gastrectomy- and ovariectomy-induced osteopaenia in the young female rat.

  The Journal of endocrinology 20021201

• Medications for postmenopausal osteoporosis prevention.

  Harvard women's health watch 20021201

• [Pharmacotherapy of osteoporosis].

  Nihon yakurigaku zasshi. Folia pharmacologica Japonica 20021201

• [Pharmacological and clinical properties of alendronate sodium hydrate].

  Nihon yakurigaku zasshi. Folia pharmacologica Japonica 20021201

• Risedronate prevents hip fractures, but who should get therapy?

  Cleveland Clinic journal of medicine 20021201

• [Osteoporosis].

  Der Internist 20021201

• Effects of alendronate on structural properties of trabecular bone in dogs.

  Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih 20021201

• [Osteoporosis: prevention of bone loss and fractures].

  MMW Fortschritte der Medizin 20021128

• [Convenient, effective and well accepted. The weekly pill against osteoporosis].

  MMW Fortschritte der Medizin 20021107

• Alendronate treatment for infants with osteogenesis imperfecta: demonstration of efficacy in a mouse model.

  Pediatric research 20021101

• Two-year results of once-weekly administration of alendronate 70 mg for the treatment of postmenopausal osteoporosis.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20021101

• Alendronate inhibits lysophosphatidic acid-induced migration of human ovarian cancer cells by attenuating the activation of rho.

  Cancer research 20021101

• Effects of short-term alendronate treatment on the three-dimensional microstructural, physical, and mechanical properties of dog trabecular bone.

  Bone 20021101

• Patient preference for once-weekly alendronate 70 mg versus once-daily alendronate 10 mg: a multicenter, randomized, open-label, crossover study.

  Clinical therapeutics 20021101

• [An elderly case suspected of familial hypocalciuric hypercalcemia subsequent to manifestation of hypercalcemia].

  Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics 20021101

• [Weeks of pain, vertebral body fractures during sleep, invalidism. Save your osteoporosis patients from this fate].

  MMW Fortschritte der Medizin 20021031

• [Patients evaluate osteoporosis therapy. Once a week is preferred].

  MMW Fortschritte der Medizin 20021003

• Osteoporotic fractures in older women.

  Current women's health reports 20021001

• Skeletal lead release during bone resorption: effect of bisphosphonate treatment in a pilot study.

  Environmental health perspectives 20021001

• Alendronate in the treatment of primary hyperparathyroid-related osteoporosis: a 2-year study.

  The Journal of clinical endocrinology and metabolism 20021001

• A randomized double-blind trial to compare the efficacy of teriparatide [recombinant human parathyroid hormone (1-34)] with alendronate in postmenopausal women with osteoporosis.

  The Journal of clinical endocrinology and metabolism 20021001

• Bisphosphonates and the upper gastrointestinal tract: skeletal gain without visceral pain?

  Mayo Clinic proceedings 20021001

• Tolerability of once-weekly alendronate in patients with osteoporosis: a randomized, double-blind, placebo-controlled study.

  Mayo Clinic proceedings 20021001

• New bone drug benefit. Less skeletal lead released.

  Environmental health perspectives 20021001

• Re: Famularo--esophageal perforation in a patient with esophageal diverticulum on daily alendronate.

  The American journal of gastroenterology 20021001

• Progression of coronary artery calcification in patients taking alendronate for osteoporosis.

  Academic radiology 20021001

• [Prediction of changes in bone density during alendronate treatment in postmenopausal women].

  Vnitrni lekarstvi 20021001

• [Alendronate in postmenopausal women with osteopenia and osteoporosis: effects on bone mineral density during treatment and after withdrawal].

  Zhonghua yi xue za zhi 20020925

• Physiological and morphological effects of alendronate on rabbit esophageal epithelium.

  American journal of physiology. Gastrointestinal and liver physiology 20020901

• Long-term predictions of the therapeutic equivalence of daily and less than daily alendronate dosing.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20020901

• 14 day endoscopy study comparing risedronate and alendronate in postmenopausal women stratified by Helicobacter pylori status.

  The Journal of rheumatology 20020901

• Bisphosphonate mechanism of action.

  Current molecular medicine 20020901

• Alendronate increases bone mineral density in long-term renal transplant recipients.

  Transplantation proceedings 20020901

• Successful treatment of dysphagia in Paget's disease of the bone.

  Digestive diseases and sciences 20020901

• Intravenous pamidronate compared with oral alendronate for the treatment of postmenopausal osteoporosis.

  The Netherlands journal of medicine 20020901

• The values of urinary NTx in postmenopausal women undergoing HRT; the role of additional alendronate therapy.

  Maturitas 20020830

• Bisphosphonates.

  Maturitas 20020830

• Changes in markers of bone turnover and inflammatory variables during alendronate therapy in pediatric patients with rheumatic diseases.

  The Journal of rheumatology 20020801

• Bisphosphonates in the treatment of thalassemia-induced osteoporosis.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20020801

• What the gastroenterologist should know about the gastrointestinal safety profiles of bisphosphonates.

  Digestive diseases and sciences 20020801

• Meta-analyses of therapies for postmenopausal osteoporosis. II. Meta-analysis of alendronate for the treatment of postmenopausal women.

  Endocrine reviews 20020801

• Osteoporosis in elderly: prevention and treatment.

  Clinics in geriatric medicine 20020801

• [Osteoporosis therapy. A comparison of bisphosphonates].

  MMW Fortschritte der Medizin 20020711

• Bone origin of the serum complex of calcium, phosphate, fetuin, and matrix Gla protein: biochemical evidence for the cancellous bone-remodeling compartment.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20020701

• A urine midmolecule osteocalcin assay shows higher discriminatory power than a serum midmolecule osteocalcin assay during short-term alendronate treatment of osteoporotic patients.

  Bone 20020701

• New anabolic therapies in osteoporosis.

  Current opinion in rheumatology 20020701

• Bisphosphonates and periodontics: potential applications for regulation of bone mass in the periodontium and other therapeutic/diagnostic uses.

  Journal of periodontology 20020701

• Curative effect of combined treatment with alendronate and 1 alpha-hydroxyvitamin D3 on bone loss by ovariectomy in aged rats.

  Japanese journal of pharmacology 20020701

• [Long-term insurance for the bones. Effective and safe over 7 years].

  MMW Fortschritte der Medizin 20020620

• Spectrophotometric determination of alendronate in pharmaceutical formulations via complex formation with Fe(III) ions.

  Journal of pharmaceutical and biomedical analysis 20020615

• Case 26-2001: scleroderma renal crisis and polymyositis.

  The New England journal of medicine 20020613

• Effect of bisphosphonates on cartilage turnover assessed with a newly developed assay for collagen type II degradation products.

  Annals of the rheumatic diseases 20020601

• Alendronate increases bone mass and reduces bone markers in postmenopausal African-American women.

  The Journal of clinical endocrinology and metabolism 20020601

• Effect of insulin-like growth factor-1 (IGF-1) plus alendronate on bone density during puberty in IGF-1-deficient MIDI mice.

  Bone 20020601

• Efficacy and safety of alendronate for the treatment of osteoporosis in diffuse connective tissue diseases in children.

  Clinical pediatrics 20020601

• No major effect of estrogen receptor beta gene RsaI polymorphism on bone mineral density and response to alendronate therapy in postmenopausal osteoporosis.

  The Journal of steroid biochemistry and molecular biology 20020601

• [The efficacy of alendronate in the prevention and treatment of postmenopausal osteoporosis].

  Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae 20020601

• Inhibitory action of bisphosphonates on bone resorption does not involve the regulation of RANKL and OPG expression.

  Experimental & molecular medicine 20020531

• Do bisphosphonates reduce the risk of osteoporotic fractures? An evaluation of the evidence to date.

  CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20020528

• Nonhealing gastric ulcer caused by chronic alendronate administration.

  MedGenMed : Medscape general medicine 20020522

• Alendronate improves bone mineral density in elderly women with osteoporosis residing in long-term care facilities. A randomized, double-blind, placebo-controlled trial.

  Annals of internal medicine 20020521

• Summaries for patients. Alendronate improves osteoporosis in elderly women living in long-term care facilities.

  Annals of internal medicine 20020521

• Alendronate inhibits invasion of PC-3 prostate cancer cells by affecting the mevalonate pathway.

  Cancer research 20020501

• Lymphoplasmacytoid lymphoma presenting as severe osteoporosis.

  American journal of hematology 20020501

• Weekly dose of osteoporosis drug.

  The American journal of nursing 20020501

• Alendronate-induced lichen planus.

  The Israel Medical Association journal : IMAJ 20020501

• The impact of bone turnover and bone-active agents on bone quality: focus on the hip.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20020501

• Heel ultrasonography in monitoring alendronate therapy: a four-year longitudinal study.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20020501

• Systemic medications: clinical significance in periodontics.

  Journal of clinical periodontology 20020501

• The gastrointestinal tolerability and safety of oral bisphosphonates.

  Expert opinion on drug safety 20020501

• [Convenient and well-tolerated therapy of osteoporosis. Preventing fractures only once a week].

  MMW Fortschritte der Medizin 20020425

• A 60-year-old woman trying to discontinue hormone replacement therapy.

  JAMA 20020424

• Gastric and duodenal safety of daily alendronate.

  Archives of internal medicine 20020422

• Promotion of osteoclast survival and antagonism of bisphosphonate-induced osteoclast apoptosis by glucocorticoids.

  The Journal of clinical investigation 20020415

• Synthesis, characterization and biodistribution of bisphosphonates Sm-153 complexes: correlation with molecular modeling interaction studies.

  Nuclear medicine and biology 20020401

• Effect of estrogen replacement plus low-dose alendronate treatment on bone density in surgically postmenopausal women with osteoporosis.

  The Journal of clinical endocrinology and metabolism 20020401

• Synergism of aminobisphosphonates and farnesyl transferase inhibitors on tumor metastasis.

  Clinical orthopaedics and related research 20020401

• Prevent corticosteroid-induced osteoporosis.

  The Nurse practitioner 20020401

• Combination treatment of osteoporosis: a clinical review.

  Journal of women's health & gender-based medicine 20020401

• Once-weekly treatment for osteoporosis.

  Hospital medicine (London, England : 1998) 20020401

• Transduction of cell survival signals by connexin-43 hemichannels.

  The Journal of biological chemistry 20020308

• For osteoporosis, are two antiresorptive drugs better than one?

  The Journal of clinical endocrinology and metabolism 20020301

• Additive effects of raloxifene and alendronate on bone density and biochemical markers of bone remodeling in postmenopausal women with osteoporosis.

  The Journal of clinical endocrinology and metabolism 20020301

• Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs.

  The American journal of medicine 20020301

• Nongranulomatous anterior uveitis associated with alendronate therapy.

  Investigacion clinica 20020301

• Use of a peripheral dexa measurement for osteoporosis screening.

  Family medicine 20020301

• Alendronate in the treatment of avascular necrosis of the hip.

  Rheumatology (Oxford, England) 20020301

• Alendronate reduces the risk of multiple symptomatic fractures: results from the fracture intervention trial.

  Journal of the American Geriatrics Society 20020301

• [Advancement of treatment for osteoporosis].

  Nihon rinsho. Japanese journal of clinical medicine 20020301

• [Bone densitometry: its clinical application and current status].

  Nihon rinsho. Japanese journal of clinical medicine 20020301

• [Comparative analyses on osteoporosis guidelines in Japan, EU and USA].

  Nihon rinsho. Japanese journal of clinical medicine 20020301

• [Treatment of male osteoporosis].

  Nihon rinsho. Japanese journal of clinical medicine 20020301

• [Bisphosphonates: pharmacology and use in the treatment of osteoporosis].

  Nihon rinsho. Japanese journal of clinical medicine 20020301

• [Alendronate in the treatment of osteoporosis].

  Nihon rinsho. Japanese journal of clinical medicine 20020301

• Treatment of male osteoporosis: recent advances with alendronate.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20020301

• Use of phalangeal bone mineral density and multi-site speed of sound conduction to monitor therapy with alendronate in postmenopausal women.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20020301

• Determination of alendronate in human urine as 9-fluorenylmethyl derivative by high-performance liquid chromatography.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20020205

• Sintered dicalcium pyrophosphate increases bone mass in ovariectomized rats.

  Journal of biomedical materials research 20020201

• Pharmacokinetic and pharmacodynamic evaluation of intermittent versus continuous alendronate administration in rats.

  Journal of pharmaceutical sciences 20020201

• Alendronate does not inhibit early bone apposition to hydroxyapatite-coated total joint implants: a preliminary study.

  The Journal of bone and joint surgery. American volume 20020201

• Effects of alendronate on particle-induced osteolysis in a rat model.

  The Journal of bone and joint surgery. American volume 20020201

• Bisphosphonates for prevention of postmenopausal osteoporosis.

  Danish medical bulletin 20020201

• [Severe acute hepatitis induced by alendronate].

  Gastroenterologie clinique et biologique 20020201

• Identification of a bisphosphonate that inhibits isopentenyl diphosphate isomerase and farnesyl diphosphate synthase.

  Biochemical and biophysical research communications 20020118

• Alendronate: suspected pancreatitis.

  CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20020108

• Case of the month. Osteoporosis in a postmenopausal woman.

  The Journal of the Arkansas Medical Society 20020101

• Alendronate increases bone density in chronic spinal cord injury: a case report.

  Archives of physical medicine and rehabilitation 20020101

• The upper GI safety and tolerability of oral alendronate at a dose of 70 milligrams once weekly: a placebo-controlled endoscopy study.

  The American journal of gastroenterology 20020101

• Inhibition of particulate debris-induced osteolysis by alendronate in a rat model.

  Orthopedics 20020101

• [Toxicoderma associated with alendronate].

  Atencion primaria 20020101

• Osteoporosis.

  The American journal of nursing 20020101

• Development of a synthetic peptide-based tartrate-resistant acid phosphatase radioimmunoassay for the measurement of bone resorption in rat serum.

  Journal of bone and mineral metabolism 20020101

• [Dose-dependent prevention of early periprosthetic bone loss by alendronate].

  Zeitschrift fur Orthopadie und ihre Grenzgebiete 20020101

• Alendronate disturbs vesicular trafficking in osteoclasts.

  Calcified tissue international 20020101

• Reduction of instability-induced bone resorption using bisphosphonates: high doses are needed in rats.

  Acta orthopaedica Scandinavica 20020101

• The underuse of therapy in the secondary prevention of hip fractures.

  Drugs & aging 20020101

• Effect of two forms of alendronate administration upon bone mass after two years of treatment.

  Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 20020101

• Alendronate and pharmacological doses of 1alpha OHD3 therapy in a patient with McCune-Albright syndrome and accompanying hypophosphatemia.

  Journal of bone and mineral metabolism 20020101

• Treatment of osteoporosis and osteopenia in long-term renal transplant patients with alendronate.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20020101

• Chemotherapy did not enhance the anti-osteolytic effects of bisphosphonate in multiple myeloma bone disease.

  Journal of bone and mineral metabolism 20020101

• Alendronate and risedronate: what you need to know about their upper gastrointestinal tract toxicity.

  Reviews in gastroenterological disorders 20020101

• Transport of inorganic phosphate in primary cultures of chondrocytes isolated from the tibial growth plate of normal adolescent chickens.

  Journal of cellular biochemistry 20020101

• Long-term tolerability of the bisphosphonates in postmenopausal osteoporosis: a comparative review.

  Drug safety 20020101

• Influence of new evidence on prescription patterns.

  The Journal of the American Board of Family Practice 20020101

• A review of combination regimens for osteoporosis--prevention and treatment.

  International journal of fertility and women's medicine 20020101

• Insufficiency fracture of the femoral neck during osteoporosis treatment: a case report.

  Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association 20020101

• Changes in bone remodeling rate influence the degree of mineralization of bone.

  Connective tissue research 20020101

• Osteoporosis treatment in elderly hyperthyroid male patients.

  Journal of endocrinological investigation 20020101

• Medical treatment of male osteoporosis.

  Journal of endocrinological investigation 20020101

• Prevention and treatment of osteoporosis.

  Clinical cornerstone 20020101

• [Ulcerative esophagitis associated with the use of alendronate sodium: histopathological and endoscopic features].

  Arquivos de gastroenterologia 20020101

• Parathyroid carcinoma: difficult management options.

  Indian journal of cancer 20020101

• [Quality of life of patients suffering from osteoporosis treated with alendronate and salmon calcitonin].

  Wiadomosci lekarskie (Warsaw, Poland : 1960) 20020101

• Alendronate for the prevention of bone loss in patients on inhaled steroid therapy.

  Bone 20011201

• A theoretical analysis of the contributions of remodeling space, mineralization, and bone balance to changes in bone mineral density during alendronate treatment.

  Bone 20011201

• Inhibition of bone resorption by alendronate and risedronate does not require osteoclast apoptosis.

  Bone 20011201

• A new monoclonal antibody ELISA for detection and characterization of C-telopeptide fragments of type I collagen in urine.

  Calcified tissue international 20011201

• Bisphosphonates for the treatment of postmenopausal osteoporosis: clinical studies of etidronate and alendronate.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20011201

• [Economic aspects of osteoporosis therapy. What does a prevented fracture cost?].

  MMW Fortschritte der Medizin 20011122

• Alendronate prevents further bone loss in renal transplant recipients.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20011101

• Tc99m-sestamibi uptake in osteitis fibrosa cystica simulating metastatic bone disease.

  The Journal of clinical endocrinology and metabolism 20011101

• Alendronate treatment of established primary osteoporosis in men: results of a 2-year prospective study.

  The Journal of clinical endocrinology and metabolism 20011101

• Role of alendronate and risedronate in preventing and treating osteoporosis.

  Cleveland Clinic journal of medicine 20011101

• Fatal esophageal perforation with alendronate.

  The American journal of gastroenterology 20011101

• Intermittent dosing of alendronate.

  The Annals of pharmacotherapy 20011101

• [Osteoporosis therapy with bisphosphonates. Once weekly is enough].

  MMW Fortschritte der Medizin 20011101

• Bisphosphonates: an overview with special reference to alendronate.

  Annals of clinical biochemistry 20011101

• The role of serial bone mineral density testing for osteoporosis.

  Journal of women's health & gender-based medicine 20011101

• Bisphosphonate treatment suppresses not only stochastic remodeling but also the targeted repair of microdamage.

  Calcified tissue international 20011101

• Do different aminobisphosphonates have similar preventive effect on experimental thyroid hormone-induced osteopenia in rats?

  Calcified tissue international 20011101

• [Alternatives to hormonal treatment for the prevention of postmenopausal osteoporosis: the bisphosphonates].

  Gynecologie, obstetrique & fertilite 20011101

• Prevention of bone loss and fracture after lung transplantation: a pilot study.

  Transplantation 20011015

• Comparison of alendronate, calcitonin and calcium treatments in postmenopausal osteoporosis.

  International journal of clinical practice 20011001

• Comparative efficacy and safety study of etidronate and alendronate in postmenopausal osteoporosis. effect of adding hormone replacement therapy.

  Joint, bone, spine : revue du rhumatisme 20011001

• Alendronate for the treatment of osteoporosis in men.

  Calcified tissue international 20011001

• Treatment of osteoporosis in men with fluoride alone or in combination with bisphosphonates.

  Calcified tissue international 20011001

• Tolerability of risedronate in postmenopausal women intolerant of alendronate.

  Aging (Milan, Italy) 20011001

• Vgamma2Vdelta2 T-cell receptor-mediated recognition of aminobisphosphonates.

  Blood 20010901

• Pharmacologic therapy for the treatment and prevention of osteoporosis.

  The Nursing clinics of North America 20010901

• Alendronate does not interfere with 99mTc-methylene diphosphonate bone scanning.

  Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20010901

• Bisphosphonate therapy for Paget's disease in a patient with hypoparathyroidism: profound hypocalcemia, rapid response, and prolonged remission.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20010901

• Update on alendronate for osteoporosis: once-weekly dosing.

  Expert opinion on pharmacotherapy 20010901

• Bisphosphonates for osteoporosis.

  Drug and therapeutics bulletin 20010901

• Risedronate: a new oral bisphosphonate.

  Clinical therapeutics 20010901

• The molecular mechanism of action of the antiresorptive and antiinflammatory drug clodronate: evidence for the formation in vivo of a metabolite that inhibits bone resorption and causes osteoclast and macrophage apoptosis.

  Arthritis and rheumatism 20010901

• Comparison of calcitonin, alendronate and fluorophosphate effects on ovariectomized rat bone.

  Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 20010901

• Study of alendronate in avascular necrosis of bone.

  The Journal of the Association of Physicians of India 20010901

• Alendronate treatment for osteoporosis in patients infected with human immunodeficiency virus.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20010801

• Effect of 17beta-estradiol or alendronate on the bone densitometry, bone histomorphometry and bone metabolism of ovariectomized rats.

  Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 20010801

• Effect of alendronate on bone mineral density in male idiopathic osteoporosis.

  Metabolism: clinical and experimental 20010801

• Alendronate increases degree and uniformity of mineralization in cancellous bone and decreases the porosity in cortical bone of osteoporotic women.

  Bone 20010801

• A controlled study of the effects of alendronate in a growing mouse model of osteogenesis imperfecta.

  Calcified tissue international 20010801

• When the patient knows best.

  The American journal of nursing 20010801

• [Bisphosphonates once weekly. Osteoporosis therapy becomes more effective].

  MMW Fortschritte der Medizin 20010726

• [Modern osteoporosis therapy. Only once weekly against osteoporosis].

  MMW Fortschritte der Medizin 20010719

• [Osteoporosis and multiple pregnancy--a case report with positive outcome].

  Medizinische Klinik (Munich, Germany : 1983) 20010715

• [Bisphosphonate treatment prevents hip fractures in 70-79 year old women with osteoporotic vertebral fractures].

  Nederlands tijdschrift voor geneeskunde 20010714

• Additional beneficial effects of alendronate in growth hormone (GH)-deficient adults with osteoporosis receiving long-term recombinant human GH replacement therapy: a randomized controlled trial.

  The Journal of clinical endocrinology and metabolism 20010701

• Male osteoporosis associated with longterm cyproterone treatment.

  The Journal of rheumatology 20010701

• Fosamax for HIV-related bone problems?

  TreatmentUpdate 20010701

• Estimating probability of non-response to treatment using mixture distributions.

  Statistics in medicine 20010630

• Osteoporosis in men.

  American family physician 20010615

• Osteoporosis.

  Tennessee medicine : journal of the Tennessee Medical Association 20010601

• Re: Lanza et al.--Endoscopic comparison of alendronate and risedronate.

  The American journal of gastroenterology 20010601

• Prevalence and determinants of osteoporosis drug prescription among patients with high exposure to glucocorticoid drugs.

  The American journal of managed care 20010601

• Medication update.

  Southern medical journal 20010601

• Effect of topical alendronate on root resorption of dried replanted dog teeth.

  Dental traumatology : official publication of International Association for Dental Traumatology 20010601

• Ocular adverse effects of alendronic acid.

  Prescrire international 20010601

• [Treatment of osteoporosis. Compliance is significantly enhanced].

  MMW Fortschritte der Medizin 20010531

• Absolute vs. relative numbers in evaluating drug therapy.

  American family physician 20010515

• New insight into calcinosis of juvenile dermatomyositis: a study of composition and treatment.

  The Journal of pediatrics 20010501

• Bisphosphonates alendronate and ibandronate inhibit artery calcification at doses comparable to those that inhibit bone resorption.

  Arteriosclerosis, thrombosis, and vascular biology 20010501

• Bones and Crohn's: should we treat Crohn's disease patients with alendronate?

  Inflammatory bowel diseases 20010501

• By the way, doctor. I recently heard that I can take Fosamax once a week for osteoporosis, rather than every day. Is it really effective when taken this way? Is there a downside?

  Harvard women's health watch 20010501

• [Alendronate-induced hepatocellular lesion].

  Gastroenterologia y hepatologia 20010501

• [Effects of aminobisphosphonates on the superior digestive tract mucosa].

  Acta gastroenterologica Latinoamericana 20010501

• [Esophagitis associated with use of alendronate in 5 postmenopausic patients].

  Acta gastroenterologica Latinoamericana 20010501

• [The treatment of osteoporosis and bone resorption of alveoli with alendronate in rat model].

  Zhonghua kou qiang yi xue za zhi = Zhonghua kouqiang yixue zazhi = Chinese journal of stomatology 20010501

• [Research and advertisement. Differences in the effectiveness of alendronate according to risk groups].

  Atencion primaria 20010430

• Short-term effects of three continuous hormone replacement therapy regimens on platelet tritiated imipramine binding and mood scores: a prospective randomized trial.

  Fertility and sterility 20010401

• Risk of ulcer soars with combination of arthritis drugs.

  The Western journal of medicine 20010401

• Fractures after long-term alendronate therapy.

  The Journal of clinical endocrinology and metabolism 20010401

• Consensus statement on the modern therapy of Paget's disease of bone from a Western Osteoporosis Alliance symposium. Biannual Foothills Meeting on Osteoporosis, Calgary, Alberta, Canada, September 9-10, 2000.

  Clinical therapeutics 20010401

• Once-a-week alendronate (Fosamax).

  The Medical letter on drugs and therapeutics 20010319

• Labelling of Re-ABP with 188Re for bone pain palliation.

  Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 20010301

• Effect of alendronate and MK-677 (a growth hormone secretagogue), individually and in combination, on markers of bone turnover and bone mineral density in postmenopausal osteoporotic women.

  The Journal of clinical endocrinology and metabolism 20010301

• Osteoporosis. Efficacy and safety of a bisphosphonate dosed once weekly.

  Geriatrics 20010301

• Managing menopause after breast cancer: balancing risks and benefits.

  Cleveland Clinic journal of medicine 20010301

• Alendronate and male osteoporosis.

  Canadian family physician Medecin de famille canadien 20010301

• Evidence-based medicine: putting theory into practice.

  Hospital medicine (London, England : 1998) 20010301

• Excretion of sweat and urine pyridinoline crosslinks in healthy controls and subjects with established metabolic bone disease.

  Clinical chemistry and laboratory medicine 20010301

• Response of cortical bone to antiresorptive treatment.

  Calcified tissue international 20010301

• Osteoporosis therapies for rheumatoid arthritis patients: minimizing gastrointestinal side effects.

  Seminars in arthritis and rheumatism 20010201

• Alendronate in rheumatoid arthritis patients treated with methotrexate and glucocorticoids.

  Rheumatology international 20010201

• Treatment of osteoporosis with bisphosphonates.

  Rheumatic diseases clinics of North America 20010201

• Clinical and radiological improvement of periodontal disease in patients with type 2 diabetes mellitus treated with alendronate: a randomized, placebo-controlled trial.

  Journal of periodontology 20010201

• Alendronate and naproxen are synergistic for development of gastric ulcers.

  Archives of internal medicine 20010108

• Effects of oral alendronate in elderly patients with osteoporosis and mild primary hyperparathyroidism.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20010101

• Bisphosphonate therapy in fibrous dysplasia.

  Clinical orthopaedics and related research 20010101

• Phosphate ions mediate chondrocyte apoptosis through a plasma membrane transporter mechanism.

  Bone 20010101

• Once-a-week alendronate for postmenopausal osteoporosis is as effective as once-daily dosing.

  Geriatrics 20010101

• Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: a randomized, double-blind, placebo-controlled extension trial.

  Arthritis and rheumatism 20010101

• What is the impact of osteoporosis education and bone mineral density testing for postmenopausal women in a managed care setting?

  Menopause (New York, N.Y.) 20010101

• Prevention of bone loss in kidney graft recipients.

  Transplantation proceedings 20010101

• Regression to the mean: what does it mean? Using bone density results to monitor treatment of osteoporosis.

  Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 20010101

• Comparison of bone and total alkaline phosphatase and bone mineral density in postmenopausal osteoporotic women treated with alendronate.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20010101

• Alendronate: an update of its use in osteoporosis.

  Drugs 20010101

• Alendronate influences bending force of femoral diaphysis after orchidectomy in rats.

  Annales chirurgiae et gynaecologiae 20010101

• Cost effectiveness of nasal calcitonin in postmenopausal women: use of Cochrane Collaboration methods for meta-analysis within economic evaluation.

  PharmacoEconomics 20010101

• [Radiopharmacokinetic and gammagraphic studies for calculating personalized dosimetry].

  Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion 20010101

• American Association of Clinical Endocrinologists 2001 Medical Guidelines for Clinical Practice for the Prevention and Management of Postmenopausal Osteoporosis.

  Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 20010101

• The effect of alendronate on fracture-related healthcare utilization and costs: the fracture intervention trial.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20010101

• The effect of alendronate (Fosamax) and implant surface on bone integration and remodeling in a canine model.

  Journal of biomedical materials research 20010101

• [Ethics and dementia in medical practice].

  Vertex (Buenos Aires, Argentina) 20010101

• Changes in bone remodeling rate influence the degree of mineralization of bone which is a determinant of bone strength: therapeutic implications.

  Advances in experimental medicine and biology 20010101

• [New aspects and opportunities in the clinical use of fosamax].

  Akusherstvo i ginekologiia 20010101

• [Esophagus-enteric anastomosis ulceration caused by alendronate].

  Arquivos de gastroenterologia 20010101

• [Patients with fractures are in the front line for osteoporosis treatment but how to treat?].

  Duodecim; laaketieteellinen aikakauskirja 20010101

• Apoptosis of osteoclast-like cells induced by alendronate is related to Fas gene expression.

  The Chinese journal of dental research : the official journal of the Scientific Section of the Chinese Stomatological Association (CSA) 20000801

• [Pain relief with alendronate therapy in a breast cancer patient with bone metastasis].

  Gan to kagaku ryoho. Cancer & chemotherapy 20000401

• Alendronate is a specific, nanomolar inhibitor of farnesyl diphosphate synthase.

  Archives of biochemistry and biophysics 20000101

• Long-term therapy for postmenopausal osteoporosis: stronger bones but weaker arteries.

  Circulation 19990727

• Ocular inflammation associated with alendronate therapy.

  Archives of ophthalmology (Chicago, Ill. : 1960) 19990601

• Pharmacokinetics of intravenous alendronate.

  Journal of clinical pharmacology 19990401

• Hepatitis after alendronate.

  The Netherlands journal of medicine 19981201

• Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including Ras.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 19980401

• Acute renal failure and alendronate.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 19971201

• Early responsiveness of women with osteoporosis to teriparatide after therapy with alendronate or risedronate.

  The Journal of clinical endocrinology and metabolism